TW201902451A - a dispersion containing a pigment or a dispersant for powder - Google Patents

a dispersion containing a pigment or a dispersant for powder Download PDF

Info

Publication number
TW201902451A
TW201902451A TW107112512A TW107112512A TW201902451A TW 201902451 A TW201902451 A TW 201902451A TW 107112512 A TW107112512 A TW 107112512A TW 107112512 A TW107112512 A TW 107112512A TW 201902451 A TW201902451 A TW 201902451A
Authority
TW
Taiwan
Prior art keywords
group
acid
membered ring
extract
carbon atoms
Prior art date
Application number
TW107112512A
Other languages
Chinese (zh)
Inventor
坂田瑞希
Original Assignee
日商日產化學工業股份有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 日商日產化學工業股份有限公司 filed Critical 日商日產化學工業股份有限公司
Publication of TW201902451A publication Critical patent/TW201902451A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04Dispersions; Emulsions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34Alcohols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/39Derivatives containing from 2 to 10 oxyalkylene groups
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/55Phosphorus compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64Proteins; Peptides; Derivatives or degradation products thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/86Polyethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00Make-up preparations; Body powders; Preparations for removing make-up

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Cosmetics (AREA)
  • Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)

Abstract

To provide: a dispersion liquid containing a pigment or powder, which is able to be prevented from separation and sedimentation of the pigment or the like over time; and a dispersant. A dispersion liquid which contains: a dispersant for pigments or powders, which is formed of a lipid peptide compound that is composed of at least one compound selected from among compounds represented by formula (1), analogous compounds thereof and pharmaceutically acceptable salts of these compounds; a surfactant; water; 1, 2-alkanediol or 1, 3-alkanediol; a fatty acid; and at least one substance selected from the group consisting of pigments and powders. Also disclosed is the above-described dispersant for pigments or powders. (In the formula, R1 represents an aliphatic group having 9 to 23 carbon atoms; R2 represents a hydrogen atom or an alkyl group having 1 to 4 carbon atoms, which may have a branched chain having 1 or 2 carbon atoms; R3 represents a -(CH2)n-X group; n represents a number of 1 to 4; and X represents an amino group, a guanidino group, a -CONH2 group, or a fused heterocyclic ring that is composed of a five-membered ring and/or a six-membered ring, which may have 1 to 3 nitrogen atoms.).

Description

含有顏料或粉體用分散劑之分散液Dispersion liquid containing dispersant for pigment or powder

本發明係有關一種含有顏料或粉體用分散劑之分散液,詳細而言,本發明係有關一種包含由脂質肽型化合物所成之顏料或粉體用分散劑之分散液及前述顏料或粉體用分散劑。The present invention relates to a dispersion liquid containing a dispersant for a pigment or a powder. In particular, the present invention relates to a dispersion liquid containing a dispersant for a pigment or a powder made of a lipid peptide compound and the aforementioned pigment or powder. Body Dispersant.

水性的組成物因使用於皮膚等時,可得到高的清涼感,相較於油性的組成物,使用後無黏膩,為清爽的使用感等,因此對於化妝料等用途有各種商品上市及提案。   例如作為固形狀的水性組成物,以往提案有包含水、脂肪酸皂、油分及粉末之固形狀水中油型(oil in water型)彩妝用化妝品(Make up Cosmetics)(專利文獻1)、含有烷基及/或烯基低聚糖苷(oligoglycosides)、油性物質、及非離子性乳化劑之條狀水性化妝品(專利文獻2)等。   又,液狀的水性組成物,以往提案有許多以水作為主成分且調配有保濕劑等之各種添加劑等的水性化妝料或、在油性成分與水性成分中調配有乳化劑之乳化型的組成物。 [先前技術文獻] [專利文獻]Water-based compositions have a high cooling sensation when used on the skin, etc. Compared to oil-based compositions, they have no stickiness after use and have a refreshing feel. Therefore, there are various products for cosmetics and other applications. proposal. For example, as a solid-shaped water-based composition, a solid-shaped oil-in-water-type make-up cosmetics (water-based fatty acid soap, oil component, and powder) including makeup (Patent Document 1) and an alkyl group have been proposed in the past. And / or strip-shaped aqueous cosmetics of oligoglycosides, oily substances, and nonionic emulsifiers (Patent Document 2) and the like. In addition, a liquid aqueous composition has conventionally been proposed as a water-based cosmetic containing water as a main component and various additives such as a moisturizing agent, or an emulsifying composition including an emulsifier in an oily component and an aqueous component. Thing. [Prior Art Literature] [Patent Literature]

[專利文獻1]日本特開平3-279319號公報   [專利文獻2]日本特表2002-516818號公報[Patent Document 1] Japanese Patent Application Laid-Open No. 3-279319 [Patent Document 2] Japanese Patent Application No. 2002-516818

[發明所欲解決之課題][Problems to be Solved by the Invention]

上述水性化妝料,雖提案有例如作為皮膚之彩色用,調配有各種顏料或粉體等之許多的製品,但是這種水性化妝料長期間靜置時,顏料、粉體會分離、沉降,有時產生硬的沉澱(hard cake)。   因此,檢討有藉由調配各種樹脂或增黏劑、分散劑等的添加劑,試圖使分散液安定化之提案,而需要更能抑制顏料或粉體之分離、沉降及彼等之凝聚或固化的技術提案。Although the above-mentioned water-based cosmetics are proposed to be used for coloring the skin, for example, many products such as various pigments or powders are prepared. However, when such water-based cosmetics are left standing for a long period of time, the pigments and powders may separate and settle. A hard cake was produced. Therefore, the review has proposed proposals to stabilize the dispersion by blending various additives such as resins, tackifiers, and dispersants, and it is necessary to further suppress the separation and sedimentation of pigments or powders and their aggregation or curing. Technical proposal.

本發明係基於上述情形而完成者,其欲解決的課題係提供在含有顏料或粉體之分散液中,可防止顏料等之隨著時間而分離、沉降的分散液及分散劑。 [用以解決課題之手段]The present invention has been completed based on the above-mentioned circumstances, and a problem to be solved is to provide a dispersion liquid and a dispersant which can prevent separation and sedimentation of pigments and the like over time in a dispersion liquid containing a pigment or powder. [Means to solve the problem]

本發明人等為了解決上述課題而精心研究的結果,發現可得到在將低分子脂質肽或其醫藥上可使用的鹽類所成之脂質肽型化合物作為顏料或粉體用分散劑使用的分散液中,抑制調配的顏料等之隨著時間而分離、沉降的分散液,而完成本發明。As a result of careful research by the present inventors in order to solve the above-mentioned problems, it has been found that a dispersion of a low-molecular-weight lipid peptide or a lipid-peptide compound formed from a pharmaceutically acceptable salt thereof can be used as a dispersant for pigments or powders. In the liquid, a dispersion liquid that suppresses separation and settling of a prepared pigment and the like with time is completed to complete the present invention.

換言之,第1觀點係有關一種分散液,其係包含:   界面活性劑、   水、   由下述式(1)至式(3)表示之化合物或其醫藥上可使用之鹽之中之至少一種所成之脂質肽型化合物所構成的顏料或粉體用分散劑、   1,2-烷二醇或1,3-烷二醇、   至少一種的脂肪酸及   選自由顏料及粉體所組成之群組之至少一種,(式中,R1 表示碳原子數9至23之脂肪族基,R2 表示氫原子、或可具有碳原子數1或2之支鏈之碳原子數1至4的烷基,R3 表示-(CH2 )n-X基,n表示1至4之數,X表示胺基、胍基(guanidino)、-CONH2 基、或可具有1至3個氮原子之5員環或6員環或由5員環與6員環所構成的縮合雜環)(式中,R4 表示碳原子數9至23之脂肪族基,R5 至R7 各自獨立表示氫原子、可具有碳原子數1或2之支鏈的碳原子數1至4之烷基、或-(CH2 )n-X基,且R5 至R7 之中至少1個以上表示-(CH2 )n-X基,n表示1至4之數,X表示胺基、胍基、-CONH2 基、或可具有1至3個氮原子之5員環或6員環或由5員環與6員環所構成的縮合雜環)(式中,R8 表示碳原子數9至23之脂肪族基,R9 至R12 各自獨立表示氫原子、可具有碳原子數1或2之支鏈的碳原子數1至4之烷基、或-(CH2 )n-X基,且R9 至R12 之中至少1個以上表示-(CH2 )n-X基,n表示1至4之數,X表示胺基、胍基、-CONH2 基、或可具有1至3個氮原子之5員環或6員環或由5員環與6員環所構成的縮合雜環)。   第2觀點係有關第1觀點的分散液,其中前述選自由前述顏料及粉體所組成之群組之至少一種,基於分散液的總質量,含有25質量%以下之比率而成。   第3觀點係有關第1觀點或第2觀點的分散液,其中前述顏料或粉體用分散劑,基於分散液之總質量,含有0.01質量%至1質量%之比率而成。   第4觀點係有關如第1觀點至第3觀點中任一觀點的分散液,其係進一步含有多元醇。   第5觀點係有關第4觀點的分散液,其中前述多元醇為甘油。   第6觀點係有關如第1觀點至第5觀點中任一觀點的分散液,其中前述界面活性劑為選自由乙二醇烷醚、磷脂質、聚甘油脂肪酸酯及聚氧乙烯聚氧丙烯烷醚所組成之群組之1種類以上的化合物。   第7觀點係有關如第1觀點至第6觀點中任一觀點的分散液,其中前述脂肪酸為硬脂酸。   第8觀點係有關如第1觀點至第7觀點中任一觀點的分散液,其係化妝料用的分散液。   第9觀點係有關一種顏料或粉體用分散劑,其係由下述式(1)至式(3)表示之化合物或其醫藥上可使用之鹽之中之至少一種所成之脂質肽型化合物所構成,(式中,R1 表示碳原子數9至23之脂肪族基,R2 表示氫原子、或可具有碳原子數1或2之支鏈之碳原子數1至4的烷基,R3 表示-(CH2 )n-X基,n表示1至4之數,X表示胺基、胍基、-CONH2 基、或可具有1至3個氮原子之5員環或6員環或由5員環與6員環所構成的縮合雜環)(式中,R4 表示碳原子數9至23之脂肪族基,R5 至R7 各自獨立表示氫原子、可具有碳原子數1或2之支鏈的碳原子數1至4之烷基、或-(CH2 )n-X基,且R5 至R7 之中至少1個以上表示-(CH2 )n-X基,n表示1至4之數,X表示胺基、胍基、-CONH2 基、或可具有1至3個氮原子之5員環或6員環或由5員環與6員環所構成的縮合雜環)(式中,R8 表示碳原子數9至23之脂肪族基,R9 至R12 各自獨立表示氫原子、可具有碳原子數1或2之支鏈的碳原子數1至4之烷基、或-(CH2 )n-X基,且R9 至R12 之中至少1個以上表示-(CH2 )n-X基,n表示1至4之數,X表示胺基、胍基、-CONH2 基、或可具有1至3個氮原子之5員環或6員環或由5員環與6員環所構成的縮合雜環)。 [發明效果]In other words, the first aspect relates to a dispersion including at least one of a surfactant, water, a compound represented by the following formula (1) to formula (3), or a pharmaceutically acceptable salt thereof. Pigment or powder dispersant composed of lipid peptide compounds, 1,2-alkanediol or 1,3-alkanediol, at least one fatty acid, and selected from the group consisting of pigments and powders At least one (In the formula, R 1 represents an aliphatic group having 9 to 23 carbon atoms, R 2 represents a hydrogen atom or an alkyl group having 1 to 4 carbon atoms which may have a branched chain of 1 or 2 carbon atoms, and R 3 represents -(CH 2 ) nX group, n represents a number of 1 to 4, X represents an amine group, guanidino, -CONH 2 group, or a 5-membered ring or a 6-membered ring which may have 1 to 3 nitrogen atoms or (Condensed heterocycle consisting of 5-membered ring and 6-membered ring) (In the formula, R 4 represents an aliphatic group having 9 to 23 carbon atoms, and R 5 to R 7 each independently represent a hydrogen atom and an alkyl group having 1 to 4 carbon atoms which may have a branched chain having 1 or 2 carbon atoms. Or-(CH 2 ) nX group, and at least one of R 5 to R 7 represents a-(CH 2 ) nX group, n represents a number from 1 to 4, and X represents an amine group, a guanidino group, and -CONH 2 Or a 5-membered ring or 6-membered ring which may have 1 to 3 nitrogen atoms or a condensed heterocyclic ring composed of a 5-membered ring and a 6-membered ring) (In the formula, R 8 represents an aliphatic group having 9 to 23 carbon atoms, and R 9 to R 12 each independently represent a hydrogen atom and an alkyl group having 1 to 4 carbon atoms which may have a branched chain having 1 or 2 carbon atoms. Or-(CH 2 ) nX group, and at least one of R 9 to R 12 represents a-(CH 2 ) nX group, n represents a number of 1 to 4, X represents an amine group, a guanidino group, and -CONH 2 Or a 5-membered ring or 6-membered ring having 1 to 3 nitrogen atoms or a condensed heterocyclic ring composed of a 5-membered ring and a 6-membered ring). A second aspect is the dispersion liquid according to the first aspect, wherein the at least one selected from the group consisting of the pigments and powders described above is based on the total mass of the dispersion liquid and contains a ratio of 25% by mass or less. A third aspect is the dispersion liquid according to the first aspect or the second aspect, wherein the pigment or powder dispersing agent contains a ratio of 0.01% by mass to 1% by mass based on the total mass of the dispersion. The fourth aspect is a dispersion liquid according to any one of the first to third aspects, and further contains a polyhydric alcohol. A fifth aspect is the dispersion liquid according to the fourth aspect, wherein the polyol is glycerin. The sixth aspect is the dispersion liquid according to any one of the first to fifth aspects, wherein the surfactant is selected from the group consisting of a glycol alkyl ether, a phospholipid, a polyglycerol fatty acid ester, and a polyoxyethylene polyoxypropylene. One or more compounds of the group consisting of alkyl ethers. The seventh aspect is the dispersion liquid according to any one of the first to sixth aspects, wherein the fatty acid is stearic acid. The eighth aspect relates to the dispersion liquid according to any one of the first to seventh aspects, and is a dispersion liquid for cosmetics. The ninth aspect relates to a dispersant for pigments or powders, which is a lipid peptide type formed from at least one of a compound represented by the following formula (1) to formula (3) or a pharmaceutically acceptable salt thereof. Made of compounds, (In the formula, R 1 represents an aliphatic group having 9 to 23 carbon atoms, R 2 represents a hydrogen atom or an alkyl group having 1 to 4 carbon atoms which may have a branched chain of 1 or 2 carbon atoms, and R 3 represents -(CH 2 ) nX group, n represents a number of 1 to 4, X represents an amine group, a guanidino group, a -CONH 2 group, or a 5-membered ring or a 6-membered ring or a 5-membered ring which may have 1 to 3 nitrogen atoms (Condensed heterocyclic ring consisting of 6-membered ring) (In the formula, R 4 represents an aliphatic group having 9 to 23 carbon atoms, and R 5 to R 7 each independently represent a hydrogen atom and an alkyl group having 1 to 4 carbon atoms which may have a branched chain having 1 or 2 carbon atoms. Or-(CH 2 ) nX group, and at least one of R 5 to R 7 represents a-(CH 2 ) nX group, n represents a number from 1 to 4, and X represents an amine group, a guanidino group, and -CONH 2 Or a 5-membered ring or 6-membered ring which may have 1 to 3 nitrogen atoms or a condensed heterocyclic ring composed of a 5-membered ring and a 6-membered ring) (In the formula, R 8 represents an aliphatic group having 9 to 23 carbon atoms, and R 9 to R 12 each independently represent a hydrogen atom and an alkyl group having 1 to 4 carbon atoms which may have a branched chain having 1 or 2 carbon atoms. Or-(CH 2 ) nX group, and at least one of R 9 to R 12 represents a-(CH 2 ) nX group, n represents a number of 1 to 4, X represents an amine group, a guanidino group, and -CONH 2 Or a 5-membered ring or 6-membered ring having 1 to 3 nitrogen atoms or a condensed heterocyclic ring composed of a 5-membered ring and a 6-membered ring). [Inventive effect]

依據本發明,藉由將脂質肽型化合物作為顏料或粉體之分散劑使用,在隨著時間下顏料或粉體不會自分散液分離或沉降,可成為使此等安定地分散的分散液。   特別是藉由使用本發明之分散劑,即使在將顏料調配達10質量%以上的情形,或調配有金箔等之比較大的粉體的情形,也可調製安定地分散的分散液。According to the present invention, by using a lipid-peptide compound as a dispersant for a pigment or a powder, the pigment or the powder does not separate or settle from the dispersion liquid with time, and it can be a dispersion liquid for stably dispersing these. . In particular, by using the dispersant of the present invention, a stable dispersed dispersion liquid can be prepared even when a pigment is blended at 10% by mass or more, or when a relatively large powder such as gold foil is blended.

又,構成本發明之分散劑之脂質肽化合物係僅由脂質與肽所構成之安全性非常高的人工低分子化合物。   此外,在本發明之分散液中,作為添加劑所含有之各種成分係作為食品或化妝品、醫藥品之添加劑而泛用的添加劑。   亦即,本發明之分散液係生物安全性高,特別是由在醫藥品或化妝品等所要求之安全性的觀點,在上述用途為非常有用。   此外,本發明之分散液使用於人的皮膚等時,可期待清涼感及延展佳的分散液,可期待作為醫藥品用途或化妝品用途之調配有顏料或粉體之液狀的基材使用,非常有用。In addition, the lipid peptide compound constituting the dispersant of the present invention is an artificial low-molecular compound having very high safety composed of only lipids and peptides. In addition, in the dispersion liquid of the present invention, various components contained as additives are additives commonly used as additives for foods, cosmetics, and pharmaceuticals. That is, the dispersion liquid of the present invention is highly biosafe, and is particularly useful for the above-mentioned applications from the viewpoint of safety required for pharmaceuticals, cosmetics, and the like. In addition, when the dispersion liquid of the present invention is used on human skin or the like, a dispersion liquid with a cool feeling and good spreadability can be expected, and it can be expected to be used as a liquid base material prepared with pigments or powders for pharmaceutical or cosmetic applications. very useful.

[實施發明之形態][Form of Implementing Invention]

本發明係有關一種分散液,其係包含:界面活性劑、水、由下述式(1)至式(3)表示之化合物或其醫藥上可使用之鹽之中之至少一種所成之脂質肽型化合物所構成的顏料或粉體用分散劑、1,2-烷二醇或1,3-烷二醇、脂肪酸、選自由顏料及粉體所組成之群組之至少一種及所期望之其他的添加劑。又,本發明係由前述脂質肽型化合物所構成之顏料或粉體用分散劑為亦為對象。   以下說明各構成成分。The present invention relates to a dispersion liquid comprising a lipid formed by at least one of a surfactant, water, a compound represented by the following formula (1) to formula (3) or a pharmaceutically acceptable salt thereof Dispersant for pigment or powder composed of peptide compound, 1,2-alkanediol or 1,3-alkanediol, fatty acid, at least one selected from the group consisting of pigment and powder, and desired Other additives. In addition, the present invention is also directed to a pigment or a dispersant for a powder composed of the aforementioned lipid peptide compound. Each component will be described below.

[顏料或粉體用分散劑:脂質肽型化合物]   作為本發明之顏料或粉體用分散劑使用之脂質肽型化合物,可使用下述式(1)至式(3)表示之化合物(脂質肽)或其醫藥上可使用的鹽類(具有疏水性部位的脂質部與親水性部位的肽部的低分子化合物)。 [Dispersant for pigment or powder: lipid peptide compound] As the lipid peptide compound used for the pigment or powder dispersant of the present invention, a compound (lipid) represented by the following formula (1) to formula (3) can be used Peptide) or a pharmaceutically acceptable salt thereof (a low molecular compound having a lipid portion having a hydrophobic portion and a peptide portion having a hydrophilic portion).

上述式(1)中,R1 表示碳原子數9至23之脂肪族基,較佳為R1 為可具有0至2個不飽和鍵之碳原子數11至23之直鏈脂肪族基。   與R1 鄰接之羰基所構成之脂質部(醯基)的具體例,可列舉月桂醯基、十二烷基羰基、肉豆蔻醯基、十四烷基羰基、棕櫚醯基、十七醯基、油醯基、反油醯基、亞麻油醯基、硬脂醯基、十八碳烯基醯基、十八烷基羰基、花生四烯醯基、二十烷基羰基、山嵛醯基、二十二碳烯醯基、二十二烷基羰基、木蠟醯基、神經醯基等,特佳者為可列舉月桂醯基、肉豆蔻醯基、棕櫚醯基、十七醯基、硬脂醯基、油醯基、反油醯基及山嵛醯基。In the above formula (1), R 1 represents an aliphatic group having 9 to 23 carbon atoms, and preferably R 1 is a straight-chain aliphatic group having 11 to 23 carbon atoms which may have 0 to 2 unsaturated bonds. Specific examples of the lipid moiety (fluorenyl group) composed of a carbonyl group adjacent to R 1 include laurylfluorenyl, dodecylcarbonyl, myristyl, tetradecylcarbonyl, palmitoyl, and heptadecyl , Oleyl, oleyl, linoleyl, stearyl, octadecenyl, octadecylcarbonyl, arachidonyl, eicosylcarbonyl, behenyl , Twenty-two alkenyl, behenyl carbonyl, xylofluorenyl, neural fluorenyl, etc. Particularly preferred are lauryl, myristyl, palmitoyl, heptadecyl, Stearyl, oleyl, anti-oleyl and behenyl.

上述式(1)中,肽部所包含之R2 表示氫原子、或可具有碳原子數1或2之支鏈之碳原子數1至4之烷基。   上述可具有碳原子數1或2之支鏈之碳原子數1至4之烷基係指主鏈之碳原子數為1至4,且可具有碳原子數1或2之支鏈之烷基,其具體例,可列舉甲基、乙基、n-丙基、i-丙基、n-丁基、i-丁基、sec-丁基或tert-丁基等。   上述R2 ,較佳為氫原子、或可具有碳原子數1之支鏈之碳原子數1至3之烷基,更佳為氫原子。   可具有碳原子數1之支鏈之碳原子數1至3之烷基係指主鏈之碳原子數為1至3,且可具有碳原子數1之支鏈的烷基,其具體例,可列舉甲基、乙基、n-丙基、i-丙基、i-丁基或sec-丁基等,較佳為甲基、i-丙基、i-丁基或sec-丁基。In the above formula (1), R 2 included in the peptide portion represents a hydrogen atom or an alkyl group having 1 to 4 carbon atoms which may have a branch having 1 or 2 carbon atoms. The above-mentioned alkyl group having 1 to 4 carbon atoms which may have a branched chain having 1 or 2 carbon atoms means an alkyl group having 1 to 4 carbon atoms in the main chain and may have a branched chain having 1 or 2 carbon atoms Specific examples include methyl, ethyl, n-propyl, i-propyl, n-butyl, i-butyl, sec-butyl, and tert-butyl. The aforementioned R 2 is preferably a hydrogen atom or an alkyl group having 1 to 3 carbon atoms, which may have a branched chain of 1 carbon atom, and more preferably a hydrogen atom. The alkyl group having 1 to 3 carbon atoms which may have a branch having 1 carbon atom means an alkyl group having 1 to 3 carbon atoms in the main chain and may have a branched chain having 1 carbon atom, and specific examples thereof, Examples include methyl, ethyl, n-propyl, i-propyl, i-butyl, or sec-butyl, and methyl, i-propyl, i-butyl, or sec-butyl is preferred.

上述式(1)中,R3 表示-(CH2 )n-X基。於上述 -(CH2 )n-X基中,n表示1至4之數,X表示胺基、胍基、 -CONH2 基、或可具有1至3個氮原子之5員環式基或6員環式基、或由5員環與6員環所構成之縮合雜環式基。   表示上述R3 之-(CH2 )n-X基中,X較佳為胺基、胍基、胺基甲醯基(-CONH2 基)、吡咯基、咪唑基、吡唑基或吲哚基,更佳為咪唑基。又,上述-(CH2 )n-X基中,n較佳為1或2,更佳為1。   因此,上述-(CH2 )n-基,較佳為表示胺基甲基、2-胺基乙基、3-胺基丙基、4-胺基丁基、胺基甲醯基甲基、2-胺基甲醯基乙基、3-胺基甲醯基丁基、2-胍基乙基、3-胍基丁基、吡咯甲基、4-咪唑甲基、吡唑甲基、或3-吲哚甲基,更佳為表示4-胺基丁基、胺基甲醯基甲基、2-胺基甲醯基乙基、3-胍基丁基、4-咪唑甲基或3-吲哚甲基,又更佳為4-咪唑甲基。In the formula (1), R 3 represents a-(CH 2 ) nX group. In the above- (CH 2 ) nX group, n represents a number of 1 to 4, and X represents an amine group, a guanidino group, a -CONH 2 group, or a 5-membered cyclic group or 6-membered group which may have 1 to 3 nitrogen atoms. A cyclic group or a condensed heterocyclic group consisting of a 5-membered ring and a 6-membered ring. In the-(CH 2 ) nX group representing the above R 3 , X is preferably an amine group, a guanidyl group, an aminoformyl group (-CONH 2 group), a pyrrolyl group, an imidazolyl group, a pyrazolyl group, or an indolyl group, More preferred is imidazolyl. In the above- (CH 2 ) nX group, n is preferably 1 or 2, and more preferably 1. Therefore, the-(CH 2 ) n- group preferably represents aminomethyl, 2-aminoethyl, 3-aminopropyl, 4-aminobutyl, aminomethylmethyl, 2-aminomethylamidinoethyl, 3-aminomethylamidinobutyl, 2-guanidinoethyl, 3-guanidinobutyl, pyrrolylmethyl, 4-imidazolylmethyl, pyrazolylmethyl, or 3-Indolemethyl, more preferably 4-aminobutyl, aminomethylmethyl, 2-aminomethylmethylethyl, 3-guanidinobutyl, 4-imidazolylmethyl or 3 -Indolemethyl, and more preferably 4-imidazolylmethyl.

上述式(1)表示之化合物中,作為脂質肽型化合物,特佳的脂質肽為由以下脂質部與肽部(胺基酸集合部)所形成之化合物。又,胺基酸之簡稱,表示丙胺酸(Ala)、天門冬醯胺酸(asparagine)(Asn)、麩醯胺酸(glutamine)(Gln)、甘胺酸(Gly)、組胺酸(His)、異白胺酸(Ile)、白胺酸(Leu)、離胺酸(Lys)、色胺酸(Trp)、擷胺酸(Val)。月桂醯-Gly-His、月桂醯-Gly-Gln、月桂醯-Gly-Asn、月桂醯-Gly-Trp、月桂醯-Gly-Lys、月桂醯-Ala-His、月桂醯-Ala-Gln、月桂醯-Ala-Asn、月桂醯-Ala-Trp、月桂醯-Ala-Lys;肉豆蔻醯-Gly-His、肉豆蔻醯-Gly-Gln、肉豆蔻醯-Gly-Asn、肉豆蔻醯-Gly-Trp、肉豆蔻醯-Gly-Lys、肉豆蔻醯-Ala-His、肉豆蔻醯-Ala-Gln、肉豆蔻醯-Ala-Asn、肉豆蔻醯-Ala-Trp、肉豆蔻醯-Ala-Lys;棕櫚醯-Gly-His、棕櫚醯-Gly-Gln、棕櫚醯-Gly-Asn、棕櫚醯-Gly-Trp、棕櫚醯-Gly-Lys、棕櫚醯-Ala-His、棕櫚醯-Ala-Gln、棕櫚醯-Ala-Asn、棕櫚醯-Ala-Trp、棕櫚醯-Ala-Lys;硬脂醯-Gly-His、硬脂醯-Gly-Gln、硬脂醯-Gly-Asn、硬脂醯-Gly-Trp、硬脂醯-Gly-Lys、硬脂醯-Ala-His、硬脂醯-Ala-Gln、硬脂醯-Ala-Asn、硬脂醯-Ala-Trp、硬脂醯-Ala-Lys。Among the compounds represented by the above formula (1), as the lipid peptide compound, a particularly preferred lipid peptide is a compound formed of the following lipid portion and peptide portion (amino acid aggregation portion). The abbreviation of amino acid means alanine (Ala), asparagine (Asn), glutamine (Gln), glycine (Gly), and histidine (His). ), Isoleucine (Ile), Leucine (Leu), Lysine (Lys), Tryptophan (Trp), Valine (Val). Laurel-Gly-His, Laurel-Gly-Gln, Laurel-Gly-Asn, Laurel-Gly-Trp, Laurel-Gly-Lys, Laurel-Ala-His, Laurel-Ala-Gln, Laurel醯 -Ala-Asn, Laurel 醯 -Ala-Trp, Laurel A-Ala-Lys; Nutmeg 醯 -Gly-His, Nutmeg 醯 -Gly-Gln, Nutmeg 醯 -Gly-Asn, Nutmeg 醯 -Gly- Trp, Nutmeg-Gly-Lys, Nutmeg-Ala-His, Nutmeg-Ala-Gln, Nutmeg-Ala-Asn, Nutmeg-Ala-Trp, Nutmeg-Ala-Lys; Palm Falcon-Gly-His, Palm Falcon-Gly-Gln, Palm Falcon-Gly-Asn, Palm Falcon-Gly-Trp, Palm Falcon-Gly-Lys, Palm Falcon-Ala-His, Palm Falcon-Ala-Gln, Palm醯 -Ala-Asn, palm 醯 -Ala-Trp, palm 醯 -Ala-Lys; stearyl 醯 -Gly-His, stearyl 醯 -Gly-Gln, stearyl 醯 -Gly-Asn, stearyl 醯 -Gly- Trp, stearylamine-Gly-Lys, stearylamine-Ala-His, stearylamine-Ala-Gln, stearylamine-Ala-Asn, stearylamine-Ala-Trp, stearylamine-Ala-Lys.

最佳者為可列舉月桂醯-Gly-His、月桂醯-Ala-His-肉豆蔻醯-Gly-His、肉豆蔻醯-Ala-His;棕櫚醯-Gly-His、棕櫚醯-Ala-His;硬脂醯-Gly-His、硬脂醯-Ala-His。The best ones can be listed as Laurel-Gly-His, Laurel-Ala-His-Myristica-Gly-His, Myristica-Ala-His; Palm-Gly-His, Palm-Ala-His; Stearylamine-Gly-His, Stearylamine-Ala-His.

上述式(2)中,R4 表示碳原子數9至23之脂肪族基,較佳的具體例,可列舉與以前述R1 定義者相同之基。   上述式(2)中,R5 至R7 各自獨立表示氫原子、或可具有碳原子數1或2之支鏈之碳原子數1至4之烷基、或-(CH2 )n-X基,且R5 至R7 之中至少1個以上表示-(CH2 )n-X基。n表示1至4之數,X表示胺基、胍基、-CONH2 基、或可具有1至3個氮原子之5員環式基或6員環式基、或由5員環與6員環所構成之縮合雜環式基。在此,R5 至R7 之較佳具體例,可列舉與前述R2 及R3 定義者相同之基。In the formula (2), R 4 represents an aliphatic group having 9 to 23 carbon atoms. Preferred specific examples include the same groups as those defined by the aforementioned R 1 . In the above formula (2), R 5 to R 7 each independently represent a hydrogen atom, or an alkyl group having 1 to 4 carbon atoms, or a-(CH 2 ) nX group, which may have a branch of 1 or 2 carbon atoms, In addition, at least one of R 5 to R 7 represents a-(CH 2 ) nX group. n represents a number of 1 to 4, and X represents an amine group, a guanidino group, a -CONH 2 group, or a 5-membered cyclic group or a 6-membered cyclic group which may have 1 to 3 nitrogen atoms, or a 5-membered ring and 6 Condensed heterocyclic group consisting of member rings. Here, preferable specific examples of R 5 to R 7 include the same bases as those defined by the aforementioned R 2 and R 3 .

上述式(2)表示之化合物中,較佳之脂質肽係由以下脂質部與肽部(胺基酸集合部)所形成之化合物。例如月桂醯-Gly-Gly-His、月桂醯-Gly-Gly-Gln、月桂醯-Gly-Gly-Asn、月桂醯-Gly-Gly-Trp、月桂醯-Gly-Gly-Lys、月桂醯-Gly-Ala-His、月桂醯-Gly-Ala-Gln、月桂醯-Gly-Ala-Asn、月桂醯-Gly-Ala-Trp、月桂醯-Gly-Ala-Lys、月桂醯-Ala-Gly-His、月桂醯-Ala-Gly-Gln、月桂醯-Ala-Gly-Asn、月桂醯-Ala-Gly-Trp、月桂醯-Ala-Gly-Lys、月桂醯-Gly-His-Gly、月桂醯基-His-Gly-Gly、肉豆蔻醯-Gly-Gly-His、肉豆蔻醯-Gly-Gly-Gln、肉豆蔻醯-Gly-Gly-Asn、肉豆蔻醯-Gly-Gly-Trp、肉豆蔻醯-Gly-Gly-Lys、肉豆蔻醯-Gly-Ala-His、肉豆蔻醯-Gly-Ala-Gln、肉豆蔻醯-Gly-Ala-Asn、肉豆蔻醯-Gly-Ala-Trp、肉豆蔻醯-Gly-Ala-Lys、肉豆蔻醯-Ala-Gly-His、肉豆蔻醯-Ala-Gly-Gln、肉豆蔻醯-Ala-Gly-Asn、肉豆蔻醯-Ala-Gly-Trp、肉豆蔻醯-Ala-Gly-Lys、肉豆蔻醯-Gly-His-Gly、肉豆蔻醯基-His-Gly-Gly、棕櫚醯-Gly-Gly-His、棕櫚醯-Gly-Gly-Gln、棕櫚醯-Gly-Gly-Asn、棕櫚醯-Gly-Gly-Trp、棕櫚醯-Gly-Gly-Lys、棕櫚醯-Gly-Ala-His、棕櫚醯-Gly-Ala-Gln、棕櫚醯-Gly-Ala-Asn、棕櫚醯-Gly-Ala-Trp、棕櫚醯-Gly-Ala-Lys、棕櫚醯-Ala-Gly-His、棕櫚醯-Ala-Gly-Gln、棕櫚醯-Ala-Gly-Asn、棕櫚醯-Ala-Gly-Trp、棕櫚醯-Ala-Gly-Lys、棕櫚醯-Gly-His-Gly、棕櫚醯-His-Gly-Gly、硬脂醯-Gly-Gly-His、硬脂醯-Gly-Gly-Gln、硬脂醯-Gly-Gly-Asn、硬脂醯-Gly-Gly-Trp、硬脂醯-Gly-Gly-Lys、硬脂醯-Gly-Ala-His、硬脂醯-Gly-Ala-Gln、硬脂醯-Gly-Ala-Asn、硬脂醯-Gly-Ala-Trp、硬脂醯-Gly-Ala-Lys、硬脂醯-Ala-Gly-His、硬脂醯-Ala-Gly-Gln、硬脂醯-Ala-Gly-Asn、硬脂醯-Ala-Gly-Trp、硬脂醯-Ala-Gly-Lys、硬脂醯-Gly-His-Gly、硬脂醯基-His-Gly-Gly。Among the compounds represented by the formula (2), a preferred lipid peptide is a compound formed from the following lipid portion and peptide portion (amino acid assembly portion). For example, Laurel-Gly-Gly-His, Laurel-Gly-Gly-Gln, Laurel-Gly-Gly-Asn, Laurel-Gly-Gly-Trp, Laurel-Gly-Gly-Lys, Laurel-Gly -Ala-His, Laurel-Gly-Ala-Gln, Laurel-Gly-Ala-Asn, Laurel-Gly-Ala-Trp, Laurel-Gly-Ala-Lys, Laurel-Ala-Gly-His, Laurel-Ala-Gly-Gln, Laurel-Ala-Gly-Asn, Laurel-Ala-Gly-Trp, Laurel-Ala-Gly-Lys, Laurel-Gly-His-Gly, Laurel-His -Gly-Gly, Nutmeg 醯 -Gly-Gly-His, Nutmeg 醯 -Gly-Gly-Gln, Nutmeg 醯 -Gly-Gly-Asn, Nutmeg 醯 -Gly-Gly-Trp, Nutmeg 醯 -Gly -Gly-Lys, Nutmeg 醯 -Gly-Ala-His, Nutmeg --Gly-Ala-Gln, Nutmeg 醯 -Gly-Ala-Asn, Nutmeg 醯 -Gly-Ala-Trp, Nutmeg 醯 -Gly -Ala-Lys, Nutmeg 醯 -Ala-Gly-His, Nutmeg 醯 -Ala-Gly-Gln, Nutmeg 醯 -Ala-Gly-Asn, Nutmeg 醯 -Ala-Gly-Trp, Nutmeg 醯 -Ala -Gly-Lys, Myristyl-Gly-His-Gly, Myristyl-His-Gly-Gly, Palm-Eat-Gly-Gly-His, Palm-Eat-Gly-Gly-Gln, Palm-Eat-Gly-Gly -Asn, Palm Falcon-Gly-Gly-Trp, Palm Falcon-Gly-Gly-Lys, Palm Falcon-Gly-Ala-His, Palm Falcon-Gly-Ala-Gln, Palm Falcon-Gly-Ala-Asn, Palm Falcon-Gly-Ala-Trp, Palm Falcon-Gly-Ala-Lys, Palm Falcon-Ala- Gly-His, Palm Falcon-Ala-Gly-Gln, Palm Falcon-Ala-Gly-Asn, Palm Falcon-Ala-Gly-Trp, Palm Falcon-Ala-Gly-Lys, Palm Falcon-Gly-His-Gly, Palm Hi-His-Gly-Gly, stearin 醯 -Gly-Gly-His, stearin 醯 -Gly-Gly-Gln, stearin 醯 -Gly-Gly-Asn, stearin 醯 -Gly-Gly-Trp, stearin醯 -Gly-Gly-Lys, stearin 醯 -Gly-Ala-His, stearin 醯 -Gly-Ala-Gln, stearin 醯 -Gly-Ala-Asn, stearin 醯 -Gly-Ala-Trp, stearin醯 -Gly-Ala-Lys, stearin 醯 -Ala-Gly-His, stearin 醯 -Ala-Gly-Gln, stearin 醯 -Ala-Gly-Asn, stearin 醯 -Ala-Gly-Trp, stearin -Ala-Gly-Lys, stearyl 醯 -Gly-His-Gly, stearyl 醯 -His-Gly-Gly.

此等之中,最佳者為可列舉月桂醯-Gly-Gly-His、肉豆蔻醯-Gly-Gly-His、棕櫚醯-Gly-Gly-His、棕櫚醯-Gly-His-Gly、棕櫚醯-His-Gly-Gly、硬脂醯-Gly-Gly-His。Among these, the best are laurel-Gly-Gly-His, nutmeg-Gly-Gly-His, palm --- Gly-Gly-His, palm --- Gly-His-Gly, palm-- -His-Gly-Gly, stearylamine-Gly-Gly-His.

上述式(3)中,R8 表示碳原子數9至23之脂肪族基,較佳之具體例,可列舉與前述R1 定義者相同之基。   上述式(3)中,R9 至R12 各自獨立表示氫原子、或可具有碳原子數1或2之支鏈之碳原子數1至4之烷基、或 -(CH2 )n-X基,且R9 至R12 之中至少1個以上表示-(CH2 )n-X基。n表示1至4之數,X表示胺基、胍基、-CONH2 基、或可具有1至3個氮原子之5員環式基或6員環式基、或由5員環與6員環所構成之縮合雜環式基。在此,R9 至R12 之較佳的具體例,可列舉與前述R2 及R3 定義者相同之基。In the above formula (3), R 8 represents an aliphatic group having 9 to 23 carbon atoms. Preferred specific examples include the same groups as those defined by the aforementioned R 1 . In the above formula (3), each of R 9 to R 12 independently represents a hydrogen atom, or an alkyl group having 1 to 4 carbon atoms, or a-(CH 2 ) nX group, which may have a branch having 1 or 2 carbon atoms, In addition, at least one of R 9 to R 12 represents a-(CH 2 ) nX group. n represents a number of 1 to 4, and X represents an amine group, a guanidino group, a -CONH 2 group, or a 5-membered cyclic group or a 6-membered cyclic group which may have 1 to 3 nitrogen atoms, or a 5-membered ring and 6 Condensed heterocyclic group consisting of member rings. Here, preferable specific examples of R 9 to R 12 include the same bases as those defined by the aforementioned R 2 and R 3 .

因此,上述式(3)表示之化合物中,較佳脂質肽型化合物,其中特佳之脂質肽,可列舉月桂醯-Gly-Gly-Gly-His、肉豆蔻醯-Gly-Gly-Gly-His、棕櫚醯-Gly-Gly-Gly-His、棕櫚醯-Gly-Gly-His-Gly、棕櫚醯-Gly-His-Gly-Gly、棕櫚醯-His-Gly-Gly-Gly、硬脂醯-Gly-Gly-Gly-His等。Therefore, among the compounds represented by the above formula (3), preferred are lipid peptide compounds, and among them, particularly preferred lipid peptides include Laurel-Gly-Gly-Gly-His, Myristium-Gly-Gly-Gly-His, Palm 醯 -Gly-Gly-Gly-His, Palm 醯 -Gly-Gly-His-Gly, Palm 醯 -Gly-His-Gly-Gly, Palm 醯 -His-Gly-Gly-Gly, Stearyl 醯 -Gly- Gly-Gly-His et al.

在本發明中,顏料或粉體用分散劑之脂質肽型化合物之調配量係相對於所得之分散液之總質量,例如為0.01質量%至1質量%、或0.01質量%以上未達1質量%,較佳為0.05質量%至0.5質量%,更佳為0.05質量%至0.3質量%,例如0.05質量%至0.2質量%。   又,在本發明中可使用之脂質肽型化合物係由上述式(1)至式(3)表示之化合物(脂質肽)或其醫藥上可使用之鹽之中之至少一種所構成,作為顏料或粉體用分散劑,可將此等化合物以單獨、或組合二種以上使用。In the present invention, the blending amount of the lipid peptide compound of the dispersant for pigment or powder is relative to the total mass of the obtained dispersion liquid, for example, 0.01 mass% to 1 mass%, or 0.01 mass% or more and less than 1 mass %, Preferably 0.05% by mass to 0.5% by mass, more preferably 0.05% by mass to 0.3% by mass, such as 0.05% by mass to 0.2% by mass. In addition, the lipid-peptide compound usable in the present invention is composed of at least one of the compound (lipid peptide) represented by the above formula (1) to formula (3) or a pharmaceutically acceptable salt thereof as a pigment Or powder dispersants, these compounds can be used alone or in combination of two or more.

[界面活性劑]   作為在本發明之分散液中使用的界面活性劑,可適合使用分子內具有親水部與疏水部,且該親水部具有甜菜鹼結構的化合物(以下亦稱為甜菜鹼系化合物)、乙二醇烷醚、聚甘油脂肪酸酯、或聚氧乙烯聚氧丙烯烷醚。[Surfactant] As the surfactant used in the dispersion of the present invention, a compound having a hydrophilic portion and a hydrophobic portion in the molecule and a betaine structure in the hydrophilic portion (hereinafter also referred to as a betaine-based compound) can be suitably used. ), Glycol alkyl ethers, polyglycerol fatty acid esters, or polyoxyethylene polyoxypropylene alkyl ethers.

如上述之甜菜鹼系化合物,可使用例如月桂基二甲基胺基乙酸甜菜鹼(月桂基甜菜鹼)等之N-烷基-N,N-二甲基胺基酸甜菜鹼;椰油醯胺丙基甜菜鹼、月桂醯胺丙基甜菜鹼等之脂肪酸醯胺烷基-N,N-二甲基胺基酸甜菜鹼;椰油醯兩性基乙酸鈉(Sodium Cocoamphoacetate)、月桂醯兩性基乙酸鈉等之咪唑啉型甜菜喊;月桂基羥基磺基甜菜鹼、烷基二甲基牛磺酸等之烷基磺基甜菜鹼;烷基二甲基胺基乙醇硫酸酯等之硫酸型甜菜鹼;烷基二甲基胺基乙醇磷酸酯等之磷酸型甜菜鹼;等兩性界面活性劑為已知的甜菜鹼系化合物。   又,上述甜菜鹼系化合物例如有磷脂醯膽鹼(Phosphatidylcholine)、磷脂醯乙醇胺、磷脂醯絲胺酸、磷脂醯肌醇(inositol)、磷脂醯甘油、二磷脂醯甘油(心磷脂(cardiolipin))、磷脂酸(phosphatidic acid)等之甘油磷脂;溶血磷脂膽鹼(溶血卵磷脂、lysolecithin)、溶血磷脂乙醇胺、溶血磷脂絲胺酸、溶血磷脂肌醇、溶血磷脂甘油、溶血磷脂酸等之溶血甘油磷脂;神經鞘磷脂(Sphingomyelin)等之鞘磷脂;及此等之氫化物等。此等之磷脂可為大豆、蛋黃等來自動植物者,也可為藉由化學或酵素的方法合成者。   上述甜菜鹼系化合物中,較佳為月桂基二甲基胺基乙酸甜菜鹼、月桂酸醯胺丙基甜菜鹼、月桂基羥基磺基甜菜鹼、硬脂基甜菜鹼、溶血磷脂膽鹼(溶血卵磷脂、lysolecithin)、溶血磷脂乙醇胺、溶血磷脂醯絲胺酸、磷脂醯肌醇、溶血磷脂醯甘油、溶血磷脂酸(Lysophosphatidic acid,LPA)等,又更佳為溶血磷脂膽鹼(溶血卵磷脂)。As the above-mentioned betaine-based compound, for example, N-alkyl-N, N-dimethylamino acid betaine such as lauryl dimethylaminoacetic acid betaine (lauryl betaine) can be used; coconut oil tincture Fatty acids such as aminopropyl betaine, lauryl aminopropyl betaine, amino alkyl-N, N-dimethylamino betaine; Sodium Cocoamphoacetate, lauryl amphoteric Imidazoline type beets such as sodium acetate; alkyl sulfobetaines such as lauryl hydroxysulfobetaine, alkyl dimethyl taurine; sulfuric acid type beets such as alkyl dimethyl amino ethanol sulfate Bases; phosphate betaines such as alkyl dimethylaminoethanol phosphate; and other amphoteric surfactants are known betaine-based compounds. The betaine-based compounds include, for example, phosphatidylcholine, phosphatidylethanolamine, phospholipid serine, phospholipids inositol, phospholipids glycerol, and diphospholipids glycerol (cardiolipin) , Glycerophospholipids such as phosphatidic acid, lysophospholipid choline (lysolecithin, lysolecithin), lysophospholipid ethanolamine, lysophospholipid serine, lysophospholipid inositol, lysophospholipid glycerol, lysophospholipid, etc. Phospholipids; sphingomyelins such as Sphingomyelin; and hydrides of these. These phospholipids may be those produced by plants such as soybeans, egg yolk, etc., or synthesized by chemical or enzyme methods. Among the above betaine-based compounds, lauryl dimethylaminoacetic acid betaine, amidopropyl betaine laurate, lauryl hydroxysulfobetaine, stearyl betaine, and lysophospholipid choline (hemolytic Lecithin, lysolecithin), lysophospholipid ethanolamine, lysophospholipid serine, phospholipid inositol, lysophospholipid, glycerol, lysophosphatidic acid (LPA), etc., and more preferably lysophospholipid choline (lysocithin) ).

上述乙二醇烷醚,可列舉聚氧化乙烯烷醚、聚氧乙烯月桂醚、聚氧乙烯棕櫚醯醚、聚氧乙烯硬脂醚等。又,乙二醇烷醚也可使用市售品,這種製品,可列舉例如花王(股)之EMULGEN(註冊商標)系列及EMANON(註冊商標)系列之中,EMULGEN 102KG、EMULGEN 103、EMULGEN 104P、EMULGEN 105、EMULGEN 106、EMULGEN 108、EMULGEN 109P、EMULGEN 120、EMULGEN 123P、EMULGEN 130K、EMULGEN 147、EMULGEN 150、EMULGEN 210P、EMULGEN 220、EMULGEN 306P、EMULGEN 320P、EMULGEN 350、EMULGEN 404、EMULGEN 408、EMULGEN 409PV、EMULGEN 420、EMULGEN 430、EMULGEN 705、EMULGEN 707、EMULGEN 709、EMULGEN 1108、EMULGEN 1118S-70、EMULGEN 1135S-70、EMULGEN 1150S-60、EMULGEN 4085、EMULGEN 2020G-HA、EMULGEN 2025G、EMANON 1112、EMANON 3199V、EMANON 3299V、EMANON 3299RV、EMANON 4110。更佳為可列舉花王(股)之EMULGEN 103、EMULGEN 104P、EMULGEN 105、EMULGEN 106、EMULGEN 108、EMULGEN 109P、EMULGEN 210P、EMULGEN 306P、EMULGEN 320P、EMULGEN 404、EMULGEN 408、EMULGEN 409PV、EMULGEN 420、EMULGEN 705、EMULGEN 707、EMULGEN 709、EMULGEN 1108、EMULGEN 2020G-HA、EMANON 1112、EMANON 4110。又更佳為可列舉花王(股)之EMULGEN 104P、EMULGEN 105、EMULGEN 106、EMULGEN 108、EMULGEN 210P、EMULGEN 306P、EMULGEN 408、EMULGEN 409PV、EMULGEN 705、EMULGEN 707、EMULGEN 709、EMULGEN 1108、EMULGEN 2020G-HA、EMANON 1112、EMANON 4110。此外,也可適宜選自NIKKO CHEMICALS(股)之NIKKOL(註冊商標)系列。可列舉例如NIKKOL BT-5、NIKKOL BT-7、NIKKOL BT-9、NIKKOL BT-12、NIKKOL BL-2、NIKKOL BL-4.2、NIKKOL BL-9EX等,最佳為可列舉NIKKOL BL-4.2。Examples of the ethylene glycol alkyl ether include polyoxyethylene alkyl ether, polyoxyethylene lauryl ether, polyoxyethylene palmitic ether, and polyoxyethylene stearyl ether. Commercial products can also be used as the glycol alkyl ethers. Examples of such products include EMULGEN (registered trademark) series and EMANON (registered trademark) series of Kao Corporation, EMULGEN 102KG, EMULGEN 103, and EMULGEN 104P. EMULGEN 105, EMULGEN 106, EMULGEN 108, EMULGEN 109P, EMULGEN 120, EMULGEN 123P, EMULGEN 130K, EMULGEN 147, EMULGEN 150, EMULGEN 210P, EMULGEN 220, EMULGEN 306P, EMULGEN 320P, EMULGEN 350, EMULGEN 404, EMULGEN 408, EMULGEN 409PV, EMULGEN 420, EMULGEN 430, EMULGEN 705, EMULGEN 707, EMULGEN 709, EMULGEN 1108, EMULGEN 1118S-70, EMULGEN 1135S-70, EMULGEN 1150S-60, EMULGEN 4085, EMULGEN 2020G-HA, EMULGEN 2025G, EMANON 1112, EMANON 3199V, EMANON 3299V, EMANON 3299RV, EMANON 4110. More preferably, EMULGEN 103, EMULGEN 104P, EMULGEN 105, EMULGEN 106, EMULGEN 108, EMULGEN 109P, EMULGEN 210P, EMULGEN 306P, EMULGEN 320P, EMULGEN 404, EMULGEN 408, EMULGEN 409PV, EMULGEN 420, EMULGEN can be listed. 705, EMULGEN 707, EMULGEN 709, EMULGEN 1108, EMULGEN 2020G-HA, EMANON 1112, EMANON 4110. Even more preferred are EMULGEN 104P, EMULGEN 105, EMULGEN 106, EMULGEN 108, EMULGEN 210P, EMULGEN 306P, EMULGEN 408, EMULGEN 409PV, EMULGEN 705, EMULGEN 707, EMULGEN 709, EMULGEN 1108, EMULGEN 2020G- HA, EMANON 1112, EMANON 4110. In addition, it may be appropriately selected from the NIKKOL (registered trademark) series of NIKKO CHEMICALS. Examples include NIKKOL BT-5, NIKKOL BT-7, NIKKOL BT-9, NIKKOL BT-12, NIKKOL BL-2, NIKKOL BL-4.2, NIKKOL BL-9EX, and the like, and most preferably NIKKOL BL-4.2.

上述聚甘油脂肪酸酯,可列舉甘油硬脂酸酯、甘油異硬脂酸酯、甘油棕櫚酸酯、甘油肉豆蔻酸酯、甘油油酸酯、甘油椰油脂肪酸酯、甘油單棉籽油脂肪酸酯、甘油單芥酸酯、甘油倍半油酸酯、α,α’-甘油油酸焦麩胺酸酯、甘油單硬脂酸蘋果酸等之甘油脂肪酸部分酯類;聚甘油-2硬脂酸酯(Polyglyceryl-2 Stearate)、同3、同4、同5、同6、同8、同10、聚甘油-6二硬脂酸酯、同10、聚甘油-2三硬脂酸酯、聚甘油-10十硬脂酸酯、聚甘油-2異硬脂酸酯、同3、同4、同5、同6、同8、同10、聚甘油-2二異硬脂酸酯(二甘油二異硬脂酸酯)、同3、同10(十甘油二異硬脂酸酯)、聚甘油-2三異硬脂酸酯、聚甘油-2四異硬脂酸酯、聚甘油-10十異硬脂酸酯、聚甘油-2油酸酯、同3、同4、同5、同6、同8、同10、聚甘油-6二油酸酯、聚甘油-2三油酸酯、聚甘油-10十油酸酯等。Examples of the polyglycerol fatty acid ester include glyceryl stearate, glyceryl isostearate, glycerol palmitate, glyceryl myristate, glyceryl oleate, glycerol coconut fatty acid ester, and glycerol mono-cotton oil fat Esters of glycerol fatty acids, such as glycerol monoerucate, glyceryl sesquioleate, α, α'-glyceryl oleate pyroglutamate, glycerol monostearate malate, etc .; polyglycerin-2 hard Polyglyceryl-2 Stearate, Same as 3, Same as 4, Same with 5, Same with 6, Same with 8, Same with 10, Polyglyceryl-6 distearate, Same with 10, Polyglycerol-2 tristearate , Polyglycerol-10 Decanostearate, Polyglycerol-2 Isostearate, Same 3, Same 4, Same 5, 5, Same 8, Same 10, Polyglycerol-2 Diisostearate ( Diglycerol diisostearate), same as 3, 10 (decaglycerol diisostearate), polyglycerol-2 triisostearate, polyglycerol-2 tetraisostearate, polyglycerin -10 Decaisostearate, Polyglycerol-2 Oleate, Same 3, Same 4, Same 5, Same 6, 8, 8, 10, Polyglycerol-6 Dioleate, Polyglycerol-2 Tri-oil Acid esters, polyglycerol-10 decaoleate, and the like.

聚氧乙烯聚氧丙烯烷醚,可列舉花王(股)之EMULGEN(註冊商標)LS-106、EMULGEN LS-110、EMULGEN LS-114、EMULGEN MS-110、及NIKKO CHEMICALS(股)之NIKKOL(註冊商標)PBC-31、NIKKOL PBC-33、NIKKOL PBC-34、NIKKOL PBC-41、NIKKOL PBC-44、NIKKOL PBN-4612、NIKKOL PBN-4620、NIKKOL PBN-4630。更佳為可列舉EMULGEN LS-106、EMULGEN LS-110、EMULGEN LS-114、EMULGEN MS-110。又更佳為可列舉EMULGEN LS-106、EMULGEN LS-110、EMULGEN MS-110。Polyoxyethylene polyoxypropylene alkyl ethers include EMULGEN (registered trademark) LS-106, EMULGEN LS-110, EMULGEN LS-114, EMULGEN MS-110, and NIKKOL (registered) of NIKKO CHEMICALS (shares). Trademarks) PBC-31, NIKKOL PBC-33, NIKKOL PBC-34, NIKKOL PBC-41, NIKKOL PBC-44, NIKKOL PBN-4612, NIKKOL PBN-4620, NIKKOL PBN-4630. More preferred examples include EMULGEN LS-106, EMULGEN LS-110, EMULGEN LS-114, and EMULGEN MS-110. More preferred examples include EMULGEN LS-106, EMULGEN LS-110, and EMULGEN MS-110.

又,在本發明中使用的界面活性劑,可適合使用其HLB(Hydrophile-Lipophile Balance)值為8至20者。更佳為HLB值為8至14。   這種界面活性劑,可列舉例如異硬脂酸山梨糖醇酐、STEARETH-8、Beheneth-10、LAURETH-4、LAURETH-5、CETETH-7、Oleth-8、PEG-8甘油異硬脂酸酯、Choleth-10、異硬脂酸PEG-10BG、PEG-30甘油三異硬脂酸酯、PEG-30甘油三異硬脂酸酯、PEG-30甘油三油酸酯、三異硬脂酸PEG-30三羥甲基丙烷、月桂酸PEG-30氫化蓖麻油、PCA異硬脂酸PEG-30氫化蓖麻油、Octyldodeceth-10、二月桂酸PEG-12、Sorbeth-40 Tetraoleate、聚甘油二異硬脂酸酯-10(二異硬脂酸十甘油酯)、PEG-20甘油二異硬脂酸酯、異硬脂酸PEG-8、PEG-10甘油異硬脂酸酯、三異硬脂酸PEG-60氫化蓖麻油、PPG-2-Deceth-7、Oleth-10、Hydrogenated Dimer Dilinoleth-20、椰子脂肪酸山梨糖醇酐、ISOSTEARETH-10、STEARETH-11、三肉豆蔻酸PEG-30三羥甲基丙烷、異硬脂酸PEG-40氫化蓖麻油、異硬脂酸PEG-40氫化蓖麻油、PCA異硬脂酸PEG-40氫化蓖麻油、LAURETH-7、ISOCETETH-10、Ceteth-10、異硬脂酸PEG-10、硬脂酸PEG-10、油酸PEG-10、PEG-10甘油硬脂酸酯、Oleth-12、DECYLTETRADECETH-15、Choleth-15、二月桂酸PEG-16、PEG-30氫化蓖麻油、PEG-40甘油三異硬脂酸酯、PEG-40甘油三油酸酯、三異硬脂酸PEG-40三羥甲基丙烷、月桂酸PEG-40氫化蓖麻油、月桂酸PEG-12等。The surfactant used in the present invention is preferably one having an HLB (Hydrophile-Lipophile Balance) value of 8 to 20. More preferably, the HLB value is 8 to 14. Examples of such a surfactant include sorbitan isostearate, STEARETH-8, Beheneth-10, LAURETH-4, LAURETH-5, CETETH-7, Oleth-8, and PEG-8 glyceryl isostearic acid. Ester, Choleth-10, PEG-10BG isostearate, PEG-30 glyceryl triisostearate, PEG-30 glyceryl triisostearate, PEG-30 glyceryl trioleate, triisostearate PEG-30 trimethylolpropane, lauric acid PEG-30 hydrogenated castor oil, PCA isostearic acid PEG-30 hydrogenated castor oil, Octyldodeceth-10, lauric acid PEG-12, Sorbeth-40 Tetraoleate, polyglycerol diiso Stearate-10 (decisoglyceryl diisostearate), PEG-20 diisostearate, PEG-8 isostearate, PEG-10 isostearate, triisostearate Acid PEG-60 hydrogenated castor oil, PPG-2-Deceth-7, Oleth-10, Hydrogenated Dimer Dilinoleth-20, coconut fatty acid sorbitan, ISOSTEARETH-10, STEARETH-11, trimyristic acid PEG-30 trihydroxy Methylpropane, PEG-40 isostearic acid hydrogenated castor oil, PEG-40 isostearic acid hydrogenated castor oil, PCA isostearic acid PEG-40 hydrogenated castor oil, LAURETH-7, ISOCETETH-10, Ceteth-10, Isostearic acid P EG-10, PEG-10 stearic acid, PEG-10 oleic acid, PEG-10 glyceryl stearate, Oleth-12, DECYLTETRADECETH-15, Choleth-15, PEG-16 dilaurate, PEG-30 hydrogenated castor Sesame oil, PEG-40 glycerol triisostearate, PEG-40 glycerol trioleate, triisostearate PEG-40 trimethylolpropane, lauric acid PEG-40 hydrogenated castor oil, lauric acid PEG-12 Wait.

在本發明中,界面活性劑之調配量係相對於所得之分散液之總質量,例如為0.01質量%至2質量%,又,例如為0.01質量%至1質量%,較佳為0.01質量%至0.5質量%,更佳為0.01質量%至0.3質量%,例如0.02質量%至0.2質量%。   又,在本發明中可使用的界面活性劑係上述界面活性劑群之至少一種,可將此等界面活性劑以單獨或組合二種以上使用。In the present invention, the compounding amount of the surfactant is relative to the total mass of the obtained dispersion liquid, for example, 0.01 mass% to 2 mass%, and, for example, 0.01 mass% to 1 mass%, preferably 0.01 mass% It is 0.5 mass%, more preferably 0.01 mass% to 0.3 mass%, for example, 0.02 mass% to 0.2 mass%. In addition, the surfactant that can be used in the present invention is at least one of the above-mentioned surfactant groups, and these surfactants can be used alone or in combination of two or more.

[1,2-烷二醇或1,3-烷二醇]   在本發明之分散液中使用的1,2-烷二醇或1,3-烷二醇,具有促進前述顏料或粉體用分散劑之脂質肽型化合物之溶解性的功能。   前述1,2-烷二醇之具體例,可列舉1,2-戊二醇、1,2-己二醇、1,2-辛二醇及1,2-癸二醇等。較佳為1,2-戊二醇、1,2-己二醇、1,2-辛二醇。又更佳為1,2-戊二醇或1,2-己二醇。   前述1,3-烷二醇之具體例,可列舉1,3-丙二醇、2-甲基-1,3-丙二醇、1,3-丁二醇、3-甲基-1,3-丁二醇、1,3-戊二醇、1,3-己二醇、2-乙基-1,3-己二醇、2-乙基-1,3-辛二醇及1,3-癸二醇等。較佳為1,3-丁二醇、1,3-戊二醇、1,3-己二醇、2-乙基-1,3-己二醇、2-乙基-1,3-辛二醇。又更佳為1,3-丁二醇、2-乙基-1,3-己二醇、2-乙基-1,3-辛二醇。   可將此等1,2-烷二醇或1,3-烷二醇,可單獨使用或組合二種以上使用。[1,2-alkanediol or 1,3-alkanediol] 的 The 1,2-alkanediol or 1,3-alkanediol used in the dispersion liquid of the present invention is used for promoting the pigment or powder. Solubility of dispersants for lipid-peptide compounds.具体 Specific examples of the 1,2-alkanediol include 1,2-pentanediol, 1,2-hexanediol, 1,2-octanediol, and 1,2-decanediol. Preferred are 1,2-pentanediol, 1,2-hexanediol, and 1,2-octanediol. Even more preferred is 1,2-pentanediol or 1,2-hexanediol. Specific examples of the 1,3-alkanediol include 1,3-propanediol, 2-methyl-1,3-propanediol, 1,3-butanediol, and 3-methyl-1,3-butanediol. Alcohol, 1,3-pentanediol, 1,3-hexanediol, 2-ethyl-1,3-hexanediol, 2-ethyl-1,3-octanediol, and 1,3-decane Alcohol and so on. Preferred are 1,3-butanediol, 1,3-pentanediol, 1,3-hexanediol, 2-ethyl-1,3-hexanediol, 2-ethyl-1,3-octane Diol. Even more preferred are 1,3-butanediol, 2-ethyl-1,3-hexanediol, and 2-ethyl-1,3-octanediol.等 These 1,2-alkanediols or 1,3-alkanediols can be used alone or in combination of two or more kinds.

在本發明中,1,2-烷二醇或1,3-烷二醇之調配量係相對於所得之分散液之總質量,例如為0.001質量%至15質量%,較佳為0.005質量%至15質量%,更佳為0.01質量%至15質量%,例如0.01質量%至12質量%。In the present invention, the blending amount of 1,2-alkanediol or 1,3-alkanediol is relative to the total mass of the obtained dispersion liquid, for example, is 0.001% by mass to 15% by mass, and preferably 0.005% by mass. 15 mass%, more preferably 0.01 mass% to 15 mass%, such as 0.01 mass% to 12 mass%.

[脂肪酸]   在本發明之分散液中使用的脂肪酸,較佳為選自由碳原子數10至20之飽和脂肪酸及不飽和脂肪酸及該等脂肪酸之鹽所組成之群組之至少1種,例如脂肪酸,可列舉癸酸、十一烷酸、月桂酸、十三烷酸、肉豆蔻酸、十五烷酸、棕櫚酸、十七烷酸、硬脂酸。又更佳癸酸、月桂酸、肉豆蔻酸、棕櫚酸、硬脂酸,其中較佳為硬脂酸。   於本發明中,使用之脂肪酸之調配量係相對於所得之分散液之總質量,例如為0.001質量%至1質量%,較佳為0.001質量%至0.1質量%,更佳為0.005質量%至0.05質量%。   又,在本發明中使用的脂肪酸係選自上述脂肪酸群之至少1種,此等脂肪酸以單獨或組合二種以上使用。[Fatty acid] (1) The fatty acid used in the dispersion of the present invention is preferably at least one selected from the group consisting of saturated fatty acids having 10 to 20 carbon atoms, unsaturated fatty acids, and salts of these fatty acids, such as fatty acids Examples include capric acid, undecanoic acid, lauric acid, tridecanoic acid, myristic acid, pentadecanoic acid, palmitic acid, heptadecanoic acid, and stearic acid. Still more preferred are capric acid, lauric acid, myristic acid, palmitic acid, and stearic acid, of which stearic acid is preferred. In the present invention, the blending amount of the fatty acid used is relative to the total mass of the obtained dispersion, for example, 0.001% to 1% by mass, preferably 0.001% to 0.1% by mass, and more preferably 0.005% by mass to 0.05% by mass. In addition, the fatty acid used in the present invention is at least one selected from the aforementioned fatty acid groups, and these fatty acids are used alone or in combination of two or more.

[顏料或粉體]   調配於本發明之分散液的顏料或粉體,無特別限定者。   例如顏料,可列舉二氧化鈦、氧化鋅等無機白色顏料;紅氧化鐵(氧化鐵紅)、鈦酸鐵等無機紅色系顏料;γ-氧化鐵等無機褐色系顏料;氧化鐵黃、黃土等無機黃色系顏料;氧化鐵黑、低價氧化鈦等無機黑色系顏料;錳紫、鈷紫等無機紫色系顏料;氧化鉻、氫氧化鉻、鈦酸鈷等無機綠色系顏料;群青、普魯士藍等之無機藍色系顏料;氧化鈦塗覆雲母、氧化鈦塗覆氯氧化鉍、氧化鈦塗覆滑石、著色氧化鈦塗覆雲母、氯氧化鉍、魚鱗箔等珠光顏料;滑石、絹雲母 雲母、高嶺土、碳酸鈣、碳酸鎂、無水矽酸、硫酸鋇、氫氧化鋁等之體質顏料;鋁粉末、銅粉末、金等之金屬粉末顏料;表面處理無機及金屬粉末顏料;鋯、鋇或鋁色澱等之有機顏料;表面處理有機顏料等。此等顏料之中,更佳為親水性的顏料。 作為粉體,可列舉雲母、滑石、高嶺土、絹雲母、蒙脫石、高嶺石、雲母、白雲母、金雲母、合成雲母、紅雲母、黑雲母、蛭石、碳酸鎂、碳酸鈣、矽酸鋁、矽酸鋇、矽酸鈣、矽酸鎂、矽酸鍶、鎢酸金屬鹽、鎂、沸石、硫酸鋇、燒成硫酸鈣、磷酸三鈣等之磷酸鈣、氟磷灰石、羥基磷灰石、陶瓷粉末、膨潤土、蒙皂石、黏土、泥、金屬皂(例如,肉豆蔻酸鋅、棕櫚酸鈣、硬脂酸鋁)、碳酸鈣、氧化鐵紅、氧化鐵黃、氧化鐵黑、群青、普魯士藍、碳黑、氧化鈦、微粒子及超微粒氧化鈦、氧化鋅、微粒子及超微粒氧化鋅、氧化鋁、二氧化矽、煙霧二氧化矽(超微粒無水矽酸)、雲母鈦、魚鱗箔、氮化硼、光致變色顏料、合成氟金雲母、微粒子複合粉體、金、銀、鉑、鋁等各種大小/形狀的無機粉體,以及將此等粉末使用氫矽氧烷、環狀氫矽氧烷等矽氧烷或其他矽烷或鈦偶合劑等各種表面處理劑進行處理,形成疏水化或親水化的粉體等無機粉體;澱粉、纖維素、尼龍粉末、聚乙烯粉末、聚甲基丙烯酸甲酯粉末、聚苯乙烯粉末、苯乙烯與丙烯酸的共聚物樹脂粉末、聚酯粉末、苯胍胺樹脂粉末、聚對苯二甲酸乙二酯/聚甲基丙烯酸甲酯積層粉末、聚對苯二甲酸乙二酯/鋁/環氧化合物積層粉末等、聚胺基甲酯粉末、矽氧烷粉末、Teflon(註冊商標)粉末等各種大小/形狀的有機系粉體及表面處理粉體、有機無機複合粉體為較佳者。   在本發明中,顏料或粉體係相對於分散液之總質量,例如可為25質量%以下,較佳為20質量%以下。又,顏料或粉體之調配量之下限無特別限定,但是例如為0.001質量%左右。   又,在本發明中可使用的上述顏料或粉體係上述顏料群及粉體群之至少一種,此等顏料或粉體,可單獨或組合二種以上使用。[Pigment or Powder] The pigment or powder to be formulated in the dispersion liquid of the present invention is not particularly limited. Examples of pigments include inorganic white pigments such as titanium dioxide and zinc oxide; inorganic red pigments such as red iron oxide (iron oxide red) and iron titanate; inorganic brown pigments such as γ-iron oxide; inorganic yellow such as iron oxide yellow and loess Pigments; inorganic black pigments such as iron oxide black and low-priced titanium oxide; inorganic violet pigments such as manganese violet and cobalt violet; inorganic green pigments such as chromium oxide, chromium hydroxide, and cobalt titanate; ultramarine and Prussian blue Inorganic blue pigments; pearlescent pigments such as titanium oxide coated mica, titanium oxide coated bismuth oxychloride, titanium oxide coated talc, colored titanium oxide coated mica, bismuth oxychloride, fish scale foil; talc, sericite , mica, Constitution pigments of kaolin, calcium carbonate, magnesium carbonate, anhydrous silicic acid, barium sulfate, aluminum hydroxide, etc .; metal powder pigments such as aluminum powder, copper powder, gold, etc .; surface treatment inorganic and metal powder pigments; zirconium, barium or aluminum color Organic pigments such as lakes; surface-treated organic pigments. Among these pigments, hydrophilic pigments are more preferred. Examples of the powder include mica, talc, kaolin, sericite, montmorillonite, kaolinite, mica, muscovite, phlogopite, synthetic mica, red mica, biotite, vermiculite, magnesium carbonate, calcium carbonate, and silicic acid. Aluminum, barium silicate, calcium silicate, magnesium silicate, strontium silicate, metal tungstate, magnesium, zeolite, barium sulfate, calcined calcium sulfate, tricalcium phosphate, etc. Limestone, ceramic powder, bentonite, smectite, clay, mud, metal soap (e.g. zinc myristate, calcium palmitate, aluminum stearate), calcium carbonate, iron oxide red, iron oxide yellow, iron oxide black , Ultramarine, Prussian blue, carbon black, titanium oxide, fine particles and ultrafine particles of titanium oxide, zinc oxide, fine particles and ultrafine particles of zinc oxide, aluminum oxide, silicon dioxide, fumes of silicon dioxide (ultrafine anhydrous silicic acid), titanium mica , Fish scale foil, boron nitride, photochromic pigment, synthetic fluorophlogopite, fine particle composite powder, gold, silver, platinum, aluminum and other inorganic powders of various sizes / shapes, and use these powders with hydrosiloxane , Cyclohydrosiloxane, etc. Various surface treatment agents such as alkane or titanium coupling agent are processed to form inorganic powders such as hydrophobized or hydrophilized powders; starch, cellulose, nylon powder, polyethylene powder, polymethyl methacrylate powder, polystyrene Powder, styrene and acrylic copolymer resin powder, polyester powder, benzoguanamine resin powder, polyethylene terephthalate / polymethyl methacrylate laminated powder, polyethylene terephthalate / aluminum / Epoxy compound laminated powder, polyurethane powder, siloxane powder, Teflon (registered trademark) powder and other organic powders and surface treatment powders and organic-inorganic composite powders of various sizes and shapes are preferred. By. In the present invention, the total mass of the pigment or powder system relative to the dispersion may be, for example, 25% by mass or less, and preferably 20% by mass or less. The lower limit of the blending amount of the pigment or powder is not particularly limited, but is, for example, about 0.001% by mass. The pigment or powder system that can be used in the present invention is at least one of the above-mentioned pigment group and powder group, and these pigments or powders can be used alone or in combination of two or more kinds.

[多元醇]   本發明之分散液,可再包含多元醇。前述多元醇係與先前所列舉之1,2-烷二醇或1,3-烷二醇不同的多元醇,其具體例可列舉甘油、丙二醇及聚乙二醇等。又,上述聚乙二醇可適合使用例如平均分子量1,000至4,000者。   在本發明中,包含多元醇時,其調配量係相對於所得之分散液之總質量,例如可為1質量%至60質量%,較佳為10質量%至30質量%。[Polyol] The dispersion liquid of the present invention may further contain a polyol. The polyhydric alcohol is a polyhydric alcohol different from the 1,2-alkanediol or 1,3-alkanediol listed above, and specific examples thereof include glycerin, propylene glycol, and polyethylene glycol. The polyethylene glycol may be suitably used, for example, an average molecular weight of 1,000 to 4,000. In the present invention, when a polyhydric alcohol is included, the blending amount may be 1 to 60% by mass, and preferably 10 to 30% by mass relative to the total mass of the obtained dispersion.

[其他之添加劑]   本發明之分散液中,必要時,可調配一般可作為化妝品用添加劑或醫藥部外品用添加劑及醫藥用添加劑使用的添加劑。作為被調配於化妝品、醫藥部外品或醫藥等之皮膚外用劑之生理活性物質及機能性物質等的添加成分,可列舉例如油性基劑、保濕劑、感觸向上劑、上述以外之界面活性劑、高分子、增黏・凝膠化劑、溶劑、抗氧化劑、還原劑、氧化劑、防腐劑、抗菌劑、殺菌劑、螯合劑、pH調整劑、酸、鹼、無機鹽、紫外線吸收劑、美白劑、維生素類及其衍生物類、生髮用藥劑、血液循環促進劑、刺激劑、激素類、抗皺紋劑、抗老化劑、緊緻(tightening)劑、冷感劑、溫感劑、創傷治癒促進劑、刺激減緩劑、鎮痛劑、細胞賦活劑、植物/動物/生物萃取物、止癢劑、角質剝離/溶解劑、止汗劑、清涼劑、收斂劑、酵素、核酸、香料、色素、著色劑、染料、消炎劑、抗消炎止痛劑(anti-inflammatory drug)、抗哮喘、抗慢性阻礙性肺病劑、抗過敏症劑、免疫調節劑、抗感染病劑及抗真菌劑等。   此等其他之添加劑之調配量係因種類可有各種變化,但是相對於分散液之總質量,例如可成為0.001質量%至20質量%、或0.01質量%至10質量%左右。[Other additives] 分散 In the dispersion of the present invention, additives which can be generally used as additives for cosmetics, additives for external products of the medical department, and additives for pharmaceuticals can be blended when necessary. Examples of the additional ingredients such as physiologically active substances and functional substances formulated for external skin preparations such as cosmetics, quasi-drugs, or pharmaceuticals include oily bases, moisturizers, touch-up agents, and surfactants other than the above. , Polymer, thickening gelling agent, solvent, antioxidant, reducing agent, oxidant, preservative, antibacterial agent, bactericide, chelating agent, pH adjuster, acid, alkali, inorganic salt, ultraviolet absorber, whitening agent Agents, vitamins and their derivatives, hair growth agents, blood circulation promoters, stimulants, hormones, anti-wrinkle agents, anti-aging agents, tightening agents, cold-sensing agents, warming agents, wound healing Accelerators, stimulants, analgesics, cell activators, plant / animal / biological extracts, antipruritic agents, keratin peels / lytic agents, antiperspirants, cooling agents, astringents, enzymes, nucleic acids, perfumes, pigments, Colorants, dyes, anti-inflammatory agents, anti-inflammatory drugs, anti-asthma, anti-chronic obstructive pulmonary disease agents, anti-allergic agents, immunomodulators, anti-infective agents and anti-inflammatory drugs Agents and so on.调 The blending amount of these other additives may vary depending on the type, but may be about 0.001% to 20% by mass, or about 0.01% to 10% by mass, relative to the total mass of the dispersion.

作為油性基劑,例如有油醇、荷荷巴醇、鮫肝醇(chimyl alcohol)、鯊油醇、鯊肝醇、己基癸醇、異硬脂醇、2-辛基月桂醇、二聚二醇等高級(多元)醇類;苄醇等芳烷基醇及其衍生物;異硬脂酸、二十二烷酸、十一碳烯酸、12-羥基硬脂酸、棕櫚油酸、油酸、亞油酸、亞麻酸、芥酸、二十二碳六烯酸、二十碳五烯酸、異十六烷酸、反異二十一烷酸、長鏈支化脂肪酸、二聚酸(dimer acid)、氫化二聚酸等;液體石蠟(礦物油)、重質液體異鏈烷烴、輕質液體異鏈烷烴、α-烯烴低聚物、聚異丁烯、氫化聚異丁烯、聚丁烯、角鯊烷、源自橄欖的角鯊烷、角鯊烯、凡士林、固體石蠟等烴類;小燭樹蠟、巴西棕櫚蠟、米蠟、木蠟、蜜蠟、褐煤蠟、地蠟、純地蠟、石蠟、微晶蠟、石蠟油、費托合成(FISCHER-TROPSCH)蠟、聚乙烯蠟、乙烯/丙烯共聚物等蠟類;椰子油、棕櫚油、棕櫚核油、紅花子油、橄欖油、蓖麻油、鱷梨油、麻油、茶油、月見草油、小麥胚芽油、夏威夷堅果油、榛子堅果油、石栗堅果油、薔薇果油、繡線菊油、桃仁油、茶樹油、薄荷油、玉米油、菜籽油、葵花油、小麥胚芽油、亞麻油、棉籽油、大豆油、花生油、米糠油、可可脂、牛油樹脂、氫化椰子油、氫化蓖麻油、荷荷巴油、氫化荷荷巴油、葡萄籽油、杏仁油(apricot油)、樁油等之植物油脂類;牛脂、乳脂、馬脂、蛋黃油、貂油、海龜油等動物性油脂類;鯨蠟、羊毛脂、橙魚油(Orange roughy oil)等動物性蠟類;液態羊毛脂、還原羊毛脂、吸附純化羊毛脂、醋酸羊毛脂、醋酸液態羊毛脂、羥基羊毛脂、聚氧乙烯羊毛脂、羊毛脂脂肪酸、硬質羊毛脂脂肪酸、羊毛脂醇、醋酸羊毛脂醇、醋酸(鯨蠟基/羊毛脂)酯等羊毛脂類;膽固醇、二氫膽固醇、羊毛甾醇、二氫羊毛甾醇、植物甾醇、膽酸等固醇類;皂苷元類;皂苷類;醋酸膽固醇酯、壬酸膽固醇酯、硬脂酸膽固醇酯、異硬脂酸膽固醇酯、油酸膽固醇酯、N-月桂醯基-L-麩胺酸二(膽固醇/二十二烷基/辛基十二烷基)酯、N-月桂醯基-L-麩胺酸二(膽固醇/辛基十二烷基)酯、N-月桂醯基-L-麩胺酸二(植物甾醇/二十二烷基/辛基十二烷基)酯、N-月桂醯基-L-麩胺酸二(植物甾醇/辛基十二烷基)酯、N-月桂醯基肌胺酸異丙基等醯基肌胺酸烷基酯、12-羥基硬脂酸膽固醇酯、夏威夷堅果油脂肪酸膽固醇酯、夏威夷堅果油脂肪酸植物甾醇、異硬脂酸植物甾醇、軟質羊毛脂脂肪酸膽固醇酯、硬質羊毛脂脂肪酸膽固醇酯、長鏈支化脂肪酸膽固醇酯、長鏈α-羥基脂肪酸膽固醇酯等固醇酯類;磷脂/膽固醇複合體、磷脂/植物甾醇複合體等脂質複合體;肉豆蔻酸辛基十二烷酯、肉豆蔻酸己基癸酯、異硬脂酸辛基十二烷酯、棕櫚酸鯨蠟酯、棕櫚酸辛基十二烷酯、辛酸鯨蠟酯、辛酸己基癸酯、異壬酸異十三烷酯、異壬酸異壬酯、異壬酸辛酯、異壬酸異十三烷基酯、新戊酸異癸酯、新戊酸異十三烷酯、新戊酸異硬脂酯、新癸酸辛基十二烷酯、油酸油烯酯、油酸辛基十二烷酯、蓖麻油酸(ricinoleic acid)辛基十二烷酯、羊毛脂脂肪酸辛基十二烷酯、二甲基辛酸己基癸酯、芥酸辛基十二烷酯、異硬脂酸硬化蓖麻油、油酸乙酯、鱷梨油脂肪酸乙酯、肉豆蔻酸異丙酯、棕櫚酸異丙酯、棕櫚酸辛酯、異硬脂酸異丙酯、羊毛脂脂肪酸異丙酯、癸二酸二乙酯、癸二酸二異丙酯、癸二酸二辛酯、己二酸二異丙酯、癸二酸二丁基辛酯、己二酸二異丁酯、琥珀酸二辛酯、檸檬酸三乙酯等單醇羧酸酯類;乳酸鯨蠟酯、蘋果酸二異硬脂酯、單異硬脂酸氫化蓖麻油等羥基酸酯類;三辛酸甘油酯(三2-乙基己酸甘油酯)、三油酸甘油酯、三異硬脂酸甘油酯、二異硬脂酸甘油酯、三(辛酸/癸酸)甘油酯、三(辛酸/癸酸/肉豆蔻酸/硬脂酸)甘油酯、氫化松香三甘油酯(氫化酯樹膠)、松香三甘油酯(酯樹膠)、二十二烷酸二十烷二酸甘油酯、三辛酸三羥甲基丙烷、三異硬脂酸三羥甲基丙烷、二辛酸新戊二醇酯、二癸酸新戊二醇酯、二辛酸2-丁基-2-乙基-1,3-丙二醇酯、二油酸丙二醇酯、四辛酸季戊四醇酯、氫化松香季戊四醇酯、三乙基己酸二三羥甲基丙烷、(異硬脂酸/癸二酸)二三羥甲基丙烷、三乙基己酸季戊四醇酯、(羥基硬脂酸/硬脂酸/松香酸)二季戊四醇酯、二異硬脂酸二甘油酯、聚甘油四異硬脂酸酯、聚甘油-10九異硬脂酸酯、聚甘油-8十(芥酸/異硬脂酸/蓖麻油酸)酯、二甘油(己基癸酸/癸二酸)低聚酯、二硬脂酸甘醇酯(二硬脂酸乙二醇酯)、二新戊酸3-甲基-1,5-戊二醇、二新戊酸2,4-二乙基-1,5-戊二醇等多元醇脂肪酸酯類;二聚體二亞麻油酸二異丙酯、二聚體二亞麻油酸二異硬脂酯、二聚體二亞麻油酸二(異硬脂基/植物甾醇)酯、二聚體二亞麻油酸(植物甾醇/二十二烷基)酯、二聚體二亞麻油酸(植物甾醇/異硬脂基/鯨蠟基/硬脂基/二十二烷基)酯、二聚體二亞麻油酸二聚亞麻油醇酯、二異硬脂酸二聚亞麻油醇酯、二聚亞麻油醇酯氫化松香縮合物、二聚體二亞麻油酸硬化蓖麻油、羥基烷基二聚亞麻油醇醚等二聚體酸或二聚二醇的衍生物;椰子油脂肪酸單乙醇醯胺(椰油醯胺MEA)、椰子油脂肪酸二乙醇醯胺(椰油醯胺DEA)、月桂酸單乙醇醯胺(月桂醯胺MEA)、月桂酸二乙醇醯胺(月桂醯胺DEA)、月桂酸單異丙醇醯胺(月桂醯胺MIPA)、棕櫚酸單乙醇醯胺(棕櫚醯胺MEA)、棕櫚酸二乙醇醯胺(棕櫚醯胺DEA)、椰子油脂肪酸甲基乙醇醯胺(椰油醯胺甲基MEA)等脂肪酸烷醇醯胺類;二甲聚矽氧烷(二甲基聚矽氧烷)、高聚合二甲聚矽氧烷(高聚合二甲基聚矽氧烷)、環聚二甲基矽氧烷(環狀二甲基矽氧烷、十甲基環戊矽氧烷(亦僅稱為環戊矽氧烷))、苯基甲基聚三甲基矽氧烷、二苯基二甲聚矽氧烷、苯基二甲聚矽氧烷、硬脂氧基丙基二甲基胺、(胺基乙基胺基丙基聚甲基聚矽氧烷/二甲聚矽氧烷)共聚物、聚二甲基矽氧烷醇、聚二甲基矽氧烷醇交聯聚合物、矽酮樹脂、矽酮橡膠、胺基丙基二甲聚矽氧烷及胺基端基二甲聚矽氧烷等之胺基改性矽酮(modified silicone)、陽離子改性矽酮、二甲聚矽氧烷共聚醇等之聚醚改性矽酮、聚甘油改性矽酮、糖改性矽酮、羧酸改性矽酮、磷酸改性矽酮、硫酸改性矽酮、烷基改性矽酮、脂肪酸改性矽酮、烷醚改性矽酮、胺基酸改性矽酮、肽改性矽酮、氟改性矽酮、陽離子改性及聚醚改性矽酮、胺基改性及聚醚改性矽酮、烷基改性及聚醚改性矽酮、聚矽氧烷/環氧烷烴共聚物等矽酮類;全氟癸烷、全氟辛烷、全氟聚醚等氟系油劑類為較佳者。Examples of the oily base include oleyl alcohol, jojoba alcohol, chimyl alcohol, squalol, sharkol, hexyldecanol, isostearyl alcohol, 2-octyl lauryl alcohol, and dimer dimer. Higher (poly) alcohols such as alcohols; aralkyl alcohols and derivatives thereof such as benzyl alcohol; isostearic acid, behenic acid, undecylenic acid, 12-hydroxystearic acid, palmitoleic acid, oil Acid, linoleic acid, linolenic acid, erucic acid, docosahexaenoic acid, eicosapentaenoic acid, isohexadecanoic acid, anteisocosanoic acid, long chain branched fatty acids, dimer acids (dimer acid), hydrogenated dimer acid, etc .; liquid paraffin (mineral oil), heavy liquid isoparaffin, light liquid isoparaffin, α-olefin oligomer, polyisobutylene, hydrogenated polyisobutylene, polybutene, Squalane, squalane derived from olive, squalene, vaseline, solid paraffin and other hydrocarbons; candelilla wax, carnauba wax, rice wax, wood wax, beeswax, montan wax, ceresin, pure ground Wax, paraffin, microcrystalline wax, paraffin oil, FISCHER-TROPSCH wax, polyethylene wax, ethylene / propylene copolymer and other waxes; coconut oil, palm oil, palm kernel oil , Safflower oil, olive oil, castor oil, avocado oil, sesame oil, tea oil, evening primrose oil, wheat germ oil, macadamia nut oil, hazelnut nut oil, stone chestnut nut oil, rosehip oil, spiraea oil, peach kernel oil , Tea tree oil, peppermint oil, corn oil, rapeseed oil, sunflower oil, wheat germ oil, linseed oil, cottonseed oil, soybean oil, peanut oil, rice bran oil, cocoa butter, shea butter, hydrogenated coconut oil, hydrogenated castor oil, Vegetable oils such as jojoba oil, hydrogenated jojoba oil, grape seed oil, almond oil (apricot oil), pile oil, etc .; animal fats such as tallow, milk fat, horse fat, egg butter, mink oil, sea turtle oil, etc. ; Animal waxes such as whale wax, lanolin, orange roughy oil; liquid lanolin, reduced lanolin, adsorption and purification of lanolin, lanolin acetate, lanolin acetate liquid, hydroxylanolin, polyoxyethylene wool Fats, lanolin fatty acids, hard lanolin fatty acids, lanolin alcohols, lanolin alcohols, lanolin acetates, lanolin acetates (cetyl / lanolin) acetates; cholesterol, dihydrocholesterol, lanosterol, dihydrolanosterol , Sterols such as phytosterol, cholic acid; saponin; saponin; cholesterol acetate, cholesterol nonanoate, cholesterol stearate, cholesterol isostearate, cholesterol oleate, N-laurate -L-glutamate di (cholesterol / docosyl / octyldodecyl) ester, N-lauryl-L-glutamate di (cholesterol / octyldodecyl) ester, N -Lauryl-L-glutamate di (phytosterol / docosyl / octyldodecyl) ester, N-lauryl-L-glutamate di (phytosterol / octyldodecyl) Alkyl alkyl esters such as alkyl) esters, N-lauroyl sarcosinate isopropyl, 12-hydroxystearate cholesterol, macadamia oil fatty acid cholesterol esters, macadamia oil fatty acid plant sterols, isopropyl Stearic acid phytosterols, soft lanolin fatty acid cholesterol esters, hard lanolin fatty acid cholesterol esters, long chain branched fatty acid cholesterol esters, long chain α-hydroxy fatty acid cholesterol esters, and other sterol esters; phospholipid / cholesterol complexes, phospholipids / Lipid complexes such as plant sterol complexes; octyldodecyl myristate, hexyl decyl myristate, isostearyl Octyldodecyl, cetyl palmitate, octyldodecyl palmitate, cetyl octanoate, hexyl decyl octoate, isotridecyl isononanoate, isononyl isononanoate, octanoic isononanoate Esters, isodosanyl isononanoate, isodecanyl pivalate, isodedecyl pivalate, isostearyl pivalate, octyldodecyl neodecanoate, oleyl oleate , Octyldodecyl oleate, ricinoleic acid octyldodecyl ester, lanolin fatty acid octyldodecyl ester, dimethylhexyldecanoate octanoate, octyldodecyl erucate, isopropyl Stearic acid hardened castor oil, ethyl oleate, avocado fatty acid ethyl ester, isopropyl myristate, isopropyl palmitate, octyl palmitate, isopropyl stearate, lanolin fatty acid isopropyl ester , Diethyl sebacate, diisopropyl sebacate, dioctyl sebacate, diisopropyl adipate, dibutyloctyl sebacate, diisobutyl adipate, succinic acid Monooctyl carboxylic acid esters such as dioctyl ester, triethyl citrate; cetyl lactate, diisostearyl malate, hydrogenated castor oil such as monoisostearic acid; trioctanoic acid Oil esters (triethyl 2-ethylhexanoate), glyceryl trioleate, glyceryl triisostearate, glyceryl diisostearate, triglyceride (caprylic / capric), tris (caprylic / Capric acid / myristic acid / stearic acid) glyceride, hydrogenated rosin triglyceride (hydrogenated ester gum), rosin triglyceride (ester gum), behenyl behenate diglyceride, trioctyl tricaprylate Methylolpropane, trimethylolpropane triisostearate, neopentyl glycol dicaprylate, neopentyl glycol didecanoate, 2-butyl-2-ethyl-1,3-propanediol dicaprylate Esters, propylene glycol dioleate, pentaerythritol tetraoctanoate, pentaerythritol ester of hydrogenated rosin, ditrimethylolpropane triethylhexanoate, (isostearic acid / sebacic acid) ditrimethylolpropane, triethyl Pentaerythritol hexanoate, (hydroxystearic acid / stearic acid / rosin acid) dipentaerythritol ester, diglyceryl diisostearate, polyglycerol tetraisostearate, polyglycerol-10 nonisostearate , Polyglycerol-8 deca (erucic acid / isostearic acid / ricinoleic acid) ester, diglycerol (hexyldecanoic acid / sebacic acid) oligoester, glycolic distearate (ethylene glycol distearate) Alcohol ester), 3-pivalic acid Polyol fatty acid esters such as -1,5-pentanediol, 2,4-diethyl-1,5-pentanediol; dimer diisopropyl linoleate, dimer Diisostearyl linoleate, bis (isostearyl / phytosterol) dilinoleate, dimer bis-linoleate (phytosterol / docosalyl), dimer Linolenic acid (phytosterol / isostearyl / cetyl / stearyl / docosalyl) ester, dimer dilinolenic acid dimer linoleyl alcohol ester, diisostearate di Derivatives of dimer linoleyl alcohol, dimer linoleyl alcohol hydrogenated rosin condensate, dimer linolenic acid hardened castor oil, hydroxyalkyl dimer linoleyl alcohol ether or dimer diol ; Coconut oil fatty acid monoethanolamine (cocoamine melamine), coconut oil fatty acid diethanolamine (cocoamine DEA), lauric acid monoethanolamine (lauramine MEA), laurate diethanolamine (Lauramine DEA), lauric acid monoisopropanolamine (lauramine amine MIPA), palmitic acid monoethanolamine (palmitamine MEA), palmitic acid diethanolamine (palmitamine DEA), coconut oil Fatty acid methylethanolamine (Coco-methylamine MEA) and other fatty acid alkanolamines; dimethyl polysiloxane (dimethyl polysiloxane), high polymer dimethyl polysiloxane (high polymer dimethyl polysiloxane) Alkane), cyclic polydimethylsiloxane (cyclic dimethylsiloxane, decamethylcyclopentylsiloxane (also known as cyclopentylsiloxane)), phenylmethyl polytrimethylsiloxane Siloxane, diphenyldimethylpolysiloxane, phenyldimethylsiloxane, stearyloxypropyldimethylamine, (aminoethylaminopropylpolymethylpolysiloxane / Dimethylpolysiloxane) copolymer, polydimethylsiloxane, polydimethylsiloxane polymer, silicone resin, silicone rubber, aminopropyldimethylsiloxane Polyether-modified silicones, polyglycerols, such as amine-modified silicones, cation-modified silicones, dimethylpolysiloxanes, and diols Modified silicone, sugar modified silicone, carboxylic acid modified silicone, phosphoric acid modified silicone, sulfuric acid modified silicone, alkyl modified silicone, fatty acid modified silicone, alkyl ether modified silicone, Amino acid modified silicone, peptide modified silicone, fluorine modified silicone, cation And polyether-modified silicones, amine-modified and polyether-modified silicones, alkyl-modified and polyether-modified silicones, polysiloxane / alkylene oxide copolymers, and other silicones; perfluorinated Fluorine oils such as decane, perfluorooctane, and perfluoropolyether are preferred.

作為保濕劑/觸感提升劑,可以列舉甘油、三羥甲基丙烷、季戊四醇、己二醇、二甘油、聚甘油、二乙二醇、二丙二醇、聚丙二醇、乙二醇.丙二醇共聚物等多元醇類及其聚合物;二乙二醇單乙醚(乙氧基二甘醇)、乙二醇單乙醚、乙二醇單丁醚、二乙二醇二丁醚等二醇烷醚類;聚甘油-10(二十烷二酸/十四烷二酸)酯、聚甘油-10十四烷二酸酯等水溶性酯類;山梨糖醇、木糖醇、赤藻糖醇、甘露醇、麥芽糖醇等糖醇類;葡萄糖、果糖、半乳糖、甘露糖、蘇阿糖、木糖、阿拉伯糖、岩藻糖、核糖、去氧核糖、麥芽糖、海藻糖、乳糖、棉子糖、葡糖酸、葡糖醛酸、環糊精類(α-、β-、γ-環糊精及麥芽糖化、羥基烷基化等修飾環糊精)、β-葡聚糖、甲殼素、幾丁聚糖、肝磷脂及衍生物、果膠、阿拉伯半乳聚糖、糊精、右旋糖酐、糖原、乙基葡糖苷、甲基丙烯酸葡糖基乙酯聚合物或共聚合物等糖類及其衍生物類;玻尿酸(Hyaluronic acid)、玻尿酸鈉;軟骨素硫酸鈉;硫酸黏液素、硫酸卡隆素、硫酸角質、硫酸皮膚素;銀耳萃取物、銀耳多糖體;褐藻素;晚香玉多糖或天然來源多糖;檸檬酸、酒石酸、乳酸等有機酸及其鹽;尿素及其衍生物;2-吡咯烷酮-5-羧酸及其鈉鹽等鹽;甜菜鹼(三甲基甘胺酸)、脯胺酸(proline)、羥基脯胺酸、精胺酸(arginine)、賴胺酸、絲胺酸、甘胺酸、丙胺酸、苯基丙胺酸、酪胺酸、β-丙胺酸、蘇胺酸、麩胺酸、穀胺醯胺酸、天冬醯胺、天冬胺酸、胱胺酸、胱胺酸、甲硫胺酸、白胺酸、異白胺酸、纈胺酸、色胺酸、組胺酸、牛磺酸等胺基酸類及其鹽;膠原蛋白、魚來源膠原蛋白、脂肪變性膠原蛋白、明膠、彈性蛋白、膠原蛋白分解肽、水解膠原蛋白、氯化羥基丙基銨水解膠原蛋白、彈性蛋白分解肽、角質素分解肽、水解角質素、殼基質分解肽、水解殼基質、絲蛋白分解肽、水解蠶絲、月桂醯基水解蠶絲鈉、大豆蛋白分解肽、小麥蛋白分解肽、水解小麥蛋白、酪素分解肽、醯基化肽等蛋白肽類及其衍生物;棕櫚醯基低聚肽、棕櫚醯基五肽、棕櫚醯基四肽等醯基化肽類;甲矽烷基化肽類;乳酸菌培養液、酵母萃取液、蛋殼膜蛋白質、牛頜下腺黏蛋白、亞牛磺酸、芝麻木酚素配糖體、麩胱甘肽、白朊、乳清;氯化膽鹼、磷醯膽鹼;胎盤萃取液、彈性蛋白、膠原蛋白、蘆薈萃取物、金縷梅水、絲瓜水、洋甘菊萃取物、甘草萃取物、雛菊萃取物、蠶絲萃取物、鐵木萃取物、蓍萃取物、桉樹萃取物、草木犀萃取物等動物/植物萃取成分、天然型神經醯胺(1、2、3、4、5、6型)、羥基神經醯胺、疑似神經醯胺、神經鞘糖脂質、神經醯胺及糖神經醯胺含有萃取物等之神經醯胺類為較佳者。Examples of the humectant / touch improver include glycerin, trimethylolpropane, pentaerythritol, hexanediol, diglycerin, polyglycerin, diethylene glycol, dipropylene glycol, polypropylene glycol, and ethylene glycol. Polyols such as propylene glycol copolymers and their polymers; glycols such as diethylene glycol monoethyl ether (ethoxy diethylene glycol), ethylene glycol monoethyl ether, ethylene glycol monobutyl ether, and diethylene glycol dibutyl ether Alkyl ethers; water-soluble esters such as polyglyceryl-10 (eicosanedioic acid / tetradecanedioic acid) esters, polyglyceryl-10 tetradecanedioic acid esters; sorbitol, xylitol, erythritol Sugar alcohols such as alcohol, mannitol, and maltitol; glucose, fructose, galactose, mannose, sucrose, xylose, arabinose, fucose, ribose, deoxyribose, maltose, trehalose, lactose, cotton Dextrose, gluconic acid, glucuronic acid, cyclodextrin (α-, β-, γ-cyclodextrin and modified cyclodextrin, such as maltosylation, hydroxyalkylation), β-glucan, crustacean , Chitosan, heparin and derivatives, pectin, arabinogalactan, dextrin, dextran, glycogen, ethyl glucoside, glucosyl ethyl methacrylate polymer or copolymer, etc. Carbohydrates and their derivatives; Hyaluronic acid, sodium hyaluronate; Chondroitin sodium sulfate; Mucin sulfate, caronin sulfate, cutin sulfate, sulfuric acid Skin pigment; Tremella fuciformis extract, Tremella polysaccharide; Fucoidan; Tuberose polysaccharide or polysaccharide of natural origin; Organic acids such as citric acid, tartaric acid, lactic acid and their salts; Urea and its derivatives; 2-Pyrrolidone-5-carboxylic acid And its sodium salts; betaine (trimethylglycine), proline, hydroxyproline, arginine, lysine, serine, glycine, propylamine Acid, phenylalanine, tyrosine, β-alanine, threonine, glutamic acid, glutamine, aspartic acid, aspartic acid, cystine, cystine, methionine Amino acids, leucine, isoleucine, valine, tryptophan, histidine, taurine and other amino acids and their salts; collagen, fish-derived collagen, steatosis collagen, gelatin, Elastin, collagen-decomposing peptide, hydrolyzed collagen, hydroxypropylammonium chloride hydrolyzed collagen, elastin-decomposing peptide, keratin-decomposing peptide, hydrolysing keratin, shell matrix decomposing peptide, hydrolyzing shell matrix, silk proteolytic peptide, Hydrolyzed Silk, Sodium Lauryl Hydrolyzed Silk, Soy Protein Decomposing Peptide, Wheat Protein Peptide peptides, hydrolyzed wheat proteins, casein-degrading peptides, amidine peptides and other protein peptides and their derivatives; palmitoyl oligopeptides, palmitoyl pentapeptides, palmitoyl tetrapeptides and other amidated peptides; Silylated peptides; lactic acid bacteria culture solution, yeast extract, eggshell membrane protein, submandibular mucin, hypotaurine, sesame lignan glycosides, glutathione, amaranth, whey; chlorine Choline, Phosphocholine; Placenta extract, Elastin, Collagen, Aloe extract, Witch hazel water, Loofah water, Chamomile extract, Licorice extract, Daisy extract, Silk extract, Ironwood extract Animal, plant extracts such as sassafras extract, eucalyptus extract, osmanthus sibirica extract, natural suramin (types 1, 2, 3, 4, 5, 6), hydroxysuramin, suspected suramin, Neuraminamines such as sphingomyelin, ceramide, and glycoceramide containing extracts are preferred.

作為界面活性劑,較佳為可以列舉陰離子性界面活性劑、非離子性界面活性劑、陽離子性界面活性劑、兩性界面活性劑、高分子界面活性劑等。界面活性劑較佳者例,其中陰離子性界面活性劑,可以列舉月桂酸鉀、肉豆蔻酸鉀等脂肪酸鹽;月桂基硫酸鈉、月桂基硫酸三乙醇胺、月桂基硫酸銨等之烷基硫酸酯鹽;月桂醇聚醚硫酸鈉、月桂醇聚醚硫酸三乙醇胺等之聚氧乙烯烷基硫酸鹽;椰油醯甲基牛磺酸鈉、椰油醯甲基牛磺酸鉀、月桂醯基甲基牛磺酸鈉、肉豆蔻醯基甲基牛磺酸鈉、月桂醯基甲基丙胺酸鈉、月桂醯基肌胺酸鈉、月桂醯基肌胺酸三乙醇胺、月桂醯基麩胺酸甲基丙胺酸鈉等之醯基N-甲基胺基酸鹽;椰油醯麩胺酸鈉、椰油醯麩胺酸三乙醇胺、月桂醯基麩胺酸鈉、肉豆蔻醯基麩胺酸鈉、硬脂醯基麩胺酸鈉、棕櫚醯基天冬醯胺酸二三乙醇胺、椰油醯丙胺酸三乙醇胺等之醯基胺基酸鹽;月桂醇乙酸鈉等之聚氧乙烯烷醚乙酸鹽;月桂醯基單乙醇醯胺琥珀酸鈉等之琥珀酸酯鹽;脂肪酸烷醇醯胺醚羧酸鹽;醯基乳酸鹽;聚氧乙烯脂肪胺硫酸鹽;脂肪酸烷醇醯胺硫酸鹽;硬化椰子油脂肪酸甘油硫酸鈉等之脂肪酸甘油酯硫酸鹽;烷基苯聚氧乙烯硫酸鹽;α-烯烴磺酸鈉等烯烴磺酸鹽;磺基琥珀酸月桂基2鈉、磺基琥珀酸二辛基鈉等烷基磺基琥珀酸鹽;磺基琥珀酸月桂醇聚醚2鈉、單月桂醯基單乙醇醯胺聚氧乙烯磺基琥珀酸鈉、月桂基聚丙二醇磺基琥珀酸鈉等之烷醚磺基琥珀酸鹽;十四烷基苯磺酸鈉、十四烷基苯磺酸三乙醇胺等之烷基苯磺酸鹽;烷基萘磺酸鹽;鏈烷磺酸鹽;α-磺基脂肪酸甲酯鹽;醯基羥乙基磺酸鹽;烷基縮水甘油醚磺酸鹽;烷基磺基乙酸鹽;月桂醇聚醚磷酸鈉、雙月桂醇聚醚磷酸鈉、三月桂醇聚醚磷酸鈉、單十八烷醇聚醚磷酸鈉等之烷醚磷酸酯鹽;月桂基磷酸鉀等烷基磷酸酯鹽;酪蛋白鈉;烷基芳醚磷酸鹽;脂肪酸醯胺醚磷酸鹽;磷脂醯甘油、磷脂醯肌醇、磷脂酸等之磷脂類;羧酸改性矽酮、磷酸改性矽酮、硫酸改性矽酮等之矽酮系陰離子性界面活性劑等;作為非離子界面活性劑,可以列舉月桂醇聚醚(聚氧乙烯月桂醚)類、鯨蠟醇聚醚(聚氧乙烯鯨蠟醚)類、硬脂醇聚醚(聚氧乙烯硬脂醚)類、山崳醇聚醚(聚氧乙烯二十二烷醚)類、異硬脂醇聚醚(聚氧乙烯異硬脂醚)類、辛醇月桂醇聚醚(聚氧乙烯辛基十二烷醚)類等之各種聚氧乙烯加成數的聚氧乙烯烷醚類;聚氧乙烯烷基苯醚;聚氧乙烯硬化蓖麻油、聚氧乙烯蓖麻油、聚氧乙烯硬化蓖麻油單異硬脂酸酯、聚氧乙烯硬化蓖麻油三異硬脂酸酯、聚氧乙烯硬化蓖麻油單焦麩胺酸單異硬脂酸二酯、聚氧乙烯硬化蓖麻油馬來酸等之蓖麻油及硬化蓖麻油衍生物;聚氧乙烯植物甾醇;聚氧乙烯膽固醇;聚氧乙烯膽甾烷醇(Cholestanol);聚氧乙烯羊毛脂;聚氧乙烯還原羊毛脂;聚氧乙烯.聚氧丙烯鯨蠟醚、聚氧乙烯.聚氧丙烯2-癸基十四烷醚、聚氧乙烯.聚氧丙烯單丁醚、聚氧乙烯/聚氧丙烯氫化羊毛脂、聚氧乙烯.聚氧丙烯甘油醚等聚氧乙烯.聚氧丙烯烷醚;聚氧乙烯/聚氧丙烯二醇;PPG-9二甘油酯等(聚)甘油聚氧丙烯二醇;硬脂酸甘油酯、異硬脂酸甘油酯、棕櫚酸甘油酯、肉豆蔻酸甘油酯、油酸甘油酯、椰子油脂肪酸甘油酯、單棉籽油脂肪酸甘油酯、單芥酸甘油酯、倍半油酸甘油酯、α,α-油酸焦麩胺酸甘油酯、單硬脂酸甘油蘋果酸等甘油脂肪酸部分酯類;聚甘油-2硬脂酸酯、聚甘油-3硬脂酸酯、聚甘油-4硬脂酸酯、聚甘油-5硬脂酸酯、聚甘油-6硬脂酸酯、聚甘油-8硬脂酸酯、聚甘油-10硬脂酸酯、聚甘油-6二硬脂酸酯、聚甘油-10二硬脂酸酯、聚甘油-2三硬脂酸酯、聚甘油-10十硬脂酸酯、聚甘油-2異硬脂酸酯、聚甘油-3異硬脂酸酯、聚甘油-4異硬脂酸酯、聚甘油-5異硬脂酸酯、聚甘油-6異硬脂酸酯、聚甘油-8異硬脂酸酯、聚甘油-10異硬脂酸酯、聚甘油-2二異硬脂酸酯(二異硬脂酸二甘油酯)、聚甘油-3二異硬脂酸酯、聚甘油-10二異硬脂酸酯、聚甘油-2三異硬脂酸酯、聚甘油-2四異硬脂酸酯、聚甘油-10十異硬脂酸酯、聚甘油-2油酸酯、聚甘油-3油酸酯、聚甘油-4油酸酯、聚甘油-5油酸酯、聚甘油-6油酸酯、聚甘油-8油酸酯、聚甘油-10油酸酯、聚甘油-6二油酸酯、聚甘油-2三油酸酯、聚甘油-10十油酸酯等聚甘油脂肪酸酯;單硬脂酸乙二醇等乙二醇單脂肪酸酯;單硬脂酸丙二醇等丙二醇單脂肪酸酯;季戊四醇部分脂肪酸酯;山梨糖醇部分脂肪酸酯;麥芽糖醇部分脂肪酸酯;麥芽糖醇醚;山梨聚糖單油酸酯、山梨聚糖單異硬脂酸酯、山梨聚糖單月桂酸酯、山梨聚糖單棕櫚酸酯、山梨聚糖單硬脂酸酯、山梨聚糖倍半油酸酯、山梨聚糖三油酸酯、五-2-乙基己基酸二甘油山梨聚糖、四-2-乙基己基酸二甘油山梨聚糖等山梨聚糖脂肪酸酯;蔗糖脂肪酸酯、甲基葡糖苷脂肪酸酯、十一碳烯酸海藻糖等糖衍生物部分酯;辛醯基葡糖苷等烷基葡糖苷;烷基多糖苷;羊毛脂醇;還原羊毛脂;聚氧乙烯二硬脂酸酯、聚乙二醇二異硬脂酸酯、聚氧乙烯單油酸酯、聚氧乙烯二油酸酯等聚氧乙烯脂肪酸單及二酯;聚氧乙烯.丙二醇脂肪酸酯;聚氧乙烯甘油單硬脂酸酯、聚氧乙烯甘油單異硬脂酸酯、聚氧乙烯甘油三異硬脂酸酯等聚氧乙烯單油酸酯等聚氧乙烯甘油脂肪酸酯;聚氧乙烯山梨聚糖單油酸酯、聚氧乙烯山梨聚糖單硬脂酸酯、聚氧乙烯山梨聚糖單油酸酯、聚氧乙烯山梨聚糖四油酸酯等聚氧乙烯山梨聚糖脂肪酸酯;聚氧乙烯山梨糖醇單月桂酸酯、聚氧乙烯山梨糖醇單油酸酯、聚氧乙烯山梨糖醇五油酸酯、聚氧乙烯山梨糖醇單硬脂酸酯等聚氧乙烯山梨糖醇脂肪酸酯;聚氧乙烯甲基葡糖苷脂肪酸酯;聚氧乙烯烷醚脂肪酸酯;聚氧乙烯山梨糖醇蜜蠟等聚氧乙烯動植物油脂類;異硬脂基甘油醚、鮫肝醇、鯊油醇、鯊肝醇等烷基甘油酯醚類;多元醇烷醚;聚氧乙烯烷基胺;四聚氧乙烯.四聚氧丙烯-乙烯二胺縮合物類;皂苷、槐糖脂等天然系界面活性劑;聚氧乙烯脂肪酸醯胺;椰子油脂肪酸單乙醇醯胺(椰油醯胺MEA)、椰子油脂肪酸二乙醇醯胺(椰油醯胺DEA)、月桂酸單乙醇醯胺(月桂醯胺MEA)、月桂酸二乙醇醯胺(月桂醯胺DEA)、月桂酸單異丙醇醯胺(月桂醯胺MIPA)、棕櫚酸單乙醇醯胺(棕櫚醯胺MEA)、棕櫚酸二乙醇醯胺(棕櫚醯胺DEA)、椰子油脂肪酸甲基乙醇醯胺(椰油醯胺甲基MEA)等脂肪酸烷醇醯胺類;月桂基胺氧化物、椰油胺氧化物、硬脂胺氧化物、山崳胺氧化物等烷基二甲基胺氧化物;烷基乙氧基二甲基胺氧化物;聚氧乙烯烷基硫醇;二甲聚矽氧烷共聚醇等聚醚改性矽酮、聚矽氧烷.環氧烷烴共聚物、聚甘油改性矽酮、糖改性矽酮等矽酮系非離子性界面活性劑等;作為陽離子性界面活性劑,可以列舉山崳基三甲基氯化銨、硬脂基三甲基氯化銨、十六烷基三甲基氯化銨(CETRIMONIUM CHLORIDE)、月桂基三甲基氯化銨等烷基三甲基氯化銨;硬脂基三甲基溴化銨等烷基三甲基溴化銨;二硬脂基二甲基氯化銨、二椰油基二甲基氯化銨等二烷基二甲基氯化銨;硬脂醯胺丙基二甲基胺、硬脂醯胺乙基二乙基胺等脂肪酸醯胺及其鹽;硬脂氧基丙基二甲基胺等烷醚胺及其鹽或四級鹽;乙基硫酸長鏈支化脂肪酸(12~31)胺基丙基乙基二甲基銨、乙基硫酸羊毛脂脂肪酸胺基丙基乙基二甲基銨等脂肪酸醯胺型四級銨鹽;聚氧乙烯烷基胺及其鹽或四級鹽;烷基胺鹽;脂肪酸醯胺胍鹽;烷醚銨鹽;烷基三烷撐二醇銨鹽;苯紮氯銨鹽(Benzalkonium Chloride);苯乙銨鹽;氯化鯨蠟基吡啶鎓鹽等吡啶鎓鹽;咪唑鹽(imidazolium salt);烷基異喹啉鹽;二烷基嗎啉鹽;多胺脂肪酸衍生物;胺基丙基二甲聚矽氧烷及胺端基二甲聚矽氧烷等胺基改性矽酮、陽離子改性矽酮、陽離子改性及聚醚改性矽酮、胺基改性及聚醚改性矽酮等矽酮系陽離子性界面活性劑等;作為兩性界面活性劑,可列舉月桂基甜菜鹼(月桂基二甲基胺基醋酸甜菜鹼)等N-烷基-N,N-二甲基胺基酸甜菜鹼;椰油醯胺丙基甜菜鹼、月桂醯胺丙基甜菜鹼等脂肪酸醯胺烷基-N,N-二甲基胺基酸甜菜鹼;椰油醯兩性基醋酸鈉、月桂醯兩性基醋酸鈉等咪唑啉型甜菜喊;烷基二甲基牛橫酸等烷基橫基甜菜喊;烷基二甲基胺基乙醇硫酸酯等硫酸型甜菜鹼;烷基二甲基胺基乙醇磷酸酯等磷酸型甜菜鹼;磷脂醯膽鹼、磷脂醯乙醇胺、磷脂醯絲胺酸、神經鞘磷脂等鞘磷脂、溶血卵磷脂、氫化大豆磷脂、部分氫化大豆磷脂、氫化蛋黃磷脂、部分氫化蛋黃磷脂、氫氧化卵磷脂等磷脂類;矽酮系兩性界面活性劑等;作為高分子界面活性劑,可列舉聚乙烯醇、褐藻酸鈉、澱粉衍生物、黃蓍膠、丙烯酸.甲基丙烯酸烷基共聚物;矽酮系各種界面活性劑為較佳者。As the surfactant, preferably, an anionic surfactant, a nonionic surfactant, a cationic surfactant, an amphoteric surfactant, a polymer surfactant, and the like can be mentioned. Preferred examples of the surfactant include anionic surfactants, such as fatty acid salts such as potassium laurate and potassium myristate; alkyl sulfates such as sodium lauryl sulfate, triethanolamine lauryl sulfate, and ammonium lauryl sulfate. Salt; polyoxyethylene alkyl sulfates such as sodium lauryl polyether sulfate, triethanolamine lauryl alcohol polyether sulfate; sodium coco-methyl taurate, potassium coco-methyl taurate, lauryl methyl Sodium taurine, sodium myristyl methyl taurine, sodium lauryl methionate, sodium lauryl sarcosinate, lauryl sarcosinate triethanolamine, lauryl glutamate methyl N-methyl N-methyl amino acid salts such as sodium propyl alanine; sodium coco glutamate, coco glutamine triethanolamine, sodium lauryl glutamate, sodium myristyl glutamate , Sodium stearyl glutamate, palmitoyl aspartate ditriethanolamine, coco propyl alanine triethanolamine, and the like; and polyoxyethylene alkyl ether acetates such as sodium lauryl acetate Salt; succinate salts of sodium lauryl monoethanolamine sodium succinate; fatty acid alkanolamine Carboxylic acid salts; fluorenyl lactate; polyoxyethylene fatty amine sulfate; fatty acid alkanol amine sulfate; fatty acid glyceride sulfate of hardened coconut oil fatty acid sodium sulfate; alkylbenzene polyoxyethylene sulfate; α -Olefin sulfonates such as sodium alkene sulfonate; alkyl sulfosuccinates such as sodium lauryl sulfosuccinate, sodium dioctyl sulfosuccinate; sodium lauryl polyether sulfosuccinate 2 Alkyl ether sulfosuccinates, such as fluorenyl monoethanol ammonium polyoxyethylene sodium sulfosuccinate, sodium lauryl polypropylene glycol sodium sulfosuccinate; sodium tetradecylbenzenesulfonate, tetradecylbenzenesulfonic acid Alkylbenzene sulfonates such as triethanolamine; alkylnaphthalene sulfonates; alkane sulfonates; α-sulfo fatty acid methyl ester salts; fluorenyl isethionates; alkyl glycidyl ether sulfonates ; Alkyl sulfoacetate; Sodium lauryl polyether phosphate, sodium dilauryl polyether phosphate, sodium trilauryl polyether phosphate, sodium monooctadecyl polyether phosphate, and other alkyl ether phosphate salts; lauryl Alkyl phosphate salts such as potassium phosphate; sodium caseinate; alkylaryl ether phosphates; fatty acid amido ether phosphates; Lipids such as lipoglycerin, phospholipids, inositol, and phosphatidic acid; silicone-based anionic surfactants such as carboxylic acid-modified silicones, phosphate-modified silicones, and sulfuric acid-modified silicones; etc .; as nonionic interfaces Examples of the active agent include lauryl alcohol polyether (polyoxyethylene lauryl ether), cetyl alcohol polyether (polyoxyethylene cetyl ether), stearyl alcohol polyether (polyoxyethylene stearyl ether), and mandrill. Alcohol polyether (polyoxyethylene behenyl ether), isostearyl alcohol polyether (polyoxyethylene isostearyl ether), octanol lauryl alcohol (polyoxyethylene octyldodecyl ether) Polyoxyethylene alkyl ethers of various polyoxyethylene addition numbers; polyoxyethylene alkyl phenyl ethers; polyoxyethylene hardened castor oil, polyoxyethylene castor oil, polyoxyethylene hardened castor oil monoisostearate, Polyoxyethylene hardened castor oil triisostearate, polyoxyethylene hardened castor oil monopyroglutamic acid monoisostearate diester, polyoxyethylene hardened castor oil maleic acid and other castor oil and hardened castor oil derivatives Products; polyoxyethylene phytosterols; polyoxyethylene cholesterol; polyoxyethylene cholestanol (Cholestanol); polyoxyethylene lanolin Polyoxyethylene reduced lanolin; polyoxyethylene. Polyoxypropylene cetyl ether, polyoxyethylene. Polyoxypropylene 2-decyl tetradecyl ether, polyoxyethylene. Polyoxypropylene monobutyl ether, polyoxyethylene / polyoxypropylene hydrogenated lanolin, polyoxyethylene. Polyoxyethylene glyceryl ether and other polyoxyethylene. Polyoxypropylene alkyl ethers; polyoxyethylene / polyoxypropylene glycol; (poly) glycerol polyoxypropylene glycol such as PPG-9 diglyceride; glyceryl stearate, glyceryl isostearate, glyceryl palmitate , Glyceryl myristate, Glyceryl oleate, Glycerol fatty acid in coconut oil, Glycerol fatty acid in single cottonseed oil, Glyceryl monoerucate, Glyceryl sesquioleate, Glyceryl α, α-oleate pyroglutamate Partial esters of glycerin fatty acids such as glycerol monostearate and malic acid; polyglycerol-2 stearate, polyglycerol-3 stearate, polyglycerol-4 stearate, polyglycerol-5 stearate , Polyglycerol-6 stearate, polyglycerol-8 stearate, polyglycerol-10 stearate, polyglycerol-6 distearate, polyglycerol-10 distearate, polyglycerol -2 tristearate, polyglycerol-10 decastearate, polyglycerol-2 isostearate, polyglycerol-3 isostearate, polyglycerol-4 isostearate, polyglycerol -5 isostearate, polyglycerol-6 isostearate, polyglycerol-8 isostearate, polyglycerol-10 isostearate, polyglycerol-2 diisostearate (two Diglyceryl isostearate), polyglycerol-3 Isostearate, polyglycerol-10 diisostearate, polyglycerol-2 triisostearate, polyglycerol-2 tetraisostearate, polyglycerol-10 deisostearate, Polyglycerol-2 oleate, polyglycerol-3 oleate, polyglycerol-4 oleate, polyglycerol-5 oleate, polyglycerol-6 oleate, polyglycerol-8 oleate, polyglycerol Polyglycerol fatty acid esters such as -10 oleate, polyglycerol-6 dioleate, polyglycerol-2 trioleate, and polyglycerol-10 decaoleate; ethylene glycol such as ethylene glycol monostearate Mono-fatty acid esters; propylene glycol mono-fatty acid esters such as propylene glycol monostearate; pentaerythritol partial fatty acid esters; sorbitol partial fatty acid esters; maltitol partial fatty acid esters; maltitol ethers; sorbitan monooleate, Sorbitan monoisostearate, Sorbitan monolaurate, Sorbitan monopalmitate, Sorbitan monostearate, Sorbitan sesquioleate, Sorbitan trioleate Esters, sorbitan fatty acid esters such as penta-2-ethylhexyl diglyceride sorbitan, tetra-2-ethylhexyl diglyceride sorbitan; sucrose fatty acid ester, methyl glucoside fat Esters, partial esters of sugar derivatives such as undecylenic acid trehalose; alkyl glucosides such as octyl glucoside; alkyl polyglycosides; lanolin alcohol; reduced lanolin; polyoxyethylene distearate, polyethylene glycol Polyoxyethylene fatty acid mono- and diesters such as alcohol diisostearate, polyoxyethylene monooleate, polyoxyethylene dioleate; polyoxyethylene. Propylene glycol fatty acid esters; polyoxyethylene glycerol fats such as polyoxyethylene glycerol monostearate, polyoxyethylene glycerol monoisostearate, polyoxyethylene glycerol triisostearate, etc. Esters; polyoxyethylene sorbitan monooleate, polyoxyethylene sorbitan monostearate, polyoxyethylene sorbitan monooleate, polyoxyethylene sorbitan tetraoleate, and other polyoxylates Ethylene sorbitan fatty acid esters; polyoxyethylene sorbitol monolaurate, polyoxyethylene sorbitol monooleate, polyoxyethylene sorbitol pentaoleate, polyoxyethylene sorbitol monostearate Esters such as polyoxyethylene sorbitol fatty acid esters; polyoxyethylene methyl glucoside fatty acid esters; polyoxyethylene alkyl ether fatty acid esters; polyoxyethylene animal and vegetable oils and fats such as polyoxyethylene sorbitol beeswax; iso Alkyl glyceryl ethers such as stearyl glyceryl ether, saponin, sharkol, and sharkol; polyhydric alcohol alkyl ethers; polyoxyethylene alkylamines; tetrapolyoxyethylene. Tetrapolyoxypropylene-ethylenediamine condensates; natural surfactants such as saponins and sophorolipids; polyoxyethylene fatty acid ammonium; coconut oil fatty acid monoethanolamine (cocoamine AMEA), coconut oil fatty acid diamine Ethanolamine (cocoamine DEA), monoethanolamine laurate (MEA), diethanolamine laurate (DEA), monoisopropanolamine laurate (MIPA ), Fatty acid alkanols such as palmitic acid monoethanolamine (palmitamine MEA), palmitic acid diethanolamine (palmitamine DEA), coconut oil fatty acid methylethanolamine (cocomethylamine MEA), and the like Amines; alkyldimethylamine oxides such as laurylamine oxide, cocoamine oxide, stearylamine oxide, behenylamine oxide; alkylethoxydimethylamine oxide; polyoxygen Ethylene alkyl mercaptan; polyether-modified silicone such as dimethyl polysiloxane and polysiloxane. Silicone-based nonionic surfactants such as alkylene oxide copolymers, polyglycerol-modified silicones, and sugar-modified silicones; as cationic surfactants, behenyltrimethylammonium chloride, hard Alkyltrimethylammonium chloride such as fatty trimethylammonium chloride, CETRIMONIUM CHLORIDE, lauryltrimethylammonium chloride; stearyltrimethyl bromide Alkyl trimethyl ammonium bromide, such as ammonium; distearyl dimethyl ammonium chloride, dicopalyl dimethyl ammonium chloride, and other dialkyl dimethyl ammonium chlorides; stearylamine propyldiamine Fatty acid amines such as methylamine, stearylamine ethyldiethylamine, and their salts; alkyl etheramines such as stearyloxypropyldimethylamine, and their salts or quaternary salts; ethyl sulfate long chain branch Fatty acid (12 ~ 31) aminopropyl ethyl dimethyl ammonium, ethyl sulfate lanolin fatty acid amino propyl ethyl dimethyl ammonium, and other fatty acid ammonium type quaternary ammonium salts; polyoxyethylene alkylamine And its salts or quaternary salts; alkylamine salts; fatty acid amidoguanidine salts; alkyl ether ammonium salts; alkyltrialkylene glycol ammonium salts; benzalkonium chloride (Benzalkonium Chloride); phenethylammonium salts; chlorine Turn into Pyridinium salts such as cetylpyridinium salts; imidazolium salts; alkyl isoquinoline salts; dialkylmorpholine salts; polyamine fatty acid derivatives; aminopropyldimethylsiloxanes and amines Amino-modified silicones such as terminal dimethyl polysiloxane, cationic modified silicones, cationic modified and polyether-modified silicones, amine-modified and polyether-modified silicones, and other cationic silicones Surfactants and the like; Examples of the amphoteric surfactants include N-alkyl-N, N-dimethylamino betaine such as lauryl betaine (lauryl dimethylaminoacetic acid betaine); coconut oil Fatty acids such as amidopropyl betaine, lauryl amidopropyl betaine, amido alkyl-N, N-dimethylamino betaine; imidazoles, such as sodium coco amphoteric amphoteric acid, and sodium lauryl amphoteric amphoteric acetate Porphyrin-type sugar beet; alkyl dimethyl taurate and other alkyl benzyl beets; alkyl dimethyl amino ethanol sulfate and other sulfate-type betaines; alkyl dimethyl amino ethanol phosphate and other phosphate types Betaine; sphingomyelin such as phospholipids choline, phospholipids ethanolamine, phospholipids serine, sphingomyelin, sphingomyelin, lysolecithin, hydrogenated soybeans Lipids, partially hydrogenated soybean phospholipids, hydrogenated egg yolk phospholipids, partially hydrogenated egg yolk phospholipids, lecithin hydroxide, and other phospholipids; silicone-based amphoteric surfactants; etc .; as polymer surfactants, polyvinyl alcohol, sodium alginate, Starch derivatives, tragacanth, acrylic acid. Methacrylic acid alkyl copolymer; silicone-based various surfactants are preferred.

作為高分子/增稠劑/凝膠化劑,可列舉瓜爾膠、槐樹豆膠、溫柏籽、卡拉膠、半乳聚糖、阿拉伯膠、他拉膠、羅望子、紅藻膠、刺梧桐樹膠、木芙蓉、沉香木膠、黃蓍膠、果膠、果膠酸及鈉鹽等鹽、褐藻酸及鈉鹽等鹽、甘露聚糖;米、玉米、土豆、小麥等澱粉;黃原膠、右旋糖酐、琥珀醯葡聚糖、凝膠多糖、透明質酸及其鹽、黃原膠、支鏈澱粉、結冷膠、甲殼素、幾丁聚糖、瓊脂、褐藻萃取物、硫酸軟骨素、酪素、膠原蛋白、明膠、白朊;甲基纖維素、乙基纖維素、羥基乙基纖維素、羥基丙基纖維素、羥基丙基甲基纖維素、羧甲基纖維素及其鈉等鹽、甲基羥基丙基纖維素、纖維素硫酸鈉、二烷基二甲基銨硫酸纖維素、結晶纖維素、纖維素末等纖維素及其衍生物;可溶性澱粉、羧甲基澱粉、甲基羥基丙基澱粉、甲基澱粉等澱粉系高分子、羥基丙基三甲基氯化銨澱粉、辛烯基琥珀酸玉米澱粉鋁等澱粉衍生物;褐藻酸鈉、褐藻酸丙二醇酯等褐藻酸衍生物;聚乙烯基吡咯烷酮(PVP)、聚乙烯醇(PVA)、乙烯基吡咯烷酮.乙烯醇共聚物、聚乙烯基甲醚;聚乙二醇、聚丙二醇、聚氧乙烯.聚氧丙烯共聚物;(甲基丙烯醯氧乙基羧基甜菜鹼/甲基丙烯酸烷基酯)共聚物、(丙烯酸酯/丙烯酸硬脂酯/甲基丙烯酸乙基胺氧化物)共聚物等之兩性甲基丙烯酸酯共聚物;(二甲聚矽氧烷/乙烯基二甲聚矽氧烷)交聯聚合物、(丙烯酸烷基酯/二丙酮丙烯醯胺)共聚物、(丙烯酸烷基酯/二丙酮丙烯醯胺)共聚物AMP;聚醋酸乙烯基部分皂化物、馬來酸共聚物;乙烯基吡咯烷酮.甲基丙烯酸二烷基胺基烷基酯共聚物;丙烯酸樹脂烷醇胺;聚酯、水分散性聚酯;聚丙烯醯胺;聚丙烯酸乙基酯等聚丙烯酸酯共聚物、羧基乙烯基聚合物、聚丙烯酸及其鈉鹽等鹽、丙烯酸.甲基丙烯酸酯共聚物;丙烯酸.甲基丙烯酸烷基酯共聚物;聚季銨鹽-10等陽離子化纖維素、聚季銨鹽-7等二烯丙基二甲基氯化銨.丙烯醯胺共聚物、聚季銨鹽-22等丙烯酸.二烯丙基二甲基氯化銨共聚物、聚季銨鹽-39等丙烯酸.二烯丙基二甲基氯化銨.丙烯醯胺共聚物、丙烯酸.陽離子化甲基丙烯酸酯共聚物、丙烯酸.陽離子化甲基丙烯酸醯胺共聚物、聚季銨鹽-47等丙烯酸.丙烯酸甲酯.氯化甲基丙烯醯胺丙基三甲基銨共聚物、氯化甲基丙烯酸膽鹼酯聚合物;陽離子化寡糖、陽離子化右旋糖酐、瓜爾膠羥基丙基三甲基氯化銨等陽離子化多糖類;聚乙烯亞胺;陽離子聚合物;聚季銨鹽-51等2-甲基丙烯醯氧乙基磷醯膽鹼的聚合物及甲基丙烯酸丁基酯共聚物等共聚物;丙烯酸樹脂乳液、聚丙烯酸乙酯乳液、聚丙烯酸烷基酯乳液、聚醋酸乙烯基酯樹脂乳液、天然橡膠乳膠、合成乳膠等高分子乳液;硝基纖維素;聚胺酯類及各種共聚物;各種矽酮類;丙烯酸類-矽酮接枝共聚物等矽酮系各種共聚物;各種氟系高分子;12-羥基硬脂酸及其鹽;棕櫚酸糊精、肉豆蔻酸糊精等糊精脂肪酸酯;矽酸酐、煙霧狀二氧化矽(超微粒矽酸酐)、矽酸鋁鎂、矽酸鈉鎂、金屬皂、二烷基磷酸金屬鹽、膨潤土、鋰蒙脫石、有機改性黏土礦物、蔗糖脂肪酸酯、低聚果糖脂肪酸酯為較佳者。前述例示中,較佳為纖維素及其衍生物、褐藻酸及其鹽、聚乙烯醇、透明質酸及其鹽、或膠原蛋白。Examples of the polymer / thickener / gelling agent include guar gum, locust bean gum, cypress seed, carrageenan, galactan, acacia gum, tara gum, tamarind, red algae gum, Echinacea gum, wood hibiscus, agarwood gum, tragacanth, pectin, pectinic acid and sodium salt, salt such as alginic acid and sodium salt, mannan; starch of rice, corn, potato, wheat, etc. Gum, dextran, succinic dextran, curdlan, hyaluronic acid and its salts, xanthan gum, amylopectin, gellan gum, chitin, chitosan, agar, brown algae extract, chondroitin sulfate , Casein, collagen, gelatin, paeony; methyl cellulose, ethyl cellulose, hydroxyethyl cellulose, hydroxypropyl cellulose, hydroxypropyl methyl cellulose, carboxymethyl cellulose and its sodium And other salts, methyl hydroxypropyl cellulose, cellulose sodium sulfate, dialkyl dimethyl ammonium sulfate cellulose, crystalline cellulose, cellulose powder and other cellulose and its derivatives; soluble starch, carboxymethyl starch, Starch polymers such as methyl hydroxypropyl starch and methyl starch Starch derivatives such as ammonium chloride starch, octenyl succinic corn starch, aluminum; alginic acid derivatives such as sodium alginate, propylene glycol alginate; polyvinylpyrrolidone (PVP), polyvinyl alcohol (PVA), vinyl Pyrrolidone. Vinyl alcohol copolymer, polyvinyl methyl ether; polyethylene glycol, polypropylene glycol, polyoxyethylene. Polyoxypropylene copolymer; (methacrylic acid oxyethyl carboxybetaine / alkyl methacrylate) copolymer, (acrylate / stearyl acrylate / ethylamine oxide methacrylate) copolymer, etc. Amphoteric methacrylate copolymer; (dimethyl polysiloxane / vinyl dimethyl polysiloxane) crosslinked polymer, (alkyl acrylate / diacetone acrylamide) copolymer, (alkyl acrylate / Diacetone acrylamide) copolymer AMP; polyvinyl acetate partially saponified, maleic acid copolymer; vinyl pyrrolidone. Dialkylamino alkyl methacrylate copolymer; acrylic resin alkanolamine; polyester, water-dispersible polyester; polyacrylamide; polyacrylate copolymers such as polyethyl acrylate, and carboxyvinyl polymerization Materials, polyacrylic acid and its sodium salts, acrylic acid. Methacrylate copolymer; acrylic acid. Copolymers of alkyl methacrylate; cationized cellulose such as polyquaternium-10, diallyldimethylammonium chloride such as polyquaternium-7. Acrylic acid copolymer, polyquaternary ammonium salt-22 and other acrylic acid. Acrylic acid such as diallyl dimethyl ammonium chloride copolymer, polyquaternium-39. Diallyl dimethyl ammonium chloride. Acrylamide copolymer, acrylic acid. Cationized methacrylate copolymer, acrylic acid. Cationic ammonium methacrylate copolymer, polyquaternary ammonium salt-47 and other acrylic acid. Methyl acrylate. Methacrylamide propyltrimethylammonium chloride copolymer, choline methacrylate polymer; cationized oligosaccharides, cationized dextran, guar hydroxypropyltrimethylammonium chloride and other cations Polysaccharides; polyethyleneimines; cationic polymers; polymers of 2-methacrylic acid oxyethylphosphonium choline such as polyquaternium-51 and copolymers such as butyl methacrylate copolymer; acrylic acid Resin emulsion, polyethylene acrylate emulsion, polyalkyl acrylate emulsion, polyvinyl acetate resin emulsion, natural rubber latex, synthetic latex and other polymer emulsions; nitrocellulose; polyurethanes and various copolymers; various silicones Various; silicone-based copolymers such as acrylic-silicone graft copolymers; various fluorine-based polymers; 12-hydroxystearic acid and its salts; palmitic dextrin, myristic acid dextrin and other dextrin fatty acids Esters; silicic anhydride, fumed silica (ultrafine particle silicic anhydride), magnesium aluminum silicate, sodium magnesium silicate, metal soaps, metal dialkyl phosphates, bentonite, hectorite, organic modified clay minerals, Sucrose fatty acid ester, fructooligosaccharide Fatty acid esters are preferred. Among the foregoing examples, cellulose and its derivatives, alginic acid and its salts, polyvinyl alcohol, hyaluronic acid and its salts, or collagen are preferred.

溶劑可列舉乙醇、2-丙醇(異丙醇)、丁醇、異丁醇等之低級醇類;丙二醇、二乙二醇、二丙二醇、異戊基二醇等之乙二醇類;二乙二醇單乙醚(乙氧基二乙二醇)、乙二醇單乙醚、乙二醇單丁醚、三乙二醇單乙醚、二乙二醇二乙醚、二乙二醇二丁醚、丙二醇單乙醚、二丙二醇單乙醚等之二醇醚類;乙二醇單乙醚乙酸酯、二乙二醇單乙醚乙酸酯、丙二醇單乙醚乙酸酯等之乙二醇醚酯類;琥珀酸二乙氧基乙酯、乙二醇二琥珀酸酯等之二醇酯類;苄醇、苄氧基乙醇、碳酸丙烯酯、碳酸二烷基、丙酮、乙酸乙酯、N-甲基吡咯烷酮;甲苯等較佳。Examples of the solvent include lower alcohols such as ethanol, 2-propanol (isopropanol), butanol, and isobutanol; ethylene glycols such as propylene glycol, diethylene glycol, dipropylene glycol, and isopentyl glycol; two Ethylene glycol monoethyl ether (ethoxy diethylene glycol), ethylene glycol monoethyl ether, ethylene glycol monobutyl ether, triethylene glycol monoethyl ether, diethylene glycol diethyl ether, diethylene glycol dibutyl ether, Glycol ethers such as propylene glycol monoethyl ether and dipropylene glycol monoethyl ether; ethylene glycol monoethyl ether acetate, diethylene glycol monoethyl ether acetate, propylene glycol monoethyl ether acetate and the like; amber Glycol esters such as diethoxyethyl acetate, ethylene glycol disuccinate; benzyl alcohol, benzyloxy ethanol, propylene carbonate, dialkyl carbonate, acetone, ethyl acetate, N-methylpyrrolidone ; Toluene and the like are preferred.

作為抗氧化劑,可列舉生育酚(維生素E)、乙酸生育酚等生育酚衍生物;BHT、BHA;沒食子酸丙酯等沒食子酸衍生物;維生素C(抗壞血酸)及/或其衍生物;異抗壞血酸及其衍生物;亞硫酸鈉等亞硫酸鹽;亞硫酸氫鈉等亞硫酸氫鹽;硫代硫酸鈉等硫代硫酸鹽;偏亞硫酸氫鹽(metabisulphite);硫代牛磺酸、亞牛磺酸;硫代甘油、硫脲、硫代乙醇酸、半胱胺酸鹽酸鹽為較佳者。Examples of the antioxidant include tocopherol derivatives such as tocopherol (vitamin E) and tocopherol acetate; BHT, BHA; gallic acid derivatives such as propyl gallate; vitamin C (ascorbic acid) and / or derivatives thereof Substances; erythorbic acid and its derivatives; sulfites such as sodium sulfite; hydrogen sulfites such as sodium bisulfite; thiosulfates such as sodium thiosulfate; metabisulphite; thiotaurine, Hypotaurine; thioglycerol, thiourea, thioglycolic acid, and cysteine hydrochloride are preferred.

還原劑可列舉硫代乙醇酸、半胱胺酸、半胱胺等為較佳者。Preferred examples of the reducing agent include thioglycolic acid, cysteine, and cysteamine.

氧化劑可列舉過氧化氫水、過硫酸銨、溴酸鈉、過碳酸等為較佳者。Preferred examples of the oxidizing agent include hydrogen peroxide water, ammonium persulfate, sodium bromate, and percarbonic acid.

作為防腐劑/抗菌劑/殺菌劑,可列舉對羥基苯甲酸甲酯、對羥基苯甲酸乙酯、對羥基苯甲酸丙酯、對羥基苯甲酸丁酯等羥基苯甲酸及其鹽或其酯;水楊酸;苯甲酸鈉;苯氧基乙醇;甲基氯異噻唑啉酮、甲基異噻唑啉酮等之異噻唑啉酮衍生物;咪唑啉脲;脫氫乙酸及其鹽;酚類;三氯生(triclosan)等之鹵化雙酚類、酸醯胺類、季銨鹽類;三氯卡班、吡啶硫酮鋅、苯紮氯銨、苯索氯銨、山梨酸、氯己定(Chlorhexidine)、葡糖酸氯己定、鹵卡班、六氯酚、檜木醇;苯酚、異丙基苯酚、甲酚、百里酚、對氯苯酚、苯基苯酚、苯基苯酚鈉等其他酚類;苯基乙醇、感光素類、抗菌性沸石、銀離子為較佳者。Examples of the preservative / antibacterial agent / fungicide include hydroxybenzoic acid such as methyl parahydroxybenzoate, ethyl parahydroxybenzoate, propyl parahydroxybenzoate, and butyl parahydroxybenzoate, and salts or esters thereof; Salicylic acid; sodium benzoate; phenoxyethanol; methylchloroisothiazolinone, methylisothiazolinone and other isothiazolinone derivatives; imidazolin urea; dehydroacetic acid and its salts; phenols; three Halogenated bisphenols, acid amines, quaternary ammonium salts such as triclosan; triclosan, zinc pyrithione, benzalkonium chloride, benzyl ammonium chloride, sorbic acid, chlorhexidine (Chlorhexidine) ), Chlorhexidine gluconate, halocarban, hexachlorophenol, linalool; phenol, isopropylphenol, cresol, thymol, p-chlorophenol, phenylphenol, sodium phenylphenol and other phenols ; Phenyl alcohol, photosensitizers, antibacterial zeolites, and silver ions are preferred.

作為螯合劑,可列舉EDTA、EDTA2Na、EDTA3Na、EDTA4Na等之乙底酸鹽(乙二胺四乙酸鹽);HEDTA3Na等之羥基乙基乙二胺三乙酸鹽;噴替酸鹽(二乙烯三胺五乙酸鹽);肌醇六磷酸;羥乙磷酸等膦酸及其鈉鹽等鹽類;聚天冬胺酸、聚麩胺酸等之聚胺基酸類;聚磷酸鈉、偏磷酸鈉、磷酸;檸檬酸鈉、檸檬酸、丙胺酸、二羥基乙基甘胺酸、葡萄糖酸、抗壞血酸、琥珀酸、酒石酸為較佳者。Examples of the chelating agent include ethylene glycolate (ethylenediaminetetraacetate) such as EDTA, EDTA2Na, EDTA3Na, and EDTA4Na; hydroxyethylethylenediamine triacetate such as HEDTA3Na; and pentanoate (diethylenetriamine) Pentaacetate); Phytic acid; Phosphonic acids such as glycolic acid and their sodium salts; Polyamino acids such as polyaspartic acid and polyglutamic acid; Sodium polyphosphate, sodium metaphosphate, phosphoric acid ; Sodium citrate, citric acid, alanine, dihydroxyethylglycine, gluconic acid, ascorbic acid, succinic acid, and tartaric acid are preferred.

作為pH調整劑/酸/鹼,可列舉抗壞血酸、檸檬酸、檸檬酸鈉、乳酸、乳酸鈉、乳酸鉀、乙醇酸、琥珀酸、乙酸、乙酸鈉、蘋果酸、酒石酸、富馬酸、磷酸、鹽酸、硫酸、單乙醇胺、二乙醇胺、三乙醇胺、異丙醇胺、三異丙醇胺、2-胺基-2-甲基-1,3-丙二醇、2-胺基-2-羥基甲基-1,3-丙二醇、精胺酸、氫氧化鈉、氫氧化鉀、胺水、碳酸胍、碳酸銨為較佳者。Examples of the pH adjusting agent / acid / base include ascorbic acid, citric acid, sodium citrate, lactic acid, sodium lactate, potassium lactate, glycolic acid, succinic acid, acetic acid, sodium acetate, malic acid, tartaric acid, fumaric acid, phosphoric acid, and hydrochloric acid. , Sulfuric acid, monoethanolamine, diethanolamine, triethanolamine, isopropanolamine, triisopropanolamine, 2-amino-2-methyl-1,3-propanediol, 2-amino-2-hydroxymethyl- 1,3-propanediol, arginine, sodium hydroxide, potassium hydroxide, amine water, guanidine carbonate, and ammonium carbonate are preferred.

作為無機鹽類,可列舉食鹽、粗鹽(並鹽)、岩鹽、海鹽、天然鹽等之含氯化鈉的鹽類;氯化鉀、氯化鋁、氯化鈣、氯化鎂、鹽鹵、氯化鋅、氯化銨;硫酸鈉、硫酸鋁、硫酸鋁/鉀(明礬)、硫酸鋁/銨、硫酸鋇、硫酸鈣、硫酸鉀、硫酸鎂、硫酸鋅、硫酸鐵、硫酸銅;磷酸1Na・2Na・3Na等之磷酸鈉類、磷酸鉀類、磷酸鈣類、磷酸鎂類為較佳者。Examples of the inorganic salts include sodium chloride-containing salts such as common salt, crude salt (co-salt), rock salt, sea salt, and natural salt; potassium chloride, aluminum chloride, calcium chloride, magnesium chloride, brine, and chloride Zinc, ammonium chloride; sodium sulfate, aluminum sulfate, aluminum / potassium sulfate (alum), aluminum / ammonium sulfate, barium sulfate, calcium sulfate, potassium sulfate, magnesium sulfate, zinc sulfate, iron sulfate, copper sulfate; 1Na ・ 2Na phosphate Sodium phosphates such as 3Na, potassium phosphates, calcium phosphates, and magnesium phosphates are preferred.

作為紫外線吸收劑,可列舉對胺基苯甲酸、對胺基苯甲酸單甘油酯、N,N-二丙氧基對胺基苯甲酸乙酯、N,N-二乙氧基對胺基苯甲酸乙酯、N,N-二甲基對胺基苯甲酸乙酯、N,N-二甲基對胺基苯甲酸丁酯、N,N-二甲基對胺基苯甲酸甲酯等之苯甲酸系紫外線吸收劑;N-乙醯鄰胺基苯甲酸高薄荷醇酯等之鄰胺基苯甲酸系紫外線吸收劑;水楊酸及其鈉鹽、水楊酸戊酯、薄荷醇水楊酸酯、高薄荷醇水楊酸酯、水楊酸辛酯、水楊酸苯酯、水楊酸苄酯、p-異丙醇苯基水楊酸酯等之水楊酸系紫外線吸收劑;肉桂酸辛酯、乙基-4-異丙基肉桂酸酯、甲基-2,5-二異丙基肉桂酸酯、乙基-2,4-二異丙基肉桂酸酯、甲基-2,4-二異丙基肉桂酸酯、丙基-p-甲氧基肉桂酸酯、異丙基-p-甲氧基肉桂酸酯、異戊基-p-甲氧基肉桂酸酯、2-乙基己基-p-甲氧基肉桂酸酯(對甲氧基肉桂酸辛酯)、2-乙氧基乙基-p-甲氧基肉桂酸酯(西諾沙酯)、環己基-p-甲氧基肉桂酸酯、乙基-α-氰基-β-苯基肉桂酸酯、2-乙基己基-α-氰基-β-苯基肉桂酸酯(奧克立林)、甘油基單-2-乙基己醯基-二對甲氧基肉桂酸酯、阿魏酸(ferulic acid)及其衍生物等之肉桂酸系紫外線吸收劑;2,4-二羥基二苯甲酮、2,2’-二羥基-4-甲氧基二苯甲酮、2,2’-二羥基-4,4’-二甲氧基二苯甲酮、2,2’,4,4’-四羥基二苯甲酮、2-羥基-4-甲氧基二苯甲酮(羥苯甲酮-3)、2-羥基-4-甲氧基-4’-甲基二苯甲酮、2-羥基-4-甲氧基二苯甲酮-5-磺酸鹽、4-苯基二苯甲酮、2-乙基己基-4’-苯基-二苯甲酮-2-羧酸酯、2-羥基-4-n-辛氧基二苯甲酮、4-羥基-3-羧基二苯甲酮等之二苯甲酮系紫外線吸收劑;3-(4’-甲基苯亞甲基)-d,1-樟腦、3-苯亞甲基-d,1-樟腦;2-苯基-5-甲基苯並唑;2,2’-羥基-5-甲基苯基苯並三唑;2-(2’-羥基-5’-t-辛基苯基)苯並三唑;2-(2’-羥基-5’-甲基苯基苯並三唑;二苄連氮;二茴香醯甲烷;5-(3,3-二甲基-2-亞降氷片基(norbornylidene)-3-戊烷-2-酮;4-t-丁基甲氧基二苯甲醯甲烷等之二苯甲醯甲烷衍生物;辛基三嗪酮;尿刊酸(urocanic acid)及尿刊酸乙酯等尿刊酸衍生物;2-(2’-羥基-5’-甲基苯基)苯並三唑、1-(3,4-二甲氧基苯基)-4,4-二甲基-1,3-戊二酮、二甲氧基苯亞甲基二氧代咪唑烷丙酸2-乙基己酯等乙內醯脲衍生物、苯基苯並咪唑磺酸、對苯二亞甲基二樟腦磺酸、甲酚曲唑三矽氧烷、鄰胺基苯甲酸甲酯、芸香苷及其衍生物、穀維素及其衍生物為較佳者。Examples of the ultraviolet absorber include p-aminobenzoic acid, p-aminobenzoic acid monoglyceride, N, N-dipropoxy p-aminobenzoic acid ethyl ester, and N, N-diethoxy p-aminobenzoic acid. Ethyl formate, N, N-dimethyl-p-aminobenzoate, N, N-dimethyl-p-aminobenzoate, N, N-dimethyl-p-aminobenzoate, etc. Benzoic acid-based ultraviolet absorber; N-ethylammonium o-aminobenzoic acid homomenthol ester and other o-aminobenzoic acid-based ultraviolet absorber; salicylic acid and its sodium salt, amyl salicylate, menthol salicylate Salicylic acid-based ultraviolet absorbers such as esters, homomenthyl salicylate, octyl salicylate, phenyl salicylate, benzyl salicylate, p-isopropanol phenylsalicylate; cinnamon Octanoate, ethyl-4-isopropylcinnamate, methyl-2,5-diisopropylcinnamate, ethyl-2,4-diisopropylcinnamate, methyl-2, 4-diisopropylcinnamate, propyl-p-methoxycinnamate, isopropyl-p-methoxycinnamate, isoamyl-p-methoxycinnamate, 2- Ethylhexyl-p-methoxycinnamate (octyl p-methoxycinnamate), 2-ethoxyethyl-p-methyl Cinnamate (cinosalate), cyclohexyl-p-methoxycinnamate, ethyl-α-cyano-β-phenylcinnamate, 2-ethylhexyl-α-cyano- β-phenyl cinnamate (Oklin), glyceryl mono-2-ethylhexyl-di-p-methoxycinnamate, ferulic acid and its derivatives, cinnamic acid UV absorber; 2,4-dihydroxybenzophenone, 2,2'-dihydroxy-4-methoxybenzophenone, 2,2'-dihydroxy-4,4'-dimethoxy Benzophenone, 2,2 ', 4,4'-tetrahydroxybenzophenone, 2-hydroxy-4-methoxybenzophenone (hydroxybenzophenone-3), 2-hydroxy-4 -Methoxy-4'-methylbenzophenone, 2-hydroxy-4-methoxybenzophenone-5-sulfonate, 4-phenylbenzophenone, 2-ethylhexyl- 4'-phenyl-benzophenone-2-carboxylic acid ester, 2-hydroxy-4-n-octyloxybenzophenone, 4-hydroxy-3-carboxybenzophenone, and other benzophenones UV absorber; 3- (4'-methylbenzylidene) -d, 1-camphor, 3-benzylidene-d, 1-camphor; 2-phenyl-5-methylbenzoxazole ; 2,2'-hydroxy-5-methylphenylbenzotriazole; 2- (2'-hydroxy-5'-t-octylphenyl) benzotriazole; 2- (2 ' -Hydroxy-5'-methylphenylbenzotriazole; dibenzylazine; dianisole-methane; 5- (3,3-dimethyl-2-norbornylidene) -3-pentane Alkan-2-one; 4-t-butylmethoxydibenzomethane derivatives, such as benzoylmethane derivatives; octyltriazinone; urocanic acid and urocanic acid ethyl ester Acid derivatives; 2- (2'-hydroxy-5'-methylphenyl) benzotriazole, 1- (3,4-dimethoxyphenyl) -4,4-dimethyl-1, Hydantoin derivatives such as 3-pentanedione, dimethoxybenzylidenedioximidazolidinepropionate, 2-ethylhexyl ester, phenylbenzimidazolesulfonic acid, p-xylylenediamine Camphor sulfonic acid, cresol triazole trisiloxane, methyl o-aminobenzoate, rutin and its derivatives, oryzanol and its derivatives are preferred.

作為美白劑,可列舉熊果苷、α-熊果苷等氫醌苷及其酯類;抗壞血酸、抗壞血酸磷酸酯鈉鹽及抗壞血酸磷酸酯鎂鹽等之抗壞血酸磷酸酯鹽、抗壞血酸四異棕櫚酸酯等之抗壞血酸脂肪酸酯、抗壞血酸乙醚等之抗壞血酸烷醚、抗壞血酸-2-葡萄醣苷等之抗壞血酸葡萄醣苷及其脂肪酸酯類、抗壞血酸硫酸酯、磷酸生育酚抗壞血酸酯等之抗壞血酸衍生物;麴酸、鞣花酸、凝血酸及其衍生物、阿魏酸及其衍生物、胎盤萃取物、谷胱甘肽、穀維素、丁基間苯二酚、油溶性洋甘菊萃取物、油溶性甘草萃取物、西河柳萃取物、虎耳草萃取物等植物萃取物為較佳者。Examples of the whitening agent include hydroquinone glycosides such as arbutin and α-arbutin, and esters thereof; ascorbic acid phosphate salts such as ascorbic acid, sodium ascorbyl phosphate and magnesium ascorbyl phosphate; and tetraisopalmitate ascorbate Ascorbic acid fatty acid esters, ascorbyl ethers such as ascorbyl ether, ascorbyl glucosides such as ascorbic acid-2-glucoside and their fatty acid esters, ascorbyl sulfate, tocopheryl phosphate ascorbate derivatives; ascorbic acid, Ellagic acid, tranexamic acid and its derivatives, ferulic acid and its derivatives, placental extract, glutathione, oryzanol, butylresorcinol, oil-soluble chamomile extract, oil-soluble licorice extract , Plant extracts such as willow extract, saxifraga, etc. are preferred.

維生素類及其衍生物類,可列舉視黃醇、乙酸視黃醇酯、棕櫚酸視黃醇酯等之維生素A類;硫胺素鹽酸鹽、硫胺素硫酸鹽、核黃素、乙酸核黃素、鹽酸吡哆醇、吡哆醇二辛酸酯、吡哆醇二棕櫚酸酯、黃素腺嘌呤二核苷酸、氰基鈷胺素、葉酸類、菸鹼酸醯胺・菸鹼酸苄酯等之菸鹼酸類、膽鹼類等之維生素B群類;抗壞血酸及其鈉等之鹽等之維生素C類;維生素D;α、β、γ、δ-生育酚等之維生素E類;泛酸、生物素等其他維生素類;抗壞血酸磷酸酯鈉鹽及抗壞血酸磷酸酯鎂鹽等之抗壞血酸磷酸酯鹽、抗壞血酸棕櫚酸酯・硬脂酸抗壞血酸酯・棕櫚酸抗壞血酸酯・二棕櫚酸抗壞血酸酯等之抗壞血酸脂肪酸酯、抗壞血酸乙醚等之抗壞血酸烷醚、抗壞血酸-2-葡萄醣苷等之抗壞血酸葡萄醣苷及其脂肪酸酯、磷酸生育酚抗壞血酸酯等之抗壞血酸衍生物;菸鹼酸生育酚、乙酸生育酚、亞麻油酸生育酚、阿魏酸生育酚、生育酚磷酸酯等之生育酚衍生物等之維生素衍生物、生育三烯酚、其他各種維生素衍生物類為較佳者。Vitamins and their derivatives include retinol, retinol acetate, retinyl palmitate, and other vitamin A; thiamine hydrochloride, thiamine sulfate, riboflavin, and acetic acid Riboflavin, Pyridoxine Hydrochloride, Pyridoxine Dicaprylate, Pyridoxine Dipalmitate, Flavin Adenine Dinucleotide, Cyanocobalamin, Folic Acids, Nicotinamide Pyramine Vitamin B groups such as nicotinic acid and choline such as benzyl alkali; vitamin C such as ascorbic acid and its salts such as sodium; vitamin D; vitamin E such as α, β, γ, and δ-tocopherol Other; vitamins such as pantothenic acid, biotin; ascorbyl phosphate sodium salt and ascorbyl phosphate magnesium salt, ascorbyl phosphate, ascorbyl palmitate, stearic acid ascorbate, palmitate ascorbate, dipalmitate ascorbate Ascorbyl fatty acid esters, ascorbyl ethers such as ascorbyl ether, ascorbyl glucosides such as ascorbyl-2-glucoside and its fatty acid esters, ascorbic acid derivatives such as tocopheryl phosphate ascorbate; tocopheryl nicotinate, Vitamin derivatives acid tocopherol, tocopherol linoleic acid, ferulic acid, tocopherol, tocopheryl phosphate derivatives of tocopherol, the tocotrienols, derivatives of a variety of other vitamins are preferred.

作為生髮用藥劑/血液循環促進劑/刺激劑,可列舉日本獐牙菜萃取物、辣椒酊、生薑酊、生薑萃取物、斑蝥酊(cantharidis tincture)等植物萃取物/酊類;辣椒素、壬酸香蘭基醯胺(Nonyl Vanillylamide)、薑油酮、魚石脂、單寧酸、龍腦、環扁桃酯、桂利嗪、妥拉唑啉、乙醯膽鹼、維拉帕米、千金藤素、γ-穀維素、維生素E及菸鹼酸生育酚.乙酸生育酚等衍生物、γ-穀維素、菸鹼酸及菸鹼醯胺.菸鹼酸苄酯.肌醇六菸鹼酸酯、菸鹼醇等衍生物、尿囊素、感光素301、感光素401、卡普氯銨、十五酸單甘油酯、黃烷酮醇衍生物、豆留醇或豆留烷醇及其配糖體(glycoside)、米諾地爾為較佳者。Examples of hair growth agents / blood circulation promoters / stimulants include Japanese amaranth extract, capsicum annuum, ginger palate, ginger extract, cantharidis tincture, and other plant extracts / capsules; capsaicin , Nonyl Vanillylamide, Gingerone, Fishstone, Tannin, Borneol, Cyclomandelate, Cinnarizine, Tolazoline, Acetylcholine, Verapamil, Qianjinteng Vitamins, γ-oryzanol, vitamin E, and nicotinic acid tocopherol. Derivatives such as tocopherol acetate, γ-oryzanol, nicotinic acid and nicotinamide. Benzyl nicotinate. Derivatives such as phyticotinate, nicotinyl alcohol, allantoin, sensitizer 301, sensitizer 401, carprochloride, monoglyceryl pentarate, flavanol derivatives, stigmitol or Stigrolitol, its glycoside and minoxidil are preferred.

作為荷爾蒙(hormone)類,可列舉雌二醇、雌酮、炔雌醇、可的松、氫化可的松、脫氫可的松(prednisone)等為較佳者。作為抗皺紋劑、抗老化劑、緊緻劑、冷感劑、溫感劑、創傷治癒促進劑、刺激緩和劑、鎮痛劑、細胞賦活劑等其他藥效劑,可列舉視黃醇類、視黃酸類、視黃酸生育酚酯;乳酸、乙醇酸、葡糖酸、果酸、水楊酸及其配糖體/酯化物等衍生物、羥基癸酸、長鏈α-羥基脂肪酸、長鏈α-羥基脂肪酸膽固醇等α-或β-果酸類及其衍生物類;γ-胺基丁酸、γ-胺基-β-羥基丁酸;肉鹼(carnitine);肌肽;肌酸;神經醯胺類、神經鞘胺醇類;咖啡因、黃嘌呤等及其衍生物;輔酶Q10、胡蘿蔔素、蕃茄紅素、蝦青素、葉黃素、α-硫辛酸(Thioctic acid)、膠態鉑(Colloidal platinum)、富勒烯類等抗氧化/活性氧清除劑;兒茶素類;槲皮素等黃酮類;異黃酮類;沒食子酸及酯糖衍生物;單寧、芝麻素、植物花青素、綠原酸、蘋果多酚等多酚類;芸香苷(Rutin)及配糖體等衍生物;橙皮苷及配糖體等衍生物;准木質素配糖體;光甘草定、光甘草素、甘草苷、異甘草苷等甘草萃取物相關物質;乳鐵傳遞蛋白(Lactoferrin);姜烯酚、薑酚;薄荷醇、雪松醇等香料物質及其衍生物;辣椒素、香草醛等及衍生物;二乙基甲苯甲醯胺等昆蟲驅避劑;生理活性物質與環糊精類的複合體為較佳者。Examples of hormones include estradiol, estrone, ethinyl estradiol, cortisone, hydrocortisone, prednisone, and the like. Examples of other medicinal agents such as anti-wrinkle agents, anti-aging agents, firming agents, cold-sensing agents, warm-sensing agents, wound healing accelerators, stimulants, analgesics, and cell-activating agents include retinols, Flavonic acid, retinoic acid tocopheryl ester; lactic acid, glycolic acid, gluconic acid, fruit acid, salicylic acid and its glycosides / esterification derivatives, hydroxydecanoic acid, long-chain α-hydroxy fatty acids, long-chain α- or β-fruit acids and their derivatives such as α-hydroxy fatty acid cholesterol; γ-aminobutyric acid, γ-amino-β-hydroxybutyric acid; carnitine; carnosine; creatine; neural crest Amines, sphingosine; caffeine, xanthine and their derivatives; coenzyme Q10, carotene, lycopene, astaxanthin, lutein, alpha-lipoic acid (Thioctic acid), colloidal platinum (Colloidal platinum), fullerenes and other antioxidant / active oxygen scavengers; catechins; quercetin and other flavonoids; isoflavones; gallic acid and ester sugar derivatives; tannin, sesamin, Plant anthocyanins, chlorogenic acids, apple polyphenols and other polyphenols; Rutin and glycoside derivatives; hesperidin and glycosides Other derivatives; quasi-lignin glycosides; Glycyrrhizin, Glycyrrhizin, Glycyrrhizin, Isoglycyrrhizin and other licorice extract-related substances; Lactoferrin; Gingerol, Gingerol; Menthol, Spice substances such as cedar alcohol and their derivatives; capsaicin, vanillin and their derivatives; insect repellents such as diethyltoluidine; and complexes of physiologically active substances and cyclodextrin are preferred.

作為植物/動物/微生物萃取物類,可列舉鳶尾萃取物、明日葉萃取物、羅漢柏萃取物、蘆筍萃取物、鱷梨萃取物、甘茶萃取物、杏樹萃取物、藥蜀葵萃取物、山金車萃取物、蘆薈萃取物、杏萃取物、杏核萃取物、銀杏萃取物、茵陳蒿萃取物、茴香萃取物、茵陳蒿萃取物、薑黃萃取物、烏龍茶萃取物、熊果萃取物、野玫瑰果萃取物、紫錐菊葉萃取物、日本香茶菜萃取物、黃芩萃取物、黃柏萃取物、黃連萃取物、大麥萃取物、中國人參萃取物、小連翹萃取物、野芝麻萃取物、紅芒柄花萃取物、西洋菜萃取物、柳橙萃取物、海水乾燥物、海藻萃取物、柿葉萃取物、火棘萃取物、水解彈性蛋白、水解小麥粉、水解蠶絲、葛根萃取物、洋甘菊萃取物、油溶性洋甘菊萃取物、胡蘿蔔萃取物、茵陳蒿萃取物、野燕麥萃取物、洛神花(karkade)萃取物、甘草萃取物、油溶性甘草萃取物、獼猴桃萃取物、kioue萃取物、木耳萃取物、金雞納皮萃取物、黃瓜萃取物、泡桐葉萃取物、鳥苷、芭樂萃取物、苦參萃取物、梔子萃取物、維氏熊竹萃取物、苦參萃取物、胡桃萃取物、栗萃取物、葡萄柚萃取物、鐵線蓮萃取物、黑米萃取物、黑砂糖萃取物、黑醋、小球藻萃取物、桑萃取物、黃龍膽萃取物、中日老鸛草(Geranium thunbergii)萃取物、紅茶萃取物、酵母萃取物、厚樸萃取物、咖啡萃取物、牛蒡萃取物、米萃取物、米發酵萃取物、米糠發酵萃取物、米胚芽油、紫草萃取物、膠原、越橘萃取物、細辛萃取物、柴胡萃取物、臍帶提取液、藏紅花萃取物、鼠尾草萃取物、肥皂草萃取物、細竹萃取物、野山楂萃取物、蠶沙萃取物、山椒萃取物、香菇萃取物、地黃萃取物、紫根萃取物、紫蘇萃取物、華東椴萃取物、繡線菊萃取物、孿葉蘇木萃取物、芍藥萃取物、生薑萃取物、菖蒲根萃取物、白樺萃取物、白木耳萃取物、問荊萃取物、甜葉菊萃取物、甜葉菊發酵物、西河柳萃取物、洋常春藤萃取物、銳刺山楂萃取物、西洋接骨木萃取物、歐蓍草萃取物、薄荷萃取物、鼠尾草萃取物、錦葵萃取物、川芎萃取物、日本獐牙菜萃取物、桑白皮萃取物、大黃萃取物、大豆萃取物、大棗萃取物、百里香萃取物、蒲公英萃取物、地衣類萃取物、茶萃取物、丁香萃取物、白茅萃取物、陳皮萃取物、茶樹油、甜茶萃取物、辣椒萃取物、當歸萃取物、金盞花萃取物、桃仁萃取物、旱谷魚鱗雲杉萃取物、魚腥草萃取物、蕃茄萃取物、納豆萃取物、胡蘿蔔萃取物、大蒜萃取物、野玫瑰萃取物、芙蓉萃取物、麥冬萃取物、蓮萃取物、歐芹萃取物、樺樹萃取物、蜂蜜、金縷梅萃取物、牆草萃取物、藍萼香茶菜萃取物、紅沒藥醇、日本扁柏萃取物、雙歧桿菌萃取物、枇杷萃取物、款冬萃取物、蜂斗菜萃取物、茯苓萃取物、假葉樹萃取物、葡萄萃取物、葡萄籽萃取物、蜂膠、絲瓜萃取物、紅花萃取物、薄荷萃取物、菩提樹萃取物、牡丹萃取物、啤酒花萃取物、玫瑰萃取物、松萃取物、婆羅果萃取物、水芭蕉萃取物、無患子萃取物、蜜蜂花萃取物、海蘊萃取物、桃萃取物、矢車菊萃取物、桉樹萃取物、虎耳草萃取物、柚子萃取物、百合萃取物、薏苡仁萃取物、蓬草萃取物、薰衣草萃取物、綠茶萃取物、蛋殼膜萃取物、蘋果萃取物、線狀阿司巴拉妥茶萃取物、靈芝萃取物、萵苣萃取物、檸檬萃取物、連翹萃取物、紫雲英萃取物、玫瑰萃取物、迷迭香萃取物、羅馬洋甘菊萃取物、蜂王漿萃取物、地榆萃取物等萃取物為較佳者。Examples of plant / animal / microbial extracts include iris extract, ashitaba extract, arborvitae extract, asparagus extract, avocado extract, sweet tea extract, apricot tree extract, hollyhock extract, mountain gold Car Extract, Aloe Vera Extract, Apricot Extract, Apricot Kernel Extract, Ginkgo Extract, Artemisia Argyi Extract, Fennel Extract, Artemisia Argyi Extract, Turmeric Extract, Oolong Tea Extract, Bear Fruit Extract, Rosehip Extract, Echinacea Leaf Extract, Japanese Tea Plant Extract, Scutellaria Baicalensis Extract, Cork Extract, Coptis Extract, Barley Extract, Chinese Ginseng Extract, Little Forsythia Extract, Wild Sesame Extract, Red Miscanthus flower extract, broccoli extract, orange extract, seawater dried extract, seaweed extract, persimmon leaf extract, pyracantha extract, hydrolyzed elastin, hydrolyzed wheat flour, hydrolyzed silk, kudzu root extract, chamomile Extract, oil-soluble chamomile extract, carrot extract, wormwood extract, wild oat extract, kalkade extract, licorice extract, oil Licorice extract, kiwi extract, kioue extract, agaric extract, cinchona extract, cucumber extract, paulownia leaf extract, guanosine, guar extract, matrine extract, gardenia extract, vitamin Bear's bamboo extract, Sophora flavescens extract, walnut extract, chestnut extract, grapefruit extract, clematis extract, black rice extract, black sugar extract, black vinegar, chlorella extract, mulberry Extract, yellow gentian extract, Geranium thunbergii extract, black tea extract, yeast extract, magnolia extract, coffee extract, burdock extract, rice extract, rice fermentation extract, Rice bran fermentation extract, rice germ oil, comfrey extract, collagen, bilberry extract, asarum extract, Bupleurum extract, umbilical cord extract, saffron extract, sage extract, soapgrass extract, Fine bamboo extract, wild hawthorn extract, silkworm sand extract, mountain pepper extract, shiitake mushroom extract, rehmannia glutinosa extract, purple root extract, perilla extract, East China tincture extract, spiraea extract, twin leaf extract Extract, Paeonia lactiflora extract, Ginger extract, Acorus calamus root extract, Birch extract, White fungus extract, Acacia extract, Stevia extract, Stevia fermented extract, Salix extract, Ivy extract , Sharp thorn hawthorn extract, western elderberry extract, yarrow extract, mint extract, sage extract, mallow extract, chuanxiong extract, japanese amaranth extract, mulberry extract , Rhubarb extract, soybean extract, jujube extract, thyme extract, dandelion extract, lichen extract, tea extract, clove extract, white grass extract, tangerine peel extract, tea tree oil, sweet tea extract , Chili extract, angelica extract, calendula extract, peach kernel extract, wadi fish scale spruce extract, houttuynia cordata extract, tomato extract, natto extract, carrot extract, garlic extract, wild rose extract Extract, hibiscus extract, Ophiopogon extract, lotus extract, parsley extract, birch extract, honey, witch hazel extract, wall grass extract, blue cilantro Extract, bisabolol, Japanese cypress extract, bifidobacteria extract, coriander extract, butterbur extract, butterbur extract, Poria extract, pseudoleaf tree extract, grape extract, grape seed extract Extract, propolis, loofah extract, safflower extract, peppermint extract, linden extract, peony extract, hop extract, rose extract, pine extract, salsa extract, plantain extract, sapinensis extract, Melissa extract, aquatic extract, peach extract, cornflower extract, eucalyptus extract, saxifraga extract, grapefruit extract, lily extract, coix kernel extract, bonsai extract, lavender extract, Green Tea Extract, Eggshell Membrane Extract, Apple Extract, Linear Aspartal Tea Extract, Ganoderma Extract, Lettuce Extract, Lemon Extract, Forsythia Extract, Mirabilis Extract, Rose Extract, Fan Extract Extracts such as rosemary extract, roman chamomile extract, royal jelly extract, and elm extract are preferred.

作為止癢劑,可列舉鹽酸苯海拉明(Diphenhydramine)、馬來酸氯苯那敏、樟腦、P物質(substance P)抑制劑等。Examples of the antipruritic agent include diphenhydramine hydrochloride, chlorpheniramine maleate, camphor, and substance P inhibitors.

作為角質剝離/溶解劑,可列舉水楊酸、硫、間苯二酚、硫化硒、吡哆醇(pyridoxine)等。Examples of the keratin peeling / dissolving agent include salicylic acid, sulfur, resorcinol, selenium sulfide, and pyridoxine.

作為抑汗劑,可列舉氯化羥鋁(ALUMINUM CHLOROHYDRATE)、氯化鋁、氧化鋅、對苯酚磺酸鋅等。Examples of the antiperspirant include aluminum chloride (Aluminum chloride), aluminum chloride, zinc oxide, and zinc p-phenolsulfonate.

作為清涼劑,可列舉薄荷醇、水楊酸甲酯等。Examples of the cooling agent include menthol and methyl salicylate.

作為收斂劑,可列舉檸檬酸、酒石酸、乳酸、硫酸鋁.鉀、單寧酸等。Examples of the astringent include citric acid, tartaric acid, lactic acid, and aluminum sulfate. Potassium, tannic acid, etc.

作為酶類,可列舉超氧化物歧化酶、過氧化氫酶、氯化溶菌酶、脂肪酶、木瓜蛋白酶、胰酶製劑、蛋白酶等。Examples of the enzymes include superoxide dismutase, catalase, chlorolysozyme, lipase, papain, trypsin preparation, and protease.

作為核酸類,可列舉核糖核酸及其鹽、去氧核糖核酸及其鹽、腺苷三磷酸二鈉為較佳者。As the nucleic acids, preferred are ribonucleic acid and its salts, deoxyribonucleic acid and its salts, and disodium adenosine triphosphate.

作為香料,可列舉乙醯雪松烯、戊基肉桂醛、烯丙基戊基乙醇酸酯、β-紫羅蘭酮、龍涎酮(Iso E Super)、異丁基喹啉、鳶尾油、鳶尾酮、吲哚、依蘭油、十一烷醛、十一烯醛、γ-十一烷酸內酯、蒿腦、丁香酚、橡苔、甜紅沒藥樹脂、柳橙油、丁香酚、橙花素、乳糖胺(galactosamine solid)、香芹酚、L-香芹酮、樟腦、canon、胡蘿蔔籽油、丁香油、肉桂酸甲酯、香葉醇、香葉腈、乙酸異冰片酯、乙酸香葉酯、乙酸二甲基苄基原酯、乙酸蘇合香酯、乙酸柏木酯、乙酸萜品酯、乙酸對叔丁基環己酯、乙酸香根酯、乙酸苄酯、乙酸沉香酯(linalyl acetate)、水楊酸異戊酯、水楊酸苄酯、檀香木油、檀香醇、兔耳草醛(cyclamen aldehyde)、環十五內酯、二氫茉莉酮酸甲酯、二氫月桂烯醇、茉莉原精、茉莉內酯、順-茉莉酮、檸檬醛、香茅醇、香茅醛、桂皮油、1,8-桉樹腦、肉桂醛、蘇合香浸膏、雪松油、雪松烯、雪松醇、芹菜籽油、百里香油、二氫大馬酮、大馬烯酮、百里酚、晚香玉原精、癸醛、癸內酯、萜品醇、γ-萜品烯、二甲基-3-環己烯-1-甲醛、橙花醇、壬醛、2,6-壬二烯醇、壬內酯、廣藿香醇、香草原精、香草醛、羅勒油、廣藿香油、羥基香茅醛、α-蒎烯、薄荷酮、苯乙醇、苯基乙醛、苦橙葉油、己基肉桂醛、順-3-己烯醇、秘魯香脂、香根草(Vetiver)油、香根草醇、薄荷油、胡椒油、胡椒醛、佛手柑油、苯甲酸苄酯、龍腦、沒藥精油、麝香酮、甲基壬基乙醛、γ-甲基紫羅蘭酮、薄荷醇、L-薄荷醇、L-薄荷酮、桉樹油、β-紫羅蘭酮、酸橙油、薰衣草油、D-1,8-萜二烯、沉香醇(linalool)、新鈴蘭醛(Lyral)、鈴蘭醛、檸檬油、玫瑰精油、玫瑰醚、玫瑰油、迷迭香油、各種精油等合成香料及天然香料以及各種調合香料為較佳者。Examples of the fragrance include acetocedarene, pentylcinnamaldehyde, allylpentyl glycolate, β-ionone, Iso E Super, isobutylquinoline, iris oil, iris ketone, Indole, ylang ylang oil, undecalaldehyde, undecenal, γ-undecanolactone, artemisinin, eugenol, oakmoss, sweet red myrrh resin, orange oil, eugenol, neroli Vegetarian, galactosamine solid, carvacrol, L-carvone, camphor, canon, carrot seed oil, clove oil, methyl cinnamate, geraniol, geranilon, isobornyl acetate, acetic acid fragrance Leaf esters, dimethyl benzyl acetate, threonyl acetate, cedar acetate, terpine acetate, p-tert-butyl cyclohexyl acetate, vetiver acetate, benzyl acetate, linalyl acetate , Isoamyl salicylate, benzyl salicylate, sandalwood oil, santalol, cyclamen aldehyde, cyclopentadenolactone, methyl dihydrojasmonate, dihydromyrcenol, Jasmine Propolis, Jasmine lactone, cis-jasmone, citral, citronellol, citronellal, cinnamon oil, 1,8-eucalyptol, cinnamaldehyde, threonine Hexiang extract, cedar oil, cedarene, cedar alcohol, celery seed oil, thyme oil, dihydrodamascenone, damascenone, thymol, tuberose essence, decanal, caprolactone, terpenes Pinol, γ-terpinene, dimethyl-3-cyclohexene-1-carbaldehyde, nerol, nonanal, 2,6-nonadienol, nonyllactone, patchouli alcohol, vanillin , Vanillin, basil oil, patchouli oil, hydroxycitronellal, α-pinene, menthol, phenethyl alcohol, phenylacetaldehyde, bitter orange leaf oil, hexylcinnamaldehyde, cis-3-hexenol, Peru Balsam, vetiver oil, vetiver alcohol, peppermint oil, pepper oil, piperonal, bergamot oil, benzyl benzoate, borneol, myrrh essential oil, muscone, methylnonylacetaldehyde, γ-methylionone, menthol, L-menthol, L-menthol, eucalyptus oil, β-ionone, lime oil, lavender oil, D-1,8-terpene diene, linalool Synthetic and natural fragrances such as Lyral, Lily of the Valley, Lily of the Valley, Lemon Oil, Rose Essential Oil, Rose Ether, Rose Oil, Rosemary Oil, Various Essential Oils, and various blended spices are preferred.

作為色素/著色劑/染料,可列舉褐色201號、黑色401號、紫色201號、紫色401號、藍色1號、藍色2號、藍色201號、藍色202號、藍色203號、藍色204號、藍色205號、藍色403號、藍色404號、綠色201號、綠色202號、綠色204號、綠色205號、綠色3號、綠色401號、綠色402號、紅色102號、紅色104-1號、紅色105-1號、紅色106號、紅色2號、紅色201號、紅色202號、紅色203號、紅色204號、紅色205號、紅色206號、紅色207號、紅色208號、紅色213號、紅色214號、紅色215號、紅色218號、紅色219號、紅色220號、紅色221號、紅色223號、紅色225號、紅色226號、紅色227號、紅色228號、紅色230-1號、紅色230-2號、紅色231號、紅色232號、紅色3號、紅色401號、紅色404號、紅色405號、紅色501號、紅色502號、紅色503號、紅色504號、紅色505號、紅色506號、橙色201號、橙色203號、橙色204號、橙色205號、橙色206號、橙色207號、橙色401號、橙色402號、橙色403號、黃色201號、黃色202-1號、黃色202-2號、黃色203號、黃色204號、黃色205號、黃色4號、黃色401號、黃色402號、黃色403-1號、黃色404號、黃色405號、黃色406號、黃色407號、黃色5號等之法定色素;Acid Red 14等之其他的酸性染料;Arianor Sienna Brown、Arianor Madder Red、Arianor Steel Blue、Arianor Straw Yellow等之鹼性染料;HC Yellow 2、HC Yellow 5、HC Red 3、4-hydoxypropylamino-3-nitrophenol、N,N’-bis(2-hydroxyethyl)-2-nitro-p-phenylenediamine、HC Blue 2、Basic Blue 26等之硝基染料;分散染料;蝦青素(astaxanthin)、茜素等蒽醌類、花青素(anthocyanidin)、β-胡蘿蔔素、胡蘿蔔醛(catenal)、辣椒紅、查耳酮、紅花素、五羥黃酮、藏花素、葉綠素、薑黃素、胭脂紅、紫草素等萘醌類、紅木素、黃酮類、β-花青素、指甲花、血紅蛋白、蕃茄紅素、核黃素、盧丁(Rutin)等天然色素.染料;對苯二胺、甲苯-2,5-二胺、o-,m-,或p-胺基苯酚、m-苯二胺、5-胺基-2-甲基苯酚、間苯二酚、1-萘酚、2,6-二胺基吡啶等及其鹽等之氧化染料中間體及成色劑;吲哚啉等之自動氧化型染料;二羥基丙酮為較佳者。Examples of the pigment / colorant / dye include brown 201, black 401, purple 201, purple 401, blue 1, blue 2, blue 201, blue 202, and blue 203. , Blue 204, blue 205, blue 403, blue 404, green 201, green 202, green 204, green 205, green 3, green 401, green 402, red 102, red 104-1, red 105-1, red 106, red 2, red 201, red 202, red 203, red 204, red 205, red 206, red 207 , Red 208, red 213, red 214, red 215, red 218, red 219, red 220, red 221, red 223, red 225, red 226, red 227, red 228, red 230-1, red 230-2, red 231, red 232, red 3, red 401, red 404, red 405, red 501, red 502, red 503 , Red 504, red 505, red 506, orange 201, orange 203, orange 204, orange 205, orange 206, Color 207, orange 401, orange 402, orange 403, yellow 201, yellow 202-1, yellow 202-2, yellow 203, yellow 204, yellow 205, yellow 4, yellow 401 No., Yellow 402, Yellow 403-1, Yellow 404, Yellow 405, Yellow 406, Yellow 407, Yellow 5 and other legal pigments; Acid Red 14 and other acid dyes; Arianor Sienna Brown, Basic dyes such as Arianor Madder Red, Arianor Steel Blue, Arianor Straw Yellow; HC Yellow 2, HC Yellow 5, HC Red 3, 4-hydoxypropylamino-3-nitrophenol, N, N'-bis (2-hydroxyethyl) -2 Nitro dyes such as -nitro-p-phenylenediamine, HC Blue 2, Basic Blue 26, etc .; disperse dyes; anthraquinones such as astaxanthin, alizarin, anthocyanidin, β-carotene, carrot Catalin, capsanthin, chalcone, safflorin, pentaflavonoids, crocetin, chlorophyll, curcumin, carmine, shikonin and other naphthoquinones, redwood, flavonoids, β-anthocyanins , Henna, hemoglobin, lycopene, riboflavin, Rutin and other natural colors . Dyes; p-phenylenediamine, toluene-2,5-diamine, o-, m-, or p-aminophenol, m-phenylenediamine, 5-amino-2-methylphenol, resorcinol , 1-naphthol, 2,6-diaminopyridine, etc. and their salts, oxidative dye intermediates and couplers; indoline and other auto-oxidative dyes; dihydroxyacetone is preferred.

作為消炎劑/抗炎症劑,可列舉甘草酸及其衍生物、甘草次酸衍生物、水楊酸衍生物、檜木醇、愈創木奧、尿囊素、吲哚美辛、酮基布洛芬、布洛芬、雙氯芬酸、洛索洛芬、塞來昔布、英夫利西單抗、依那西普、氧化鋅、乙酸氫化可的松、脫氫可的松、鹽酸二苯胺明(diphenhydramine)、馬來酸氯苯那敏;桃葉萃取物、蓬葉萃取物等植物萃取物為較佳者。Examples of the anti-inflammatory agent / anti-inflammatory agent include glycyrrhizic acid and its derivatives, glycyrrhetinic acid derivatives, salicylic acid derivatives, ligulin, guaiac, allantoin, indomethacin, and ketobulol Fen, ibuprofen, diclofenac, loxoprofen, celecoxib, infliximab, etanercept, zinc oxide, hydrocortisone acetate, dehydrocortisone, diphenhydramine hydrochloride , Chlorpheniramine maleate; plant extracts such as peach leaf extract and canopy leaf extract are preferred.

作為抗哮喘、抗慢性阻塞性肺疾病、抗過敏(antiallergy)、免疫調節劑,可列舉胺基茶鹼、茶鹼類、類固醇類(氟替卡松、倍氯米松等)、白三烯拮抗藥類、血栓素抑制藥類、色甘酸鈉、β2刺激藥類(福莫特羅、沙美特羅、沙丁胺醇、妥布特羅、克侖特羅、腎上腺素等)、噻托銨、異丙托銨、右美沙芬、二甲啡烷、溴己新、曲尼司特、酮替芬、氮卓斯汀、西替利嗪、氯苯那敏、美喹他嗪、他克莫司、環孢菌素、西羅莫司、甲胺蝶呤、細胞激素(cytokine)調整劑類、干擾素、奧馬珠單抗、蛋白/抗體製劑為較佳者。Examples of anti-asthma, anti-chronic obstructive pulmonary disease, antiallergy, and immunomodulators include amino theophylline, theophylline, steroids (fluticasone, beclomethasone, etc.), leukotriene antagonists, Thromboxane inhibitors, sodium cromoglycate, beta2 stimulants (formoterol, salmeterol, salbutamol, tobutrolol, clenbuterol, adrenaline, etc.), tiotropium, ipratropium, Dextromethorphan, dimethylmorphane, bromhexine, tranilast, ketotifen, azelastine, cetirizine, chlorpheniramine, mequitazine, tacrolimus, cyclosporin Peptin, sirolimus, methotrexate, cytokine regulators, interferon, omazumab, and protein / antibody preparations are preferred.

作為抗感染症劑、抗真菌劑,可列舉奧司他韋(Oseltamivir)及紮那米韋、伊曲康唑(itraconazole)為較佳者。此外,還有以公知的組合及調配比/調配量含有化妝品原料基準、化妝品種別調配成分規格、日本化妝品工業聯合會成分表示名稱表、INCI辭典(The International Cosmetic Ingredient Dictionary and Handbook)、醫藥部外品原料規格、日本藥局方、醫藥品添加物規格、食品添加物公定書等所記載的成分及國際專利分類IPC屬於A61K7及A61K8之分類的日本及各國專利公報及專利公開公報(包含公表公報、再公表)所記載的成分等公知的化妝料成分、藥品成分、食品成分等。As an anti-infective agent and an antifungal agent, oseltamivir, zanamivir, and itraconazole are preferable. In addition, there are well-known combinations and formulation ratios / dosage ratios that contain cosmetic raw material standards, specifications for the composition of cosmetic types, the Japan Cosmetics Industry Federation ingredient name list, the INCI dictionary (The International Cosmetic Ingredient Dictionary and Handbook), and the Ministry of Medicine. Ingredients and international patent classification IPC belonging to the classification of A61K7 and A61K8 in Japanese and international patent publications and patent publications (including public announcements) , Re-publication table) and other well-known cosmetic ingredients, pharmaceutical ingredients, food ingredients, and the like.

[分散液之製造方法]   本發明之分散液,可藉由使用由前述式(1)至式(3)表示之化合物或其醫藥上可使用之鹽之中之至少一種所成之脂質肽型化合物所構成的顏料或粉體用分散劑、界面活性劑、水、1,2-烷二醇或1,3-烷二醇、脂肪酸、及選自由顏料及粉體所組成之群組之至少一種、及所期望之多元醇等之其他的添加劑,邊加熱邊將此等混合、攪拌後,攪拌冷卻至成為室溫左右來製造。[Manufacturing method of dispersion liquid] 分散 The dispersion liquid of the present invention can be a lipid peptide type formed by using at least one of the compounds represented by the aforementioned formulae (1) to (3) or a pharmaceutically acceptable salt thereof. Dispersant for pigment or powder composed of compound, surfactant, water, 1,2-alkanediol or 1,3-alkanediol, fatty acid, and at least one selected from the group consisting of pigment and powder One kind and other additives such as a desired polyol are produced by mixing and stirring these while heating, and then stirring and cooling to about room temperature.

例如,本發明之分散液,其一例為藉由下述步驟來製造。   a)調配上述顏料或粉體用分散劑(脂質肽化合物)、界面活性劑及水,加熱調製溶解液(或分散液)的步驟,   b)將上述溶解液(或分散液)添加於水中,在以室溫以上未達100℃的溫度進行加熱的步驟,   c)邊攪拌至比前述加熱步驟中之溫度更低的溫度,邊進行冷卻,得到本發明之分散液的步驟。   在此,1,2-烷二醇或1,3-烷二醇、脂肪酸及選自由顏料及粉體所組成之群組之至少一種、及其他的成分,可於在a)步驟中之溶解液(或分散液)之調製步驟中添加,也可在b)步驟中,預先添加於添加溶解液(或分散液)之水中。   又,相對於如此所得之本發明之(包含選自由顏料及粉體所組成之群組之至少一種)分散液的總質量,水為60質量%以上99.9質量%以下為佳。For example, the dispersion liquid of the present invention is produced by the following steps. a) the step of preparing the pigment or powder dispersant (lipid peptide compound), a surfactant, and water, and heating to prepare a dissolving solution (or dispersing solution); b) adding the dissolving solution (or dispersing solution) to water, The step of heating at a temperature of not less than 100 ° C above room temperature, c) the step of obtaining the dispersion liquid of the present invention while cooling to a temperature lower than the temperature in the aforementioned heating step while stirring. Here, 1,2-alkanediol or 1,3-alkanediol, fatty acids, at least one selected from the group consisting of pigments and powders, and other components can be dissolved in step a). In the preparation step of the liquid (or dispersion), it may also be added in advance to the water to which the dissolving solution (or dispersion) is added in step b). Furthermore, it is preferable that the water is 60% by mass or more and 99.9% by mass or less with respect to the total mass of the dispersion liquid of the present invention (including at least one selected from the group consisting of pigments and powders).

前述a)步驟及b)步驟中之加熱溫度,較佳為50℃至90℃,更佳為60℃至90℃,例如為80℃,邊加熱邊進行攪拌為佳。此時各個步驟中之加熱攪拌的時間係依使用的顏料或粉體用分散劑(脂質肽化合物)或界面活性劑外,其他成分的種類及彼等之調配量而異,通常可以1分鐘至50分鐘左右溶解、分散。   a)、b)步驟後,邊攪拌至液溫成為比b)步驟中之溫度更低的溫度邊進行冷卻的(c)步驟)。在此,冷卻溫度,例如為室溫至80℃,室溫至60℃、或室溫至40℃左右。The heating temperature in the foregoing steps a) and b) is preferably 50 ° C to 90 ° C, more preferably 60 ° C to 90 ° C, such as 80 ° C, and it is preferable to perform stirring while heating. At this time, the heating and stirring time in each step depends on the type of pigment and powder dispersant (lipid peptide compound) or surfactant, and the types of other components and their blending amounts. Usually, it can be from 1 minute to Dissolve and disperse in about 50 minutes. (I) Steps (a) and (b) are followed by cooling (step (c)) while stirring until the liquid temperature becomes lower than the temperature in step b). Here, the cooling temperature is, for example, about room temperature to 80 ° C, room temperature to 60 ° C, or room temperature to about 40 ° C.

又,製造本發明之分散液為預混物(premix)的水性組成物後,也可在該預混物中,適宜添加其他調配的成分來製造。   例如,經過預混後之分散液的製造方法,可列舉以下者。   1)調製預混物的步驟   1-1)將包含界面活性劑及水與由顏料或粉體用分散劑(前述式(1)至式(3)表示之化合物或其醫藥上可使用的鹽之中之至少一種所成之脂質肽型化合物)的混合系,加熱至室溫以上未達100℃之溫度的加熱步驟,   1-2)接著,在經加熱後之前述混合系中,適宜添加1,2-烷二醇或1,3-烷二醇、脂肪酸及其他添加劑的步驟,   1-3)將前述溶解液或分散液冷卻,得到水性組成物(預混物)的調製步驟,   2)使用預混物製造分散液的步驟   2-1)在加熱至室溫以上未達100℃之溫度的水相中,添加加熱至室溫以上未達100℃之溫度的上述水性組成物(預混物),進行混合或在加熱至室溫以上未達100℃之溫度之上述水性組成物(預混物)中,添加經加熱至室溫以上未達100℃之溫度的水相,進行混合的混合步驟,   2-2)將前述混合步驟所得之混合物進行攪拌冷卻,得到分散液的冷卻步驟。   上述2-1)步驟中之水相包含水,可再包含高級醇、顏料,也可包含1,2-烷二醇或1,3-烷二醇、脂肪酸及其他的添加劑。又,2-1)中,在水性組成物(預混物)中,混合了顏料或其他的添加劑後,也可與水相組合。   此外,前述混合步驟中,藉由進一步添加藥劑之溶解液,也可製造添加了藥劑的分散液(製劑)。In addition, after the aqueous composition of the present invention is prepared as a premix, the premix may be produced by suitably adding other components to the premix. For example, the following methods can be used as a method for producing a dispersion after premixing. 1) Step 1-1 of preparing a premix: a surfactant and water and a dispersant for a pigment or a powder (the compound represented by the aforementioned formula (1) to formula (3) or a pharmaceutically acceptable salt thereof) A mixture of at least one of the lipid peptide compounds formed), a heating step of heating to a temperature above room temperature and not more than 100 ° C, 1-2), and then, to the aforementioned mixed system after heating, it is suitable to add Step of 1,2-alkanediol or 1,3-alkanediol, fatty acid and other additives, 1-3) The step of preparing the aqueous solution (premix) by cooling the aforementioned dissolving solution or dispersion, 2 ) Step 2-1 of preparing a dispersion using a premix 2-1) In the water phase heated to a temperature above room temperature and not higher than 100 ° C, add the above-mentioned aqueous composition (preliminarily heated to a temperature above room temperature and less than 100 ° C) (Mixture), mixed or added to the above-mentioned aqueous composition (premix) heated to a temperature above room temperature and not more than 100 ° C, adding an aqueous phase heated to a temperature above room temperature and less than 100 ° C, and mixed The mixing step, 2-2) the obtained mixing step The mixture was cooled by stirring to obtain a cooling step of the dispersion.水 The water phase in the above step 2-1) contains water, and may further contain higher alcohols, pigments, and may also include 1,2-alkanediol or 1,3-alkanediol, fatty acids, and other additives. In addition, in 2-1), a pigment or other additives may be mixed with an aqueous composition (premix), and then it may be combined with water. In addition, in the mixing step, a pharmaceutical-added dispersion liquid (formulation) can also be produced by further adding a pharmaceutical solution.

前述1-1)步驟及1-2)步驟中之混合系(及水性組成物)的加熱溫,較佳為50℃至90℃,更佳為60℃至90℃,例如70℃或80℃。本步驟,較佳為邊攪拌邊實施為佳。此時之各步驟中之加熱(攪拌)的時間係依水性組成物所包含之顏料或粉體用分散劑(脂質肽化合物)或界面活性劑外其他成分的種類及彼等之調配量而異,通常為5分鐘至50分鐘左右。藉由本步驟,成為使水性組成物均勻地溶解的狀態。   又,前述1-3)步驟中之冷卻溫度,例如為室溫至80℃、室溫至60℃、或室溫至40℃左右。於此步驟中,較佳為邊攪邊冷卻,然後,停止攪拌後、靜置更佳。   又,相對於藉由1)步驟所得之水性組成物(預混物)之總質量,水為30質量%以上未達80質量%為佳。The heating temperature of the mixing system (and the aqueous composition) in the foregoing steps 1-1) and 1-2) is preferably 50 ° C to 90 ° C, and more preferably 60 ° C to 90 ° C, such as 70 ° C or 80 ° C. . This step is preferably carried out while stirring. The time for heating (stirring) in each step at this time varies depending on the type of pigment or powder dispersant (lipid peptide compound) or surfactant other than the ingredients contained in the aqueous composition, and their blending amounts. , Usually 5 minutes to 50 minutes. With this step, a state in which the aqueous composition is uniformly dissolved is obtained. In addition, the cooling temperature in the foregoing steps 1-3) is, for example, about room temperature to 80 ° C, room temperature to 60 ° C, or room temperature to about 40 ° C. In this step, it is preferable to cool while stirring, and then, after stirring is stopped, it is better to stand still. In addition, it is preferable that the water is 30 mass% or more and less than 80 mass% with respect to the total mass of the aqueous composition (premix) obtained in step 1).

前述2-1)步驟中之水相及水性組成物(預混物)的加熱溫度,較佳為50℃至90℃,更佳為60℃至90℃,例如70℃、或80℃、或90℃。水相之加熱係因包含其他的成分,故邊攪拌邊進行加熱為佳,至含有的成分均勻地溶解、分散,通常實施加熱(攪拌)1分鐘至50分鐘左右為佳。又,水相之加熱溫度,也可與上述水性組成物(預混物)之加熱溫度相同溫度。The heating temperature of the aqueous phase and the aqueous composition (premix) in the aforementioned step 2-1) is preferably 50 ° C to 90 ° C, more preferably 60 ° C to 90 ° C, such as 70 ° C, or 80 ° C, or 90 ° C. Since the heating of the water phase contains other components, it is preferable to heat it while stirring, until the contained components are uniformly dissolved and dispersed, and it is usually preferable to perform heating (stirring) for about 1 to 50 minutes. The heating temperature of the water phase may be the same as the heating temperature of the aqueous composition (premix).

接著,在前述2-2)步驟中,將前步驟所得之混合物進行攪拌冷卻,得到分散液。邊攪拌邊進行冷卻時,例如實施攪拌至冷卻溫度成為室溫至80℃、室溫至60℃,例如60℃左右後,然後,停止攪拌、靜置、冷卻亦可。Next, in the aforementioned step 2-2), the mixture obtained in the previous step is stirred and cooled to obtain a dispersion liquid. When cooling with stirring, for example, stirring may be performed until the cooling temperature reaches room temperature to 80 ° C and room temperature to 60 ° C, for example, about 60 ° C, and then the stirring may be stopped, left to stand, and cooled.

即使在如此使用水性組成物(預混物)所得之分散液中,水的調配量係相對於分散液之總質量,較佳為60質量%以上99.9質量%以下。 [實施例]Even in the dispersion obtained by using the aqueous composition (premix) in this manner, the amount of water to be formulated is preferably 60% by mass or more and 99.9% by mass or less with respect to the total mass of the dispersion. [Example]

以下舉實施例及試驗例為例,詳細說明本發明,但是本發明不限定於此等之例。The following examples and test examples are taken as examples to describe the present invention in detail, but the present invention is not limited to these examples.

[合成例1:脂質肽(N-棕櫚醯-Gly-His)之合成]   在本實施例中使用之脂質肽型化合物係以以下所示的方法合成。   在500mL之四口燒瓶中,投入組胺酸14.2g (91.6mmol)、N-棕櫚醯-Gly-甲基30.0g(91.6mmol)、甲苯300g,再添加鹼的甲醇鈉28%甲醇溶液35.3g (183.2mmol),使用油浴加熱至60℃,持續攪拌1小時。然後,移開油浴,放置冷卻至25℃,將此溶液以丙酮600g再沉澱,過濾取得。將此所得的固體溶解於水600g與甲醇750g之混合溶液中,於此添加6N(規定度)鹽酸30.5ml (183.2mmol)進行中和使固體析出,進行過濾。接著,將所得之固體於四氫呋喃120g與水30g之混合溶液中,以60℃使溶解,添加乙酸乙酯150g,由60℃冷卻至30℃。然後,將析出的固體過濾。再將所得之固體溶解於四氫呋喃120g與乙腈60g溶劑中,加熱至60℃,攪拌1小時後,冷卻、過濾。在此所得之固體使用水120g洗淨,過濾後進行減壓乾燥,得到N-棕櫚醯-Gly-His游離體(free form)(以下亦僅稱為Pal-GH)之白色結晶26.9g(收率65%)。[Synthesis Example 1: Synthesis of Lipid Peptide (N-palmidine-Gly-His)] The lipid peptide-type compound used in this example was synthesized by the method shown below. In a 500 mL four-necked flask, put 14.2 g (91.6 mmol) of histidine, 30.0 g of N-palmidine-Gly-methyl (91.6 mmol), and 300 g of toluene, and then add 35.3 g of a sodium 28% methanol solution in alkali. (183.2 mmol), heated to 60 ° C using an oil bath, and continued stirring for 1 hour. Then, the oil bath was removed, and it was left to cool to 25 ° C. This solution was reprecipitated with 600 g of acetone and filtered to obtain it. This obtained solid was dissolved in a mixed solution of 600 g of water and 750 g of methanol, and 30.5 ml (183.2 mmol) of 6N (predetermined degree) hydrochloric acid was added thereto to neutralize and precipitate a solid, followed by filtration. Next, the obtained solid was dissolved in a mixed solution of 120 g of tetrahydrofuran and 30 g of water, dissolved at 60 ° C, 150 g of ethyl acetate was added, and the temperature was cooled from 60 ° C to 30 ° C. Then, the precipitated solid was filtered. The obtained solid was dissolved in a solvent of 120 g of tetrahydrofuran and 60 g of acetonitrile, heated to 60 ° C., stirred for 1 hour, and then cooled and filtered. The solid obtained here was washed with 120 g of water, filtered and dried under reduced pressure to obtain 26.9 g of white crystals of N-palmidine-Gly-His free form (hereinafter also referred to as Pal-GH) (collected Rate 65%).

[實施例1:調配有顏料10質量%之粉底液之製作]   依據下述表1,調製調配有顏料10質量%的粉底液。在Laboran標準瓶(No.7、AS ONE(股))中,將顏料5.0g與純水33.0g以80℃攪拌2分鐘,在此添加已加熱至80℃的1,2-己二醇1.0g,進行2分鐘攪拌混合。   在此,添加已加熱至80℃之組成物[1]1.0g,進行2分鐘攪拌混合後,添加已加熱至80℃之甘油10.0g,進行3分鐘攪拌混合,該狀態下攪拌冷卻至成為室溫,得到粉底液。   又,組成物[1]為以表1所示之組成,混合Pal-GH、聚氧乙烯月桂醚及純水,加熱攪拌至70℃,在此添加1,2-己二醇及硬脂酸,再於70℃下加熱攪拌後,藉由放置冷卻至室溫而得。又,即使在以下的實施例也使用以相同的步驟得到的組成物[1]。   以上製造步驟中之攪拌均以400rpm進行。[Example 1: Preparation of 10% by mass pigment liquid foundation] According to the following Table 1, a 10% by mass pigment liquid foundation was prepared. In a Laboran standard bottle (No. 7, AS ONE), 5.0 g of pigment and 33.0 g of pure water were stirred at 80 ° C for 2 minutes, and 1,2-hexanediol 1.0 heated to 80 ° C was added here. g, stirring and mixing for 2 minutes. Here, 1.0 g of the composition [1] which has been heated to 80 ° C. is added and stirred for 2 minutes, and then 10.0 g of glycerin which has been heated to 80 ° C. is added and stirred for 3 minutes. In this state, it is stirred and cooled to become a chamber. Warm to get liquid foundation. In addition, the composition [1] has the composition shown in Table 1. Pal-GH, polyoxyethylene lauryl ether, and pure water were mixed, and the mixture was heated to 70 ° C, and 1,2-hexanediol and stearic acid were added thereto. After heating and stirring at 70 ° C, it is obtained by leaving to cool to room temperature. The composition [1] obtained by the same procedure was used in the following examples.搅拌 Stirring in the above manufacturing steps was performed at 400 rpm.

[實施例2:調配有顏料10質量%之粉底液之製作]   除了組成物[1]為0.5g、純水為33.5g外,以與實施例1同樣的步驟,製造如表1所示調配有顏料10質量%的粉底液。[Example 2: Preparation of foundation liquid with 10% by mass of pigment] Except that the composition [1] is 0.5 g and pure water is 33.5 g, the same procedures as in Example 1 were used to manufacture the formulation as shown in Table 1. Liquid foundation with 10% by mass of pigment.

[實施例3:調配有顏料15質量%之粉底液之製作]   除了顏料為7.5g、純水為31g外,以與實施例2同樣的步驟,製造如表1所示調配有顏料15質量%的粉底液。[Example 3: Preparation of 15% by weight pigment base liquid preparation] Except that the pigment was 7.5g and pure water was 31g, the same procedure as in Example 2 was used to produce a 15% by weight pigment base powder as shown in Table 1. Liquid foundation.

[比較例1]   除了未調配組成物[1],純水為34.0g外,以與實施例1同樣的步驟,製造如表1所示調配有顏料10質量%之比較例的粉底。[Comparative Example 1] In the same procedure as in Example 1 except that the composition [1] was not prepared and pure water was 34.0 g, a foundation of a comparative example prepared with a pigment of 10% by mass as shown in Table 1 was produced.

圖1表示實施例1至實施例3及比較例1的粉底(外觀)。   如圖1所示,在調配含有Pal-GH之組成物[1]之實施例1至實施例3中,顏料分散,確認顏料之分散安定性。又,藉由調整含有Pal-GH之組成物[1]的調配量,可調製黏性高的粉底液型(實施例1)與相較於其,黏性較低之粉底型(實施例2及實施例3)。   又,未調配含有Pal-GH之組成物[1]的比較例1,如圖1所示,顏料與其他的成分產生分離,顏料沉澱。FIG. 1 shows foundations (appearances) of Examples 1 to 3 and Comparative Example 1. FIG. (1) As shown in FIG. 1, in Examples 1 to 3 in which the composition [1] containing Pal-GH was prepared, the pigment was dispersed, and the dispersion stability of the pigment was confirmed. In addition, by adjusting the blending amount of the composition [1] containing Pal-GH, a liquid foundation type with high viscosity (Example 1) and a foundation type with lower viscosity (Example 2) can be prepared. And Example 3). In addition, in Comparative Example 1 in which the composition [1] containing Pal-GH was not prepared, as shown in FIG. 1, the pigment was separated from other components and the pigment was precipitated.

[實施例4:調配珠光顏料2質量%之分散液之製作]   依據下述表2,調製調配珠光顏料2質量%的分散液。   在Laboran標準瓶(No.7、AS ONE(股))中,將珠光顏料1.0g與純水33.5g以80℃攪拌2分鐘,在此添加已加熱至80℃的1,3-丁二醇(1,3-丁二醇)5.0g,進行2分鐘攪拌混合。   在此,添加已加熱至80℃之組成物[1]0.5g,進行2分鐘攪拌混合後,添加已加熱至80℃之甘油10.0g,進行3分鐘攪拌混合,該狀態下攪拌冷卻至成為室溫,得到分散液。   以上製造步驟中之攪拌均以400rpm進行。[Example 4: Preparation of 2% by mass of pearlescent pigment dispersion] According to the following Table 2, a 2% by mass of pearlescent pigment dispersion was prepared. In a Laboran standard bottle (No. 7, AS ONE), 1.0 g of pearlescent pigment and 33.5 g of pure water were stirred at 80 ° C for 2 minutes, and 1,3-butanediol heated to 80 ° C was added here. (1,3-butanediol) 5.0 g, and stirred and mixed for 2 minutes. Here, 0.5 g of the composition [1] heated to 80 ° C. is added, and the mixture is stirred and mixed for 2 minutes. Then, 10.0 g of glycerin heated to 80 ° C. is added, and stirred and mixed for 3 minutes. In this state, it is stirred and cooled to become a chamber. Warm to obtain a dispersion.搅拌 Stirring in the above manufacturing steps was performed at 400 rpm.

[實施例5:調配珠光顏料0.5質量%之分散液之製作]   依據下述表2,調製調配珠光顏料0.5質量%的分散液。   在Laboran標準瓶(No.7、AS ONE(股))中,將珠光顏料0.25g與純水49.25g以80℃攪拌2分鐘,在此,添加已加熱至80℃之組成物[1]0.5g,進行2分鐘攪拌混合後,該狀態下攪拌冷卻至成為室溫,得到分散液。   以上製造步驟中之攪拌均以400rpm進行。[Example 5: Preparation of 0.5% by mass of pearlescent pigment dispersion] According to the following Table 2, a 0.5% by mass of pearlescent pigment dispersion was prepared. In a Laboran standard bottle (No.7, AS ONE), stir 0.25g of pearlescent pigment and 49.25g of pure water at 80 ° C for 2 minutes, and then add the composition heated to 80 ° C [1] 0.5 g, After stirring and mixing for 2 minutes, the mixture was stirred and cooled to room temperature in this state to obtain a dispersion.搅拌 Stirring in the above manufacturing steps was performed at 400 rpm.

[比較例2]   除了未調配組成物[1],純水為34.0g外,以與實施例4同樣的步驟,製造如表2所示調配珠光顏料2質量%之比較例的分散液。[Comparative Example 2] A dispersion liquid of a comparative example in which 2% by mass of a pearlescent pigment was prepared as shown in Table 2 was produced in the same procedure as in Example 4 except that the composition [1] was not prepared and pure water was 34.0 g.

圖2表示實施例4及實施例5及比較例2之調配珠光顏料之分散液(外觀)。   如圖2所示,在未調配含有Pal-GH之組成物[1]的比較例2中,珠光顏料與其他的成分分離結果,珠光顏料沉澱,但是在調配該組成物[1]之實施例4及實施例5中,結果珠光顏料之分散性改善。FIG. 2 shows the dispersion liquid (appearance) of the pearlescent pigments prepared in Example 4 and Example 5 and Comparative Example 2. FIG. As shown in FIG. 2, in Comparative Example 2 in which the composition [1] containing Pal-GH was not formulated, the pearlescent pigment was separated from other components, and the pearlescent pigment was precipitated. However, in the example in which the composition [1] was formulated, As a result, in 4 and Example 5, the dispersibility of the pearlescent pigment was improved.

[實施例6:磷酸三鈣分散液之製作]   依據下述表3,調製調配有磷酸三鈣0.5質量%的分散液。   在Laboran標準瓶(No.7、AS ONE(股))中,將磷酸三鈣0.25g與純水49.25g以80℃攪拌2分鐘,在此添加已加熱至80℃之組成物[1]0.5g,進行2分鐘攪拌混合後,該狀態下攪拌冷卻至成為室溫,得到分散液。   以上製造步驟中之攪拌均以400rpm進行。[Example 6: Preparation of Tricalcium Phosphate Dispersion Liquid] According to the following Table 3, a 0.5% by mass dispersion of tricalcium phosphate was prepared. In a Laboran standard bottle (No.7, AS ONE), stir 0.25g of tricalcium phosphate and 49.25g of pure water at 80 ° C for 2 minutes, and add the composition heated to 80 ° C [1] 0.5 g, After stirring and mixing for 2 minutes, the mixture was stirred and cooled to room temperature in this state to obtain a dispersion.搅拌 Stirring in the above manufacturing steps was performed at 400 rpm.

[比較例3]   除了未調配組成物[1],純水為49.75g外,以與實施例5同樣的步驟,製造如表3所示調配有磷酸三鈣0.5質量%之比較例的分散液。[Comparative Example 3] In the same procedure as in Example 5, except that the composition [1] was not prepared, and pure water was 49.75 g, a dispersion liquid of a comparative example prepared with tricalcium phosphate 0.5% by mass as shown in Table 3 was prepared. .

圖3表示實施例6及比較例3之調配磷酸三鈣之分散液(外觀)。   如圖3所示,在未調配含有Pal-GH之組成物[1]的比較例3中,磷酸三鈣與其他的成分分離,磷酸三鈣沉澱,但是在調配有該組成物[1]之實施例6中,結果磷酸三鈣之分散性改善。FIG. 3 shows the dispersion liquid (appearance) of the prepared tricalcium phosphate in Example 6 and Comparative Example 3. FIG. As shown in FIG. 3, in Comparative Example 3 in which the composition [1] containing Pal-GH was not formulated, tricalcium phosphate was separated from other components and tricalcium phosphate was precipitated, but when the composition [1] was prepared, As a result of Example 6, the dispersibility of tricalcium phosphate was improved.

[實施例7:調配金箔0.01質量%之分散液之製作]   依據下述表4,調製調配有金箔(約2mm四方~10mm四方)0.01質量%的分散液。   在Laboran標準瓶(No.7、AS ONE(股))中,將金箔5mg與純水49.745g以80℃攪拌2分鐘,在此添加已加熱至80℃之組成物[1]0.25g,進行2分鐘攪拌混合後,該狀態下攪拌冷卻至成為室溫,得到分散液。   以上製造步驟中之攪拌均以400rpm進行。[Example 7: Preparation of 0.01% by mass dispersion of gold foil] Prepare a 0.01% by mass dispersion of gold foil (about 2mm square to 10mm square) according to Table 4 below. In a Laboran standard bottle (No. 7, AS ONE), stir 5 mg of gold foil and 49.745 g of pure water at 80 ° C for 2 minutes, and add 0.25 g of the composition [1] which has been heated to 80 ° C, and proceed After stirring and mixing for 2 minutes, the mixture was stirred and cooled to room temperature in this state to obtain a dispersion.搅拌 Stirring in the above manufacturing steps was performed at 400 rpm.

[實施例8:調配金箔0.05質量%之分散液之製作]   除了金箔為25mg、組成物[1]為0.5g、純水為49.475g外,以與實施例7同樣的步驟,製造如表4所示調配有金箔0.05質量%之的分散液。[Example 8: Preparation of a dispersion of 0.05% by mass of gold foil] Except for 25 mg of gold foil, 0.5 g of the composition [1], and 49.475 g of pure water, the same steps as in Example 7 were used to manufacture, as shown in Table 4 As shown, a dispersion of 0.05% by mass of gold foil was prepared.

[比較例4]   除了未調配組成物[1],純水為49.95g外,以與實施例7同樣的步驟,製造如表4所示調配有金箔0.01質量%之比較例的分散液。[Comparative Example 4] A dispersion liquid of Comparative Example prepared with 0.01% by mass of gold foil as shown in Table 4 was prepared in the same procedure as in Example 7 except that the composition [1] was not prepared and pure water was 49.95 g.

圖4表示實施例7及實施例8及比較例4之調配金箔之分散液(外觀)。   如圖4所示,在未調配含有Pal-GH之組成物[1]的比較例4中,金箔與其他的成分分離,金箔浮遊或因其重量而沉澱,但是在調配有該組成物[1]之實施例7及實施例8中,結果磷酸三鈣之分散性改善。   又,此時,藉由調整含有Pal-GH之組成物[1]之調配量,結果可調整金箔之調配量或分散液之透明性。FIG. 4 shows the dispersion liquid (appearance) of the prepared gold foil in Example 7 and Example 8 and Comparative Example 4. FIG. As shown in FIG. 4, in Comparative Example 4 in which the composition [1] containing Pal-GH was not prepared, the gold foil was separated from other components, and the gold foil floated or precipitated due to its weight. However, the composition [1] ] In Examples 7 and 8, the dispersibility of tricalcium phosphate was improved. At this time, by adjusting the compounding amount of the composition [1] containing Pal-GH, the compounding amount of gold foil or the transparency of the dispersion liquid can be adjusted as a result.

[實施例9:調配顏料17質量%之O/W粉底液之製作]   依據下述表5,調製將顏料17質量%均勻地分散的粉底。   在200mL燒杯(HARIO股份公司製)中,混合顏料(Fresh color base AQUA)34.0g、純水139.6g、N-硬脂醯基甲基牛磺酸鈉(NIKKOL SMT、NIKKO CHEMICALS (股))0.2g、卵磷脂(lecithin)(LPA、NIKKO CHEMICALS (股))0.2g、EDTA-2Na(純正化學(股))0.2g、羥基丙基纖維素(NISSO SSL、日本曹達(股))0.4g、黃原膠(KELTROL-CG-ST、三晶(股))0.4g,於75℃下加熱攪拌10分鐘(B相)。   在200mL燒杯(HARIO股份公司製)中,加入NIKKOL NIKKOMULESE41(NIKKO CHEMICALS(股))4.0g、NIKKOL NATURAL OILS(NIKKO CHEMICALS (股))14.0g、NIKKOL NIKKOGUARD 88(NIKKO CHEMICALS(股)) 1.0g,於75℃下加熱攪拌10分鐘(A相)。   將A相在緩慢攪拌下添加於B相中,將所得之混合物於75℃中使用均質機(QUICK HOMO MIXER LR-1A、Mizuho工業股份公司製),以5,000rpm進行3分鐘乳化處理。再添加已加熱至75℃的組成物[1]2.0g,在75℃中加熱攪拌2分鐘後,室溫下攪拌冷卻至40℃。確認成為40℃後,添加NIKKOL NET-813-1(NIKKO CHEMICALS(股)) 4.0g(C相),進行攪拌冷卻至35℃。   在以上步驟中,攪拌均以200rpm進行。[Example 9: Production of O / W foundation liquid with 17% by mass of pigment] According to Table 5 below, a foundation with 17% by mass of pigment uniformly dispersed was prepared. In a 200 mL beaker (manufactured by HARIO Co., Ltd.), 34.0 g of fresh color base AQUA, 139.6 g of pure water, and sodium N-stearylmethyltaurine (NIKKOL SMT, NIKKO CHEMICALS (shares)) 0.2 g, lecithin (LPA, NIKKO CHEMICALS (stock)) 0.2 g, EDTA-2Na (pure chemical (stock)) 0.2 g, hydroxypropyl cellulose (NISSO SSL, Japan Soda (stock)) 0.4 g, 0.4 g of xanthan gum (KELTROL-CG-ST, tricrystal (strand)) was heated and stirred at 75 ° C for 10 minutes (phase B). In a 200mL beaker (HARIO Co., Ltd.), add 4.0g of NIKKOL NIKKOMULESE41 (NIKKO CHEMICALS (shares)), 14.0g of NIKKOL NATURAL OILS (NIKKO CHEMICALS (shares)), 1.0g of NIKKOL NIKKOGUARD 88 (NIKKO CHEMICALS (shares)), Heat and stir at 75 ° C for 10 minutes (phase A).相 Add phase A to phase B with slow stirring, and use a homogenizer (QUICK HOMO MIXER LR-1A, manufactured by Mizuho Industrial Co., Ltd.) at 75 ° C. to perform an emulsification treatment at 5,000 rpm for 3 minutes. Then, 2.0 g of the composition [1] heated to 75 ° C. was added, and after heating and stirring at 75 ° C. for 2 minutes, the mixture was cooled to 40 ° C. with stirring at room temperature. After confirming that it was 40 ° C, 4.0 g (C phase) of NIKKOL NET-813-1 (NIKKO CHEMICALS (stock)) was added, and the mixture was cooled to 35 ° C with stirring.搅拌 In the above steps, stirring was performed at 200 rpm.

[比較例5]   依據下述表5,調製調配有顏料17質量%的粉底。   在200mL燒杯(HARIO股份公司製)中,混合顏料(Fresh color base AQUA)34.0g、純水139.6g、N-硬脂醯基甲基牛磺酸鈉(NIKKOL SMT、NIKKO CHEMICALS (股))0.2g、卵磷脂(lecithin)(LPA、NIKKO CHEMICALS (股))0.2g、EDTA-2Na(純正化學(股))0.2g、羥基丙基纖維素(NISSO SSL、日本曹達(股))0.4g、黃原膠(KELTROL-CG-ST、三晶(股))0.4g,於75℃下加熱攪拌10分鐘(B相)。   在200mL燒杯(HARIO股份公司製)中,加入NIKKOL NIKKOMULESE41(NIKKO CHEMICALS(股))4.0g、NIKKOL NATURAL OILS(NIKKO CHEMICALS(股)) 14.0g、NIKKOL NIKKOGUARD 88(NIKKO CHEMICALS (股))1.0g,於75℃下加熱攪拌10分鐘(A相)。   將A相在緩慢攪拌下添加於B相,將所得之混合物於75℃中使用均質機(QUICK HOMO MIXER LR-1A、Mizuho工業股份公司製),以5,000rpm進行3分鐘乳化處理。然後,在室溫下攪拌冷卻至40℃,添加NIKKOL NET-813-1(NIKKO CHEMICALS(股))4.0g(C相),進行攪拌冷卻至35℃為止。   在以上步驟中,攪拌均以200rpm進行。[Comparative Example 5] 17 A powder foundation having a mass of 17% by mass was prepared in accordance with Table 5 below. In a 200 mL beaker (manufactured by HARIO Co., Ltd.), 34.0 g of fresh color base AQUA, 139.6 g of pure water, and sodium N-stearylmethyltaurine (NIKKOL SMT, NIKKO CHEMICALS (shares)) 0.2 g, lecithin (LPA, NIKKO CHEMICALS (stock)) 0.2 g, EDTA-2Na (pure chemical (stock)) 0.2 g, hydroxypropyl cellulose (NISSO SSL, Japan Soda (stock)) 0.4 g, 0.4 g of xanthan gum (KELTROL-CG-ST, tricrystal (strand)) was heated and stirred at 75 ° C for 10 minutes (phase B). In a 200 mL beaker (HARIO Co., Ltd.), add NIKKOL NIKKOMULESE41 (NIKKO CHEMICALS (stock)) 4.0g, NIKKOL NATURAL OILS (NIKKO CHEMICALS (stock)) 14.0g, NIKKOL NIKKOGUARD 88 (NIKKO CHEMICALS (stock)) 1.0g, Heat and stir at 75 ° C for 10 minutes (phase A).相 Add phase A to phase B with slow stirring, and use a homogenizer (QUICK HOMO MIXER LR-1A, manufactured by Mizuho Industrial Co., Ltd.) at 75 ° C. to perform an emulsification treatment at 5,000 rpm for 3 minutes. Then, it stirred-cooled to 40 degreeC at room temperature, 4.0 g (C phase) of NIKKOL NET-813-1 (NIKKO CHEMICALS (stock)) was added, and it stirred-cooled to 35 degreeC.搅拌 In the above steps, stirring was performed at 200 rpm.

圖5表示實施例9及比較例5之O/W粉底液,藉由偏光顯微鏡(Olympus(股)製)觀察(照片)而得之顏料分散性評價的結果。如圖5所示,在未調配含有Pal-GH之組成物[1]的比較例5中,觀察到許多顏料凝聚,結果分散性變不均勻,但是在調配有該組成物[1]之實施例9中,結果顏料之分散性改善。Fig. 5 shows the results of pigment dispersibility evaluation of the O / W foundation liquids of Example 9 and Comparative Example 5 obtained by observing (photographs) a polarizing microscope (manufactured by Olympus). As shown in FIG. 5, in Comparative Example 5 in which the composition [1] containing Pal-GH was not formulated, many pigments were observed to aggregate, and as a result, the dispersion became uneven, but implementation of the composition [1] As a result of Example 9, the dispersibility of the pigment was improved.

圖6表示粉底液調製後,靜置保存1個月後之實施例9及比較例5之O/W粉底液(外觀)。如圖6所示,在未調配含有Pal-GH之組成物[1]的比較例5中,觀察到顏料或油分之分離(圖中,觀察到分離之狀態為顏色不均),結果分散性變不均勻,但是在調配有該組成物[1]之實施例9中,結果顏料之分散性改善的結果。FIG. 6 shows the O / W liquid foundation (appearance) of Example 9 and Comparative Example 5 after the liquid foundation was prepared and left to stand for one month. As shown in FIG. 6, in Comparative Example 5 in which the composition [1] containing Pal-GH was not formulated, separation of pigment or oil was observed (in the figure, the state of separation was observed as color unevenness), and the dispersibility was obtained. It became uneven, but in Example 9 in which the composition [1] was formulated, the dispersibility of the pigment was improved as a result.

[圖1]圖1係表示實施例1至實施例3及比較例1所調製之顏料調配10質量%(實施例1、實施例2及比較例1)及顏料調配15質量%(實施例3)之粉底(Foundation)的外觀之圖。   [圖2]圖2係表示實施例4、實施例5及比較例2所調製之調配珠光顏料之分散液的外觀之圖。   [圖3]圖3係表示實施例6及比較例3所調製之調配磷酸三鈣之分散液的外觀之圖。   [圖4]圖4係表示實施例7、實施例8及比較例4所調製之調配金箔之分散液的外觀之圖。   [圖5]圖5表示實施例9及比較例5所調製之O/W粉底液(Liquid Foundation)之偏光顯微鏡的觀察結果(照片)圖。   [圖6]圖6表示實施例9及比較例5所調製之O/W粉底液之調製1個月後的外觀之圖。[Fig. 1] Fig. 1 shows 10% by mass of pigments prepared in Examples 1 to 3 and Comparative Example 1 (Example 1, Example 2 and Comparative Example 1) and 15% by mass of pigments (Example 3) ) Of the foundation (Foundation) of the picture. [Fig. 2] Fig. 2 is a diagram showing the appearance of a dispersion liquid prepared by blending pearlescent pigments prepared in Example 4, Example 5, and Comparative Example 2. [Fig. 3] Fig. 3 is a diagram showing the appearance of the dispersion liquid prepared with tricalcium phosphate prepared in Example 6 and Comparative Example 3. [FIG. 4] FIG. 4 is a diagram showing the appearance of a dispersion of gold foil prepared in Example 7, Example 8, and Comparative Example 4. FIG. [Fig. 5] Fig. 5 shows the observation results (photographs) of a polarizing microscope of the O / W foundation liquid (Liquid Foundation) prepared in Example 9 and Comparative Example 5. [Fig. 6] Fig. 6 is a diagram showing the appearance of the O / W foundation liquid prepared in Example 9 and Comparative Example 5 after one month of preparation.

Claims (9)

一種分散液,其係包含:   界面活性劑、   水、   由下述式(1)至式(3)表示之化合物或其醫藥上可使用之鹽之中之至少一種所成之脂質肽型化合物所構成的顏料或粉體用分散劑、   1,2-烷二醇或1,3-烷二醇、   至少一種的脂肪酸及   選自由顏料及粉體所組成之群組之至少一種,(式中,R1 表示碳原子數9至23之脂肪族基,R2 表示氫原子、或可具有碳原子數1或2之支鏈之碳原子數1至4的烷基,R3 表示-(CH2 )n-X基,n表示1至4之數,X表示胺基、胍基、-CONH2 基、或可具有1至3個氮原子之5員環或6員環或由5員環與6員環所構成的縮合雜環)(式中,R4 表示碳原子數9至23之脂肪族基,R5 至R7 各自獨立表示氫原子、可具有碳原子數1或2之支鏈的碳原子數1至4之烷基、或-(CH2 )n-X基,且R5 至R7 之中至少1個以上表示-(CH2 )n-X基,n表示1至4之數,X表示胺基、胍基、-CONH2 基、或可具有1至3個氮原子之5員環或6員環或由5員環與6員環所構成的縮合雜環)(式中,R8 表示碳原子數9至23之脂肪族基,R9 至R12 各自獨立表示氫原子、可具有碳原子數1或2之支鏈的碳原子數1至4之烷基、或-(CH2 )n-X基,且R9 至R12 之中至少1個以上表示-(CH2 )n-X基,n表示1至4之數,X表示胺基、胍基、-CONH2 基、或可具有1至3個氮原子之5員環或6員環或由5員環與6員環所構成的縮合雜環)。A dispersion liquid comprising: a surfactant, water, a lipid-peptide compound formed from at least one of a compound represented by the following formulae (1) to (3) or a pharmaceutically acceptable salt thereof A dispersant for pigment or powder, 1,2-alkanediol or 1,3-alkanediol, at least one fatty acid, and at least one selected from the group consisting of pigment and powder, (In the formula, R 1 represents an aliphatic group having 9 to 23 carbon atoms, R 2 represents a hydrogen atom or an alkyl group having 1 to 4 carbon atoms which may have a branched chain of 1 or 2 carbon atoms, and R 3 represents -(CH 2 ) nX group, n represents a number of 1 to 4, X represents an amine group, a guanidino group, a -CONH 2 group, or a 5-membered ring or a 6-membered ring or a 5-membered ring which may have 1 to 3 nitrogen atoms (Condensed heterocyclic ring consisting of 6-membered ring) (In the formula, R 4 represents an aliphatic group having 9 to 23 carbon atoms, and R 5 to R 7 each independently represent a hydrogen atom and an alkyl group having 1 to 4 carbon atoms which may have a branched chain having 1 or 2 carbon atoms. Or-(CH 2 ) nX group, and at least one of R 5 to R 7 represents a-(CH 2 ) nX group, n represents a number from 1 to 4, and X represents an amine group, a guanidino group, and -CONH 2 Or a 5-membered ring or 6-membered ring which may have 1 to 3 nitrogen atoms or a condensed heterocyclic ring composed of a 5-membered ring and a 6-membered ring) (In the formula, R 8 represents an aliphatic group having 9 to 23 carbon atoms, and R 9 to R 12 each independently represent a hydrogen atom and an alkyl group having 1 to 4 carbon atoms which may have a branched chain having 1 or 2 carbon atoms. Or-(CH 2 ) nX group, and at least one of R 9 to R 12 represents a-(CH 2 ) nX group, n represents a number of 1 to 4, X represents an amine group, a guanidino group, and -CONH 2 Or a 5-membered ring or 6-membered ring having 1 to 3 nitrogen atoms or a condensed heterocyclic ring composed of a 5-membered ring and a 6-membered ring). 如請求項1之分散液,其中前述選自由顏料及粉體所組成之群組之至少一種,基於分散液的總質量,含有25質量%以下之比率而成。For example, the dispersion liquid of claim 1, wherein the at least one selected from the group consisting of pigments and powders is based on the total mass of the dispersion liquid and contains a ratio of 25% by mass or less. 如請求項1或請求項2之分散液,其中前述顏料或粉體用分散劑,基於分散液之總質量,含有0.01質量%至1質量%之比率而成。For example, the dispersion liquid according to claim 1 or claim 2, wherein the aforementioned dispersant for pigment or powder contains a ratio of 0.01% by mass to 1% by mass based on the total mass of the dispersion. 如請求項1至請求項3中任一項之分散液,其係進一步含有多元醇。The dispersion according to any one of claims 1 to 3, further comprising a polyhydric alcohol. 如請求項4之分散液,其中前述多元醇為甘油。The dispersion of claim 4, wherein the aforementioned polyol is glycerin. 如請求項1至請求項5中任一項之分散液,其中前述界面活性劑為選自由乙二醇烷醚、磷脂質、聚甘油脂肪酸酯及聚氧乙烯聚氧丙烯烷醚所組成之群組之1種類以上的化合物。The dispersion according to any one of claim 1 to claim 5, wherein the aforementioned surfactant is selected from the group consisting of glycol alkyl ethers, phospholipids, polyglycerol fatty acid esters, and polyoxyethylene polyoxypropylene alkyl ethers. One or more compounds in the group. 如請求項1至請求項6中任一項之分散液,其中前述脂肪酸為硬脂酸。The dispersion according to any one of claim 1 to claim 6, wherein the fatty acid is stearic acid. 如請求項1至請求項7中任一項之分散液,其係化妝料用的分散液。The dispersion liquid according to any one of claim 1 to claim 7, which is a dispersion liquid for cosmetics. 一種顏料或粉體用分散劑,其係由下述式(1)至式(3)表示之化合物或其醫藥上可使用之鹽之中之至少一種所成之脂質肽型化合物所構成,(式中,R1 表示碳原子數9至23之脂肪族基,R2 表示氫原子、或可具有碳原子數1或2之支鏈之碳原子數1至4的烷基,R3 表示-(CH2 )n-X基,n表示1至4之數,X表示胺基、胍基、-CONH2 基、或可具有1至3個氮原子之5員環或6員環或由5員環與6員環所構成的縮合雜環)(式中,R4 表示碳原子數9至23之脂肪族基,R5 至R7 各自獨立表示氫原子、可具有碳原子數1或2之支鏈的碳原子數1至4之烷基、或-(CH2 )n-X基,且R5 至R7 之中至少1個以上表示-(CH2 )n-X基,n表示1至4之數,X表示胺基、胍基、-CONH2 基、或可具有1至3個氮原子之5員環或6員環或由5員環與6員環所構成的縮合雜環)(式中,R8 表示碳原子數9至23之脂肪族基,R9 至R12 各自獨立表示氫原子、可具有碳原子數1或2之支鏈的碳原子數1至4之烷基、或-(CH2 )n-X基,且R9 至R12 之中至少1個以上表示-(CH2 )n-X基,n表示1至4之數,X表示胺基、胍基、-CONH2 基、或可具有1至3個氮原子之5員環或6員環或由5員環與6員環所構成的縮合雜環)。A dispersant for pigments or powders, which is a lipopeptide compound formed from at least one of the compounds represented by the following formulae (1) to (3) or a pharmaceutically acceptable salt thereof, (In the formula, R 1 represents an aliphatic group having 9 to 23 carbon atoms, R 2 represents a hydrogen atom or an alkyl group having 1 to 4 carbon atoms which may have a branched chain of 1 or 2 carbon atoms, and R 3 represents -(CH 2 ) nX group, n represents a number of 1 to 4, X represents an amine group, a guanidino group, a -CONH 2 group, or a 5-membered ring or a 6-membered ring or a 5-membered ring which may have 1 to 3 nitrogen atoms (Condensed heterocyclic ring consisting of 6-membered ring) (In the formula, R 4 represents an aliphatic group having 9 to 23 carbon atoms, and R 5 to R 7 each independently represent a hydrogen atom and an alkyl group having 1 to 4 carbon atoms which may have a branched chain having 1 or 2 carbon atoms. Or-(CH 2 ) nX group, and at least one of R 5 to R 7 represents a-(CH 2 ) nX group, n represents a number from 1 to 4, and X represents an amine group, a guanidino group, and -CONH 2 Or a 5-membered ring or 6-membered ring which may have 1 to 3 nitrogen atoms or a condensed heterocyclic ring composed of a 5-membered ring and a 6-membered ring) (In the formula, R 8 represents an aliphatic group having 9 to 23 carbon atoms, and R 9 to R 12 each independently represent a hydrogen atom and an alkyl group having 1 to 4 carbon atoms which may have a branched chain having 1 or 2 carbon atoms. Or-(CH 2 ) nX group, and at least one of R 9 to R 12 represents a-(CH 2 ) nX group, n represents a number of 1 to 4, X represents an amine group, a guanidino group, and -CONH 2 Or a 5-membered ring or 6-membered ring having 1 to 3 nitrogen atoms or a condensed heterocyclic ring composed of a 5-membered ring and a 6-membered ring).
TW107112512A 2017-04-12 2018-04-12 a dispersion containing a pigment or a dispersant for powder TW201902451A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2017-079128 2017-04-12
JP2017079128 2017-04-12

Publications (1)

Publication Number Publication Date
TW201902451A true TW201902451A (en) 2019-01-16

Family

ID=63793228

Family Applications (1)

Application Number Title Priority Date Filing Date
TW107112512A TW201902451A (en) 2017-04-12 2018-04-12 a dispersion containing a pigment or a dispersant for powder

Country Status (3)

Country Link
JP (1) JPWO2018190383A1 (en)
TW (1) TW201902451A (en)
WO (1) WO2018190383A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113957730A (en) * 2021-12-13 2022-01-21 高阳县信誉印染有限公司 Printing and dyeing agent for fabric and printing and dyeing process thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6274440B2 (en) * 2012-06-25 2018-02-07 日産化学工業株式会社 Dispersion and hydrogel formation method
EP3087971B1 (en) * 2013-12-25 2019-06-12 Nissan Chemical Corporation Base material containing lipid-peptide compound
WO2016121822A1 (en) * 2015-01-28 2016-08-04 国立大学法人九州大学 Moisturizing base material including lipid-peptide compound
BR112017015958A2 (en) * 2015-01-28 2018-03-20 Nissan Chemical Industries Ltd transdermally absorbable base material containing lipid-peptide compound
JP6470614B2 (en) * 2015-03-31 2019-02-13 株式会社ナリス化粧品 Aqueous gel cosmetics
JP6254971B2 (en) * 2015-03-31 2017-12-27 株式会社ナリス化粧品 Solid cosmetics
CN107683128A (en) * 2015-06-24 2018-02-09 日产化学工业株式会社 The method for adjusting the hardness of the bar-shaped base material containing lipid peptide type compound
US20180200173A1 (en) * 2015-06-24 2018-07-19 Nissan Chemical Industries, Ltd. Stick-shaped base material comprising lipid peptide compound

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113957730A (en) * 2021-12-13 2022-01-21 高阳县信誉印染有限公司 Printing and dyeing agent for fabric and printing and dyeing process thereof

Also Published As

Publication number Publication date
JPWO2018190383A1 (en) 2020-02-27
WO2018190383A1 (en) 2018-10-18

Similar Documents

Publication Publication Date Title
TWI652107B (en) Method for forming dispersion and hydrogel
CN108635240B (en) Dispersion liquid and hydrogel forming method
KR102158165B1 (en) Hydrogel-forming material, premix, and hydrogel formation method
TWI650140B (en) Strip substrate containing lipid peptide type compound
EP3315138B1 (en) Stick-shaped substrate containing lipid-peptide-type compound
KR102319636B1 (en) Moisturizing base containing lipopeptide compound
WO2016121867A1 (en) Transdermally absorbable base material comprising lipid peptide-type compound
JP2015051961A (en) Percutaneous absorption substrate
KR102419538B1 (en) Thickened composition containing lipid peptide-type compound
KR102294367B1 (en) A method for adjusting the hardness of a stick-like substrate containing a lipopeptide compound
TW202137973A (en) Anti-pollution material
WO2016208442A1 (en) Stick-shaped substrate containing lipid-peptide-type compound
KR20200108447A (en) Composition containing powder
TW201834634A (en) Stick-shaped solid base material for external use on skin
TW201902451A (en) a dispersion containing a pigment or a dispersant for powder
TW201906594A (en) Polypeptide-containing rod substrate
JP2022189546A (en) Compositions that enhance lipid fluidization
TW201904612A (en) High water-containing rod-shaped substrate
KR20230098211A (en) Composition containing lipopeptide and sucrose ester
TW202137983A (en) Material for promoting penetration
JP2012020959A (en) Skin care external preparation having new optical effect